Sentence,class,file
"Nat Rev Cancer 2007;7:861-9; PMID:17943134; http://dx.doi.org/10.1038/nrc2248 63. van Vugt MA, Yaffe MB.",Non-OADS,/arxiv_data1/oa_pdf/2d/7d/kccy-15-01-1121326.PMC4825783.pdf
CellCycle 2010; 9:2097-101; PMID:20505366; http://dx.doi.org/10.4161/cc.9.11.11840 64.,OADS,/arxiv_data1/oa_pdf/2d/7d/kccy-15-01-1121326.PMC4825783.pdf
Cancer Cell 2005; 8:353-4; PMID:16286243; http://dx.doi.org/10.1016/j.ccr.2005.10.017 65.,OADS,/arxiv_data1/oa_pdf/2d/7d/kccy-15-01-1121326.PMC4825783.pdf
EMBO J 2010; 29:1272-84; PMID:20186124; http://dx.doi.org/10.1038/emboj.2010.11 66.,Non-OADS,/arxiv_data1/oa_pdf/2d/7d/kccy-15-01-1121326.PMC4825783.pdf
Cell Immunol 2010; 260:75-82; PMID:19917503; http://dx.doi.org/10.1016/j.cellimm.2009.10.006 69.,OADS,/arxiv_data1/oa_pdf/2d/7d/kccy-15-01-1121326.PMC4825783.pdf
J Transl Med 2013; 11:56; PMID:23510656; http://dx.doi.org/10.1186/1479-5876-11-56 70.,Non-OADS,/arxiv_data1/oa_pdf/2d/7d/kccy-15-01-1121326.PMC4825783.pdf
Expert Opin Biol Ther 2013; 13:1387-400; PMID:23930703; http://dx.doi.org/ 10.1517/14712598.2013.826187 71.,Non-OADS,/arxiv_data1/oa_pdf/2d/7d/kccy-15-01-1121326.PMC4825783.pdf
Cell and Tissue Biol 2012; 6:1-11; PMID:22359950; http://dx.doi.org/10.1134/ S1990519X12010129 72.,Non-OADS,/arxiv_data1/oa_pdf/2d/7d/kccy-15-01-1121326.PMC4825783.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/82/93/amep-7-233.PMC4825817.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/82/93/amep-7-233.PMC4825817.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 233–240Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.com Dove press 233 O R I G I N A L  R E S E A R C Hopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/AMEP .S99447Student and staff experiences of attendance  monitoring in undergraduate obstetrics and  gynecology: a cross-sectional survey Richard P Deane   Deirdre J Murphy Department of Obstetrics and  Gynaecology, Trinity College Dublin,  The University of Dublin, Coombe  Women & Infants University Hospital,  Dublin, Republic of IrelandBackground:  Despite the widespread introduction of active learning strategies to engage stu - dents across modern medical curricula, student attendance and attendance monitoring remain a  challenging issue for medical educators.",Non-OADS,/arxiv_data1/oa_pdf/82/93/amep-7-233.PMC4825817.pdf
"For medical students, attendance is an important factor in developing clinical com - petence with evidence that attendance during clinical rotations correlates positively Correspondence: Richard P Deane   Department of Obstetrics and  Gynaecology, Trinity College Dublin,   The University of Dublin, Coombe  Women & Infants University Hospital,  Dublin 8, Republic of Ireland   Tel +353 1 408 5365 Email deaneri@tcd.ieJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCH Y ear: 2016 V olume: 7 Running head verso: Deane and Murphy Running head recto: Monitoring of student attendance within clinical rotations DOI: http://dx.doi.org/ 10.2147/AMEP .S99447",Non-OADS,/arxiv_data1/oa_pdf/82/93/amep-7-233.PMC4825817.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-   reviewed, open access journal that aims to present and publish research   on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/82/93/amep-7-233.PMC4825817.pdf
Visit http://www.dovepress.com/testimonials.php to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/93/amep-7-233.PMC4825817.pdf
Available from: http://www.gmc-uk.org/Medical_students___ professional_values_and_fitness_to_practise_1114.pdf_48905163.pdf.,Non-OADS,/arxiv_data1/oa_pdf/82/93/amep-7-233.PMC4825817.pdf
Available from: http://telepen.co.uk/ student-attendance-system/.,Non-OADS,/arxiv_data1/oa_pdf/82/93/amep-7-233.PMC4825817.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d0/2b/amep-7-219.PMC4825818.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d0/2b/amep-7-219.PMC4825818.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 219–231submit your manuscript | www.dovepress.com Dove press  219 http: //dx.doi.org/10.2147/AMEP .S76976Advances in Medical Education and Practice Dove press R E V I E Wopen access to scientific and medical research Open Access Full T ext Article Diagnosing COPD: advances in training and  practice – a systematic review Vladimir Koblizek1,2 Barbora Novotna1–3 Zuzana Zbozinkova3 Karel Hejduk3 1Department of Pneumology,  University Hospital Hradec Kralove,   Hradec Králové, Czech Republic;  2Faculty of Medicine in Hradec  Kralove, Charles University in Prague,  Hradec Králové, Czech Republic;  3Institute of Biostatistics and  Analyses, Faculty of Medicine, Masaryk  University, Brno, Czech RepublicAbstract:  Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung  syndrome, caused by long-term inhalation of noxious gases and particles, which leads to gradual  airflow limitation.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/amep-7-219.PMC4825818.pdf
"The traditional medical terms chronic bronchitis and  emphysema are now part of the COPD diagnosis, as most COPD subjects encountered  in practice share both of these features.1–3 The most common symptoms of COPD are Correspondence: Vladimir Koblizek Department of Pneumology, University  Hospital Hradec Kralove, Charles  University in Prague, Faculty of Medicine  in Hradec Kralove, Sokolska 581, 500 05  Hradec Králové, Czech Republic   Tel +420 495 834 771 Email vladimir.koblizek@fnhk.czJournal name: Advances in Medical Education and Practice Article Designation: REVIEW Y ear: 2016 V olume: 7 Running head verso: Koblizek et al Running head recto: Diagnosing COPD DOI: http://dx.doi.org/10.2147/AMEP .S76976",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/amep-7-219.PMC4825818.pdf
Available from: http://www.goldcopd.org/uploads/users/files/ GOLD_Report_2014_Jun11.pdf.,OADS,/arxiv_data1/oa_pdf/d0/2b/amep-7-219.PMC4825818.pdf
Available from:  http://www.who.int/respiratory/copd/en/.,Non-OADS,/arxiv_data1/oa_pdf/d0/2b/amep-7-219.PMC4825818.pdf
Available from: http://www.nice.org.uk/CG101.,Non-OADS,/arxiv_data1/oa_pdf/d0/2b/amep-7-219.PMC4825818.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-   reviewed, open access journal that aims to present and publish research   on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/d0/2b/amep-7-219.PMC4825818.pdf
Visit http://www.dovepress.com/testimonials.php to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/2b/amep-7-219.PMC4825818.pdf
"2, 196 –212 http://dx.doi.org/10.1080/15384101.2015.1120925",Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nature 2013; 502:333-9; http://dx.doi.org/10.1038/nature12634 2.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2013; 155:369-83; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Oncogene 2014; 33:1890-903; http://dx.doi.org/10.1038/ onc.2013.137 5.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Rev Mol Cell Biol 2008; 9:713-24; http://dx.doi.org/10.1038/nrm2469 6.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 1999; 13:1501-12; http://dx.doi.org/10.1101/gad.13.12.1501 7.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Biochim Biophys Acta 2014; 1843:150-62; http://dx.doi.org/10.1016/j.bbamcr.2013.02.028 8.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
PLoS Biol 2006; 4:e83; http://dx.doi.org/10.1371/journal.pbio.0040083 9.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Science 2008; 321:1095-100; http://dx.doi.org/10.1126/science.1155998 10.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
PLoS Genet 2011; 7:e1002362; http://dx.doi.org/ 10.1371/journal.pgen.1002362 12.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Dev Biol 1987; 121:10-9; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Onco- gene 2005; 24:2877-98; http://dx.doi.org/10.1038/sj.onc.1208608 15.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Stem Cell Res 2007; 1:45-60; http://dx.doi.org/10.1016/j.scr.2007.09.002 16.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell Cycle 2010; 9:1893-900; http://dx.doi.org/10.4161/cc.9.10.11598 17.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Oncogene 2002; 21:8320-33; http://dx.doi.org/10.1038/sj.onc.1206015 18.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Stem Cells Dev 2013; 22:279-95; http://dx.doi.org/10.1089/scd.2012.0168 19.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Stem Cell Res 2013; 10:118-31; http://dx.doi.org/ 10.1016/j.scr.2012.10.004 20.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Stem Cells 2012; 30:1097-108; http://dx.doi.org/10.1002/ stem.1078 21.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell Stem Cell 2009; 5:320-31; http://dx.doi.org/10.1016/j.stem.2009.05.026 22.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
J Cell Sci 2003; 116:4947-55; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2013; 155:135-47; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 2012; 26:2673-83; http://dx.doi.org/10.1101/ gad.207415.112 25.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Rev Mol CellBiol 2011; 12:349-61; http://dx.doi.org/10.1038/nrm3118 26.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Dev Cell 2014;28:225-38; http://dx.doi.org/10.1016/j.devcel.2013.12.020 27.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Proc Natl Acad Sci U S A 1989; 86:5434-8; http://dx.doi.org/ 10.1073/pnas.86.14.5434 28.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Science 1995; 267:1022-4; http://dx.doi.org/10.1126/ science.7863328 29.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell Biol 1994; 14:5259-67; http://dx.doi.org/ 10.1128/MCB.14.8.5259 30.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
J Biol Chem 1997; 272:791-7; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
EMBO J 1999; 18:6983-93; http://dx.doi.org/10.1093/emboj/18.24.6983 32.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell Biol 2015; 35:1633-47; http://dx.doi.org/10.1128/MCB.01461-14 33.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 2002;16:1792-805; http://dx.doi.org/10.1101/gad.U-9988R 34.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell Biol 1999; 19:3167-76.http://dx.doi.org/10.1128/MCB.19.4.3167 35.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell Biol 1999; 19:7621-9; http://dx.doi.org/10.1128/MCB.19.11.7621 36.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Exp Cell Res 2000; 259:300-7; http://dx.doi.org/10.1006/excr.2000.4973 37.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell Biol1998; 18:4994-9; http://dx.doi.org/10.1128/MCB.18.9.4994 38.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 2015; 29:513-25; http://dx.doi.org/10.1101/gad.254532.114 39.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Rev Neurosci 2007; 8:438-50; http://dx.doi.org/10.1038/nrn2097 40.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Rev Genet 2001; 2:120-9; http://dx.doi.org/10.1038/35052535 41.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
EMBO Rep 2014; 15:351-64;http://dx.doi.org/10.1002/embr.201438447 42.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Neuroscience 2013; 253:256-73; http://dx.doi.org/10.1016/j.neuroscience.2013.08.029 43.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Trends Genet TIG 2014; 30:254-61; http://dx.doi.org/ 10.1016/j.tig.2014.04.001 46.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Cell Biol 2005; 7:56- 62; http://dx.doi.org/10.1038/ncb1203 48.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Dev Biol 2010; 337:415-24; http://dx.doi.org/10.1016/j.ydbio.2009.11.012 49.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
PloS One 2007; 2:e407; http://dx.doi.org/10.1371/journal.pone.0000407 50.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
PLoS Genet 2011; 7:e1001348; http://dx.doi.org/10.1371/journal.pgen.1001348 51.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Dev Cell 2009; 17:355-64; http://dx.doi.org/ 10.1016/j.devcel.2009.08.003 53.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
EMBO Rep 2001; 2:27-34; http://dx.doi.org/10.1093/embo-reports/ kve008CELL CYCLE 209,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
"Korenjak M, Brehm A. E2F-Rb complexes regulating transcrip- tion of genes important for differentiation and development.Curr Opin Genet Dev 2005; 15:520-7; http://dx.doi.org/10.1016/j.gde.2005.07.001 55.",OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nature 2004; 432:1040-5; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
"Busanello A, Battistelli C, Carbone M, Mostocotto C, Maione R. MyoD regulates p57kip2 expression by interacting with a distant cis-element and modifying a higher order chromatin structure.Nucleic Acids Res 2012; 40:8266-75; http://dx.doi.org/10.1093/nar/gks619 58.",Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Science 1995; 267:1018-21; http://dx.doi.org/10.1126/science.7863327 59.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Science 1995; 267:1024-7; http://dx.doi.org/10.1126/science.7863329 60.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Dev Cell 2010; 18:662-74; http://dx.doi.org/ 10.1016/j.devcel.2010.02.014 61.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 1999; 13:213-24; http://dx.doi.org/10.1101/ gad.13.2.213 62.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell Cycle 2010; 9:1972-80; http://dx.doi.org/10.4161/cc.9.10.11602 63.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell Biol 2010; 30:2811-22; http://dx.doi.org/10.1128/MCB.01016-09 64.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell Biol 2012; 32:2596-607; http://dx.doi.org/10.1128/MCB.06745-11 66.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Rev Genet 2014; 15:93-106; http://dx.doi.org/10.1038/nrg3607 67.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Adv Cancer Res 2001; 82:1-54; http://dx.doi.org/10.1016/S0065-230X(01)82001-7 68.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 2003; 17:2308-20; http://dx.doi.org/ 10.1101/gad.1116703 69.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Protein Cell 2011; 2:864-78; http://dx.doi.org/ 10.1007/s13238-011-1117-z 70.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Rev Cancer 2013; 13:585-95; http://dx.doi.org/10.1038/nrc3556 71.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell Cycle 2012; 11:3189-98; http://dx.doi.org/10.4161/cc.21263 72.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
J Biol Chem2007; 282:20116-23; http://dx.doi.org/10.1074/jbc.M701406200 73.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genetics 2004; 167 :1177-85; http://dx.doi.org/ 10.1534/genetics.103.024554 74.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2015; 162:300-13; http://dx.doi.org/10.1016/j.cell.2015.06.013 75.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nature 2001; 412:561-5; http://dx.doi.org/10.1038/35087620 77.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2007; 129:915-28; http://dx.doi.org/10.1016/j.cell.2007.03.048 78.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2004; 119:181-93; http://dx.doi.org/10.1016/j.cell.2004.09.034 79.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genetics 2007; 176:255- 71; http://dx.doi.org/10.1534/genetics.106.069633 81.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell2007; 26:539-51; http://dx.doi.org/10.1016/j.molcel.2007.04.015 82.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 2004; 18:2929-40; http://dx.doi.org/10.1101/gad.1255204 83.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Proc Natl AcadSci U S A 2014; 111:E4234-43; http://dx.doi.org/10.1073/ pnas.1416321111 84.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Curr Biol CB 2002; 12:906-11; http://dx.doi.org/10.1016/S0960-9822(02)00844-8 85.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2007; 128:735-45; http://dx.doi.org/10.1016/j.cell.2007.02.009 88.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Rev Mol Cell Biol 2011; 12:799-814; http://dx.doi.org/ 10.1038/nrm3230 89.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell Stem Cell 2014; 14:735-51; http://dx.doi.org/10.1016/j.stem.2014.05.006 90.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2002; 111:197-208; http://dx.doi.org/10.1016/S0092-8674 (02)00976-5210 S. RUIJTENBERG AND S. VAN DEN HEUVEL,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell Stem Cell2008; 2:437-47; PMID:18462694; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2006; 125:315-26; PMID:16630819; http://dx.doi.org/10.1016/j.cell.2006.02.041 93.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 2013; 27:1318-38; PMID:23788621; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nature 1999; 397:164- 8; PMID:9923679; http://dx.doi.org/10.1038/16476 95.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell Cycle 2014; 5:1189- 97; http://dx.doi.org/10.4161/cc.5.11.2781 96.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 2006; 20:1123-36; PMID:16618801;http://dx.doi.org/10.1101/gad.381706 98.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nature 2007; 448:553-60; PMID:17603471; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Neuron 2009; 63:600-13; PMID:19755104; http://dx.doi.org/ 10.1016/j.neuron.2009.08.021 100.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nature 2009; 458:529-33; PMID:19212323; http://dx.doi.org/10.1038/nature07726 101.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Genes Dev 2004; 18:2627-38;PMID:15520282; http://dx.doi.org/10.1101/gad.1241904 102.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
J Cell Biol 2007; 179:1399-412; PMID:18166651; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Proc Natl Acad Sci U S A 2011; 108:E149-58; PMID:21551099; http://dx.doi.org/ 10.1073/pnas.1102223108 104.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell Rep 2012; 2:1178-86; PMID:23103163; http://dx.doi.org/10.1016/j.celrep.2012.09.020 105.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Genet 2013; 45:592- 601; PMID:23644491; http://dx.doi.org/10.1038/ng.2628 106.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Clin Cancer Res 2014; 20:21-7; http://dx.doi.org/10.1158/1078-0432.CCR-13-0280107.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Rev Cancer 2011; 11:481-92; PMID:21654818; http://dx.doi.org/10.1038/nrc3068 108.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 1998; 95:717-28; PMID:9845373;http://dx.doi.org/10.1016/S0092-8674(00)81641-4 109.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell1999; 3:247-53; PMID:10078207; http://dx.doi.org/10.1016/S1097-2765(00)80315-9 110.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nature 2004; 432:107-12; PMID:15525990; http://dx.doi.org/10.1038/nature03071 112.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell Biol 2005; 25:3997-4009; PMID:15870273;http://dx.doi.org/10.1128/MCB.25.10.3997-4009.2005 113.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
EMBO J 2012; 31:301-16; PMID:22068056; http://dx.doi.org/10.1038/emboj.2011.391 114.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cell Biol 2008; 28:3457-64; PMID:18332116; http://dx.doi.org/10.1128/MCB.02019-07 115.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cancer Cell 2010; 18:316-28;PMID:20951942; http://dx.doi.org/10.1016/j.ccr.2010.09.006 116.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Reexpres- sion of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism.Cancer Res 2010; 70:1854-65; PMID:20179200; http://dx.doi.org/ 10.1158/0008-5472.CAN-09-1922 117.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Mol Cancer Res MCR 2013; 11:251-60; PMID:23364536; http://dx.doi.org/ 10.1158/1541-7786.MCR-12-0390 118.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Biochem J 2011; 434:83-92;PMID:21118156; http://dx.doi.org/10.1042/BJ20101358 119.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2014;156:1259-73; PMID:24630726; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Cell Biol 2013; 15:491-501; PMID:23604319; http://dx.doi.org/10.1038/ncb2720 121.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2000; 101:79-89; PMID:10778858; http://dx.doi.org/10.1016/S0092-8674(00)80625-XCELL CYCLE 211,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
J Biol Chem 2009; 284:10067-75; PMID:19144648; http://dx.doi.org/10.1074/jbc.M808782200 123.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
J CellBiol 2010; 191:809-25; PMID:21059851; http://dx.doi.org/10.1083/ jcb.201003048 124.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2008; 132:567-82;PMID:18295576; http://dx.doi.org/10.1016/j.cell.2008.01.015 126.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2007; 131:378-90; PMID:17956737; http://dx.doi.org/10.1016/j.cell.2007.09.036 128.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Dev Cell 2007; 12:631-43;PMID:17419999; http://dx.doi.org/10.1016/j.devcel.2007.02.020 129.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
J Cell Biol 2010; 189:981-96; PMID:20548101;http://dx.doi.org/10.1083/jcb.200910006 130.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Science 2011; 331:1078-80; PMID:21350179;http://dx.doi.org/10.1126/science.1200708 131.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nature 2013; 497:249-53; PMID:23594737;http://dx.doi.org/10.1038/nature12054 132.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Struct Mol Biol 2007; 14:1150-6; PMID:18026121; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/ 10.1016/j.cell.2011.02.013134.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
J Cell Biol 1995; 131:227-34;PMID:7559779; http://dx.doi.org/10.1083/jcb.131.1.227 136.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Nat Rev Immunol2007; 7:105-17; PMID:17259967; http://dx.doi.org/10.1038/nri2024 138.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
On cogene 2015. http://www.nature.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
com.proxy.library.uu.nl/onc/j ournal/vaop/ncurrent/full/ onc2015195a.html; http://dx.doi.org/10.1038/onc.2015.195 139.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
PLoS ONE 2013; 8:e55119; PMID:23355908; http://dx.doi.org/10.1371/journal.pone.0055119 140.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Cancer Genet 2014; 207:365-72; PMID:24853101; http://dx.doi.org/10.1016/j.cancergen.2014.04.004 141.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Oncogene 2006; 25:722-34; PMID:16302003; http://dx.doi.org/10.1038/sj.onc.1209112 142.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Anticancer Drugs 2010; 21:514-22; PMID:20147838; http://dx.doi.org/10.1097/CAD.0b013e3283375d5c 143.,Non-OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Proc Natl Acad Sci U S A2011; 108:319-24; PMID:21173237; http://dx.doi.org/10.1073/ pnas.0913297108 144.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
Proc Natl Acad Sci U S A 2005; 102:12129-34; PMID:16099835; http://dx.doi.org/10.1073/ pnas.0505300102 145.,OADS,/arxiv_data1/oa_pdf/ba/3c/kccy-15-02-1120925.PMC4825819.pdf
"These resultsshow that the genes encoded by the E. coliKeywords: biobased plastic, Escherichia coli, polyhydroxyalkanoate, polyhydroxy- butyrate, poly(lactic acid), sigma factor © Ryosuke Kadoya, Yu Kodama, Ken ’ichiro Matsu- moto, and Seiichi Taguchi *Correspondence to: Seiichi Taguchi; Email: staguchi @eng.hokudai.ac.jp Submitted: 06/08/2015Revised: 06/28/2015Accepted: 06/30/2015 http://dx.doi.org/10.1080/21655979.2015.1069449 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
"22As the result, no gene was found to be related to lactic acid production according to the COGs category (http:// www.ncbi.nlm.nih.gov/COG/) ( Table 2 ) and KEGG pathway (http://www.genome.jp/).",OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Biomacromolecules 2006; 7:2249-58; PMID:16903667; http://dx.doi.org/ 10.1021/bm060317c 2.,Non-OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Curr OpinBiotechnol 2013; 24:1054-60; PMID:23545442; http://dx.doi.org/10.1016/j.copbio.2013.02.021 3.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Biomacromolecules 2010; 11:815-9; PMID:20166718; http://dx.doi.org/10.1021/bm901437z 4.,Non-OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
FEMS Microbiol Rev 1998; 22:127-50; PMID:9818380;http://dx.doi.org/10.1111/j.1574-6976.1998.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Mol Microbiol 1991; 5:49-59; PMID:1849609; http://dx.doi.org/10.1111/j.1365- 2958.1991.tb01825.x15.,Non-OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Proc Natl Acad Sci U S A 1989; 86:830-4; PMID:2644646; http://dx.doi.org/10.1073/ pnas.86.3.830 17.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Curr Opin Microbiol 2003; 6:173-80; PMID:12732308; http://dx.doi.org/10.1016/S1369- 5274(03)00022-5 18.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Metab Eng 2013; 15:159-66; PMID:23202750; http://dx.doi.org/10.1016/j.ymben.2012.11.007 20.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
DNA Res 2005; 12:291-9;PMID:16769691; http://dx.doi.org/10.1093/dnares/ dsi012 21.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Nucleic Acids Res 2010; 38:1273-83; PMID:19969540; http://dx.doi.org/10.1093/nar/ gkp1123 22.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Nucleic Acids Res 2007; 35:288-98; PMID:17170009; http://dx.doi.org/10.1093/nar/gkl1018 23.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
DNA Res 2013; 20:525-35; PMID:23861321; http://dx.doi.org/10.1093/dnares/ dst028 24.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Appl Micro- biol Biotechnol 2014; 98:2453-60; PMID:24337250; http://dx.doi.org/10.1007/ s00253-013-5401-0 25.,Non-OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
PLoS One 2015; 10:e0125163;PMID:26039058; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/24/54/kbie-06-05-1069449.PMC4825821.pdf
Nat Cell Biol 2015; 17(10):1327-38; PMID: 26389665; http://dx.doi.org/10.1038/ncb3240.,OADS,/arxiv_data1/oa_pdf/41/0d/kccy-15-02-1118908.PMC4825903.pdf
"2, 156 –157 http://dx.doi.org/10.1080/15384101.2015.1118908",Non-OADS,/arxiv_data1/oa_pdf/41/0d/kccy-15-02-1118908.PMC4825903.pdf
Science 2013; 339 (6122):959-961; PMID:23348503; http://dx.doi.org/10.1126/science.1230062 3.,Non-OADS,/arxiv_data1/oa_pdf/41/0d/kccy-15-02-1118908.PMC4825903.pdf
"Li Y, Tergaonkar V. Cancer Res 2014; 74(6):1639-44; PMID:24599132; http://dx.doi.org/10.1158/0008-5472.CAN-13-3568 5.",Non-OADS,/arxiv_data1/oa_pdf/41/0d/kccy-15-02-1118908.PMC4825903.pdf
J Clin Invest 2015; 125(5):2109-22; PMID:25893605; http://dx.doi.org/10.1172/JCI79134 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/41/0d/kccy-15-02-1118908.PMC4825903.pdf
"Soc., 2012, 71, 478-487. http://dx.doi.org/ 10.1017/S0029665112000602 [3] la Fleur, S.E.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Metab., 2014, 28, 649-659. http://dx.doi.org/10.1016/j.beem.2014.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2015, 69, 40-46. http://dx.doi.org/10.1038/ejcn.2014.139 [5] Lanfer, A.; Knof, K.; Barba, G.; Veidebaum, T.; Papoutsou, S.; de Henauw, S.; Soós, T.; Moreno, L.A.; Ahrens, W.; Lissner, L. Taste preferences in association with dietary habits and weight status in European children: results from the IDEFICS study.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obes., 2012, 36, 27-34. http://dx.doi.org/10.1038/ijo.2011.164 [6] Sampey, B.P.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obesity, 2011, 19, 1109-1117. http://dx.doi.org/10.1038/oby.2011.18 [7] la Fleur, S.E.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obes., 2014, 38, 643-649. http://dx.doi.org/10.1038/ijo.2013.159",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Med., 2012, 42, 563-570. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obes., 2013, 37, 889-891. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2010, 92, 1257-1264. http://dx.doi.org/10.3945/ajcn.2010.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"J., 2009, 3, 132-138. http://hsj.gr/medicine/obesity-disease.pdf (Accessed June 16, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 2007, 17, 253-275. http://dx.doi.org/10.1016/S0731-2199(06)17010-7 [16] Field, A.E.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pediatrics, 2003, 112, 900-906. http://dx.doi.org/10.1542/peds.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"J., 2011, 10, 9. http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1186/1475-2891-10-9 [18] Ramos-Leví, A.M.; Rubio Herrera, M.A.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2014, 61, 35-46. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Surg., 2014, 31, 6-12. http://dx.doi.org/ 10.1159/000351440 [20] Sesti, G.; Folli, F.; Perego, L.; Hribal, M.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3050899/pdf/pone.0017737.pdf (Accessed June 16, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Diabetes Rev., 2014, 10, 208-214. http://dx.doi.org/10.2174/1573399810666140616144141 [22] Edholm, D.; Näslund, I.; Anders Karlsson, F.; Rask, E.; Sundbom, M. Twelve-year results for revisional gastric bypass after failed restrictive surgery in 131 patients.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Dis., 2014, 10, 44-48. http://dx.doi.org/10.1016/j.soard.2013.05.011 [23] Stein, J.; Stier, C.; Raab, H.; Weiner, R. Review article: the nutritional and pharmacological consequences of obesity surgery.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Ther., 2014, 40, 582-609. http://dx.doi.org/ 10.1111/apt.12872 [24] Shimizu, H.; Annaberdyev, S.; Motamarry, I.; Kroh, M.; Schauer, P.R.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Surg., 2013, 23, 1766-1773. http://dx.doi.org/10.1007/s11695-013-1012-1 [25] Mala, T. Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Dis., 2014, 10, 1220-1225. http://dx.doi.org/10.1016/j.soard.2014.01.010 [26] McKenna, D.; Selzer, D.; Burchett, M.; Choi, J.; Mattar, S.G. Revisional bariatric surgery is more effective for improving obesity-related co-morbidities than it is for reinducing major weight loss.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Dis., 2014, 10, 952-972. http://dx.doi.org/10.1016/j.soard.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Surg., 2013, 8, 58. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923426/pdf/1749-7922-8-58.pdf (Accessed June 16, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1186/ 1749-7922-8-58 [29] Rui, L. Brain regulation of energy balance and body weight.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Disord., 2013, 14, 387-407. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1530/JOE-13-0398 [31] Chambers, A.P.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1016/j.cub.2013.03.020 [32] Näslund, E.; Hellström, P.M. Appetite signaling: from gut peptides and enteric nerves to brain.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2007, 92, 256-262. http://dx.doi.org/10.1016/j.physbeh.2007.05.017 [33] Neunlist, M.; Schemann, M. Nutrient-induced changes in the phenotype and function of the enteric nervous system.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Physiol., 2014, 592, 2959-2965. http://dx.doi.org/10.1113/jphysiol.2014.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinol., 2014, 5, 58. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4005944/pdf/fendo-05-00058.pdf (Accessed June 16, 2015).",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.3389/fendo.2014.00058 [35] Egecioglu, E.; Skibicka, K.P.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Disord., 2011, 12, 141-151. http://dx.doi.org/10.1007/s11154-011-9166-4 [36] Berridge, K.C.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2010, 1350, 43-64. http://dx.doi.org/ 10.1016/j.brainres.2010.04.003 [37] Castro, D.C.; Cole, S.L.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2015, 9, 90. http://www.ncbi.nlm.nih.gov/",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.3389/fnsys.2015.00090 [38] Olszewski, P.K.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Rev., 2008, 32, 945-956. http://dx.doi.org/10.1016/j.neubiorev.2008.01.007 [39] Williams, D.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2014, 136, 194-199. http://dx.doi.org/10.1016/j.physbeh.2014.03.013 [40] Delaere, F.; Akaoka, H.; De Vadder, F.; Duchampt, A.; Mithieux, G. Portal glucose influences the sensory, cortical and reward systems in rats.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2013, 38, 3476-3486. http://dx.doi.org/ 10.1111/ejn.12354 [41] Burger, K.S.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2014, 136, 121-127. http://dx.doi.org/10.1016/j.physbeh.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroimage, 2010, 50, 1560-1565. http://dx.doi.org/10.1016/ j.neuroimage.2010.01.065 [43] Figlewicz, D. P.; Bennett-Jay, J. L.; Kittleson, S.; Sipols, A. J.; Zavosh, A. Sucrose self-administration and CNS activation in the rat.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/ 10.1152/ajpregu.00655.2010 [44] Kirkham, T.C.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"231-253. http://dx.doi.org/10.1007/978-3-540-88955-7_9 [45] Kanoski, S.E.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2012, 106, 337-344. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2012, 107, 527-532. http://dx.doi.org/10.1016/j.physbeh.2012.04.004 [49] Pickering, C.; Alsiö, J.; Hulting, A.L.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2009, 204, 431-443. http://dx.doi.org/10.1007/s00213-009-1474-y [50] Burton, P.; Smit, H.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2007, 49, 191-197. http://dx.doi.org/10.1016/j.appet.2007.01.007 [51] Alsiö, J.; Olszewski, P.K.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroendocrinol., 2012, 33, 127-139. http://dx.doi.org/10.1016/j.yfrne.2012.01.002 [52] Ransleyb, J.K.; Donnellya, J.K.; Bothama, H.; Kharaa, T.N.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2003, 41, 141-148. http://dx.doi.org/ 10.1016/S0195-6663(03)00051-5 [53] De Silva, A.; Salem, V.; Matthews, P.M.; Dhillo, W.S.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Diabetes Res., 2012, 2012, 764017. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3376546/ (Accessed October 13, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroimage Clin., 2015, 8, 1-31. http://dx.doi.org/10.1016/ j.nicl.2015.03.016 [55] Avena, N.M.; Rada, P.; Hoebel, B.G.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropharmacology, 2011, 61, 109-122. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Rev., 2014, 47, 295-306. http://dx.doi.org/10.1016/ j.neubiorev.2014.08.016 [58] Rolls, E.T.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurobiol., 2015, 127-128, 64-90. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"JAMA Pediatr., 2014, 168, 338-344. http://dx.doi.org/10.1001/ jamapediatrics.2013.4944 [61] Journel, M.; Chaumontet, C.; Darcel, N.; Fromentin, G.; Tomé, D. Brain responses to high-protein diets.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2012, 3, 322-329. http://dx.doi.org/10.3945/an.112.002071 [62] Simpson, S.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Rev., 2005, 6, 133-142. http://dx.doi.org/ 10.1111/j.1467-789X.2005.00178.x [63] Krebs, J.R.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2013, 97, 677-688. http://dx.doi.org/10.3945/ ajcn.112.053116 [65] Alkerwi, A.; Sauvageot, N.; Buckley, J.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Public Health Nutr., 2015, 22, 1-8. http://dx.doi.org/10.1017/s1368980014002596 [66] Smith, J.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2015, 101, 1216-1224. http://dx.doi.org/10.3945/ajcn.114.100867 [67] Di Marzo, V.; Ligresti, A.; Cristino, L. The endocannabinoid system as a link b e t w e e n  h o m o e o s t a t i c  a n d  h e d o n i c  p a t h w a y s  involved in energy balance regulation.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1038/ijo.2009.67 [68] Silvestri, C.; Di Marzo, V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Cell Metab., 2013, 17, 475-490. http://dx.doi.org/10.1016/j.cmet.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Biofactor, 2014, 40, 389-397. http://dx.doi.org/10.1002/biof.1168 [70] Jager, G.; Witkamp, R.F.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"2014, 27, 172-185. http://dx.doi.org/10.1017/S0954422414000080 [71] Escartín-Pérez, R.E.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2009, 96, 646-650. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Biol., 2013, 24, 226-231. http://dx.doi.org/ 10.1016/j.semcdb.2012.08.004 [73] Simiand, J.; Keane, M.; Keane, P.E.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"2    133 Behav., 2007, 86, 766-773. http://dx.doi.org/10.1016/j.pbb.2007.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1186/1475-2891-11-50 [76] Horder, J.; Harmer, C.; Cowen, P.; McCabe, C. Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropsychopharmacol., 2010, 13, 1103-1113. http://dx.doi.org/ 10.1017/S1461145710000453 [77] Mathes, C.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1152/ajpregu.00150.2008 [78] Arnone, M.; Maruani, J.; Chaperon, F.; Thiébot, M.H.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 1997, 132, 104-106. http://dx.doi.org/10.1007/s002130050326 [79] Droste, S.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2010, 95, 443-448. http://dx.doi.org/10.1016/j.pbb.2010.03.005 [80] Ward, S.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Ther., 2008, 325, 567-576. http://dx.doi.org/ 10.1124/jpet.107.131771 [81] Mancino, S.; Burokas, A.1.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2014, 25, 53-60. http://dx.doi.org/10.1097/FBP.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2009, 20, 605-613. http://dx.doi.org/10.1097/FBP.0b013e328331ba30 [85] Mathes, C.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2009, 94, 119-123. http://dx.doi.org/10.1016/ j.pbb.2009.07.016 [86] Brand, T.; Spanagel, R.; Schneider, M. Decreased reward sensitivity in rats from the Fischer344 strain compared to Wistar rats is paralleled by differences in endocannabinoid signaling.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3275578/pdf/pone.0031169.pdf (Accessed June 16, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1371/journal.pone.0031169 [87] Le Merrer, J.; Becker, J.A.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Rev., 2009, 89, 1379-1412. http://dx.doi.org/10.1152/physrev.00005.2009 [88] Nogueiras, R.; Romero-Picó, A.; Vazquez, M.J.; Novelle, M.G.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Facts., 2012, 19, 196-207. http://dx.doi.org/10.1159/000338163 [89] Taha, S.A.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2010, 100, 429-437. http://dx.doi.org/ 10.1016/j.physbeh.2010.02.027 [90] Peciña, S.; Smith, K.S.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2010, 97, 34-46. http://dx.doi.org/10.1016/ j.pbb.2010.05.016 [91] Davis, C.M.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2009, 203, 421-429. http://dx.doi.org/10.1007/s00213-008-1233-5 [92] Wong, K.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2009, 92, 528-536. http://dx.doi.org/10.1016/j.pbb.2009.02.002 [93] Cooper, S.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1989, 33, 17-20. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1993, 46, 917-921. http://dx.doi.org/10.1016/0091-3057(93)90222-F [96] Glass, M.J.; Grace, M.; Cleary, J.P.; Billington, C.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2010, 96, 507-514. http://dx.doi.org/ 10.1016/j.pbb.2010.07.013 [98] Gugusheff, J.R.; Ong, Z.Y.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2014, 133, 14-21. http://dx.doi.org/10.1016/j.physbeh.2014.04.007 [99] Norris, J.N.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2009, 94, 81-87. http://dx.doi.org/10.1016/j.pbb.2009.07.012 [100] Dym, C.T.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2007, 1135, 136-145. http://dx.doi.org/10.1016/j.brainres.2006.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Drug Alcohol Depend., 2012, 122, 152-155. http://dx.doi.org/10.1016/ j.drugalcdep.2011.09.016 [102] Rabiner, E.A.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Mol Psychiatry, 2011, 16, 826-835. http://dx.doi.org/10.1038/mp.2011.29 [103] Murray, E.; Brouwer, S.; McCutcheon, R.; Harmer, C.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2014, 231, 4323-4335. http://dx.doi.org/ 10.1007/s00213-014-3573-7 [104] Yeomans, M.R.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1996, 60, 439-446. http://dx.doi.org/10.1016/S0031-9384(96)80017-5 [105] Langleben, D.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2012, 220, 559-564. http://dx.doi.org/10.1007/s00213-011-2503-1 [106] Drewnowski, A.; Krahn, D.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1992, 51, 371-379. http://dx.doi.org/10.1016/0031-9384(92)90155-U",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacother., 2009, 10, 1841-1845. http://dx.doi.org/10.1517/14656560903048959 [109] Fernandes, M.F.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"J. Diabetes, 2013, 37, 260-268. http://dx.doi.org/10.1016/j.jcjd.2013.04.004 [110] Kennett, G.A.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2010, 97, 63-83. http://dx.doi.org/10.1016/j.pbb.2010.07.020 [111] Volkow, N.D.; Wang, G.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Sci., 2011, 15, 37-46. http://dx.doi.org/10.1016/j.tics.2010.11.001 [112] Björklund, A.; Dunnett, S.B.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2012, 24, 1-4. http://dx.doi.org/10.1176/appi.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuron, 2006, 51, 811-822. http://dx.doi.org/10.1016/j.neuron.2006.09.006 [116] Hommel, J.D.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuron, 2006, 51, 801-810. http://dx.doi.org/10.1016/j.neuron.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1152/ ajpendo.00413.2013 [118] Hajnal, A.; Norgren, R. Accumbens dopamine mechanisms in sucrose intake.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2001, 904, 76-84. http://dx.doi.org/ 10.1016/S0006-8993(01)02451-9 [119] Shimura, T.; Kamada, Y.; Yamamoto, T. Ventral tegmental lesions reduce overconsumption of normally preferred taste fluid in rats.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2002, 134, 123-130. http://dx.doi.org/10.1016/ S0166-4328(01)00461-2 [120] Martínez-Hernández, J.; Lanuza, E.; Martínez-García, F. Selective dopaminergic lesions of the ventral tegmental area impair preference for sucrose but not for male sexual pheromones in female mice.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2006, 24, 885-893. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Lett., 2006, 403, 119-124. http://dx.doi.org/10.1016/j.neulet.2006.04.023 [122] Anderberg, R.H.; Anefors, C.; Bergquist, F.; Nissbrandt, H.; Skibicka, K.P.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2014, 136, 135-144. http://dx.doi.org/10.1016/j.physbeh.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Rev., 1998, 28, 309-369. http://dx.doi.org/10.1016/ S0165-0173(98)00019-8 [124] Peciña, S.; Cagniard, B.; Berridge, K.C.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"BMB Rep., 2013, 46, 519-526. http://dx.doi.org/ 10.5483/BMBRep.2013.46.11.207 [127] Cooper, S.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropharmacology, 2006, 50, 953-963. http://dx.doi.org/10.1016/j.neuropharm.2006.01.006 [128] van Gestel, M.A.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2014, 171, 4767-4784. http://dx.doi.org/10.1111/bph.12789 [129] Cosgrove, K.P.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Synapse, 2015, 69, 195-202. http://dx.doi.org/10.1002/syn.21809 [130] Karlsson, H.K.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2015, 35, 3959-3965. http://dx.doi.org/10.1523/JNEUROSCI.4744-14.2015 [131] de Weijer, B.A.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Diabetologia, 2014, 57, 1078-1080. http://dx.doi.org/10.1007/s00125-014-3178-z [132] van de Giessen, E.; Celik, F.; Schweitzer, D.H.; van den Brink, W.; Booij, J.5.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacol., 2014, 28, 866-873. http://dx.doi.org/10.1177/0269881114531664 [133] Volkow, N.D.; Wang, G.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroimage, 2008, 42, 1537-1543. http://dx.doi.org/10.1016/ j.neuroimage.2008.06.002 [134] Wang, G.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Lancet, 2001, 357, 354-357. http://dx.doi.org/10.1016/S0140-6736(00)03643-6 [135] Geiger, B.M.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"FASEB J., 2008, 22, 2740-2746. http://dx.doi.org/10.1096/fj.08-110759 [136] Wang, G.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC4084890/ (Accessed October 14, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2015, 35, 10316-10324. http://dx.doi.org/ 10.1523/JNEUROSCI.3607-14.2015 [138] Seger, D. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Toxicol., 2010, 48, 695-708. http://dx.doi.org/10.3109/15563650.2010.516263 [139] Schep, L.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psycho- pharmacology, 1992, 106, 221-227. http://dx.doi.org/10.1007/ BF02801976 [141] Foltin, R.W.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1995, 58, 899-907. http://dx.doi.org/10.1016/0031-9384(95)00149-D [142] Foltin, R.W.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2005, 45, 110-120. http://dx.doi.org/10.1016/ j.appet.2005.03.011",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obesity, 2014, 22, 781-785. http://dx.doi.org/10.1002/ oby.20574 [144] Goldfield, G.S.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Metab., 2011, 36, 1009-1013. http://dx.doi.org/10.1139/h11-098 [145] Leddy, J.J.; Epstein, L.H.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 2004, 12, 224-232. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"JRSM Open, 2014, 5, 2042533313517690. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012651/ (Accessed May 27, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1177/2042533313517690 [147] Levy, L.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obes., 2009, 33, 326-334. http://dx.doi.org/10.1038/ijo.2009.5 [148] Bello, N.T.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Bull., 2006, 70, 422-429. http://dx.doi.org/10.1016/j.brainresbull.2006.07.006 [149] Minet-Ringuet, J.; Even, P.C.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2005, 163, 204-211. http://dx.doi.org/10.1016/j.bbr.2005.05.004 [150] Schneider, L.H.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Bull., 1986, 17, 605-611. http://dx.doi.org/10.1016/0361-9230(86) 90231-5 [151] Boomhower, S.R.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2014, 25, 705-716. http://dx.doi.org/ 10.1097/FBP.0000000000000058 [152] Fell, M.J.; Anjum, N.; Dickinson, K.; Marshall, K.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2007, 194, 221-231. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2015, 232, 2377-2391. http://dx.doi.org/10.1007/s00213-015-3872-7 [154] Smith, G.C.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 2009, 115, 30-40. http://dx.doi.org/10.1016/j.schres.2009.07.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 2007, 32, 1772-1782. http://dx.doi.org/10.1007/ s11064-007-9343-8 [157] Ventura, R.; Morrone, C.; Puglisi-Allegra, S. Prefrontal/accumbal catecholamine system determines motivational salience attribution  to both reward- a n d  a v e r s i o n-related stimuli.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Sci., 2008, 29, 208-217. http://dx.doi.org/10.1016/j.tips.2008.01.008 [159] Savard, P.; Mérand, Y.; Leblanc, J.; Dupont, A.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Life Sci., 1983, 33, 2513-2519. http://dx.doi.org/10.1016/ 0024-3205(83)90160-1 [160] Leibowitz, S.F.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Bull., 1985, 14, 561-567. http://dx.doi.org/10.1016/0361-9230(85)90105-4 [161] Chafetz, M.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1989, 46, 999-1002. http://dx.doi.org/10.1016/0031-9384(89)90204-7 [162] Gehlert, D.R.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2012, 26, 969-973. http://dx.doi.org/10.1037/a0028948 [164] Lerman, C.; Berrettini, W.; Pinto, A.; Patterson, F.; Crystal-Mansour, S.; Wileyto, E.P.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"2004, 174, 571-577. http://dx.doi.org/10.1007/s00213-004-1823-9 [165] Billes, S.K.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 2014, 84, 1-11. http://dx.doi.org/10.1016/ j.phrs.2014.04.004 [166] Wang, G.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obes., 2014, 38, 682-688. http://dx.doi.org/10.1038/ijo.2013.145 [167] Lam, D.D.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Rev., 2011, 35, 1419-1449. http://dx.doi.org/10.1016/j.neubiorev.2011.03.005 [169] Garfield, A.S.; Heisler, L.K.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Physiol., 2009, 587, 49-60. http://dx.doi.org/10.1113/jphysiol.2008.164152 [170] Voigt, J.P.; Fink, H. Serotonin controlling feeding and satiety.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2015, 277, 14-31. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1988, 31, 113-122. http://dx.doi.org/10.1016/0091-3057(88)90321-8 [172] Cangiano, C.; Laviano, A.; Del Ben, M.; Preziosa, I.; Angelico, F.; Cascino, A.; Rossi-Fanelli, F. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Disord., 1998, 22, 648-654. http://dx.doi.org/10.1038/sj.ijo.0800642 [173] Antonatos, S.; Galanopoulou, P. Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychiatry, 2006, 30, 112-119. http://dx.doi.org/10.1016/j.pnpbp.2005.08.018 [174] Heisler, L.K.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1997, 58, 767-773. http://dx.doi.org/ 10.1016/S0091-3057(97)00036-1 [175] Heisler, L.K.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1999, 63, 377-385. http://dx.doi.org/10.1016/S0091-3057(99) 00021-0 [176] Duhault, J.; Lacour, F.; Espinal, J.; Rolland, Y.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 1993, 20, 135-144. http://dx.doi.org/10.1006/appe.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 1993, 112, 375-382. http://dx.doi.org/10.1007/BF02244936",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Senses, 2013, 38, 211-220. http://dx.doi.org/10.1093/ chemse/bjs096 [179] Foltin, R.W.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 1996, 27, 165-181. http://dx.doi.org/10.1006/ appe.1996.0043 [180] Ward, A.S.; Comer, S.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1999, 66, 815-821. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2003, 80, 243-252. http://dx.doi.org/10.1016/j.physbeh.2003.07.010 [182] Hansen, G.; Jelsing, J.; Vrang, N. Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Amino Acids, 2011, 40, 477-485. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Lett., 2010, 484, 30-34. http://dx.doi.org/ 10.1016/j.neulet.2010.08.011 [185] van der Zwaal, E.M.: Janhunen, S.K.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacol., 2015, 5, 158-165. http://dx.doi.org/10.1177/2045125315577057  [187] Smith, B.K.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1998, 60, 105-114. http://dx.doi.org/ 10.1016/S0091-3057(97)00549-2 [188] Jourdan, D.;, Piec, I.; Gaulier, J.M.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Aging, 2003, 24, 67-76. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Metabolism, 1995, 44, Suppl 2, 33-37. http://dx.doi.org/10.1016/0026-0495(95)90207-4 [192] Atchley, D.P.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2005, 86, 265-271. http://dx.doi.org/10.1016/j.physbeh.2005.08.001 [193] Foltin, R.W.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2008, 199, 583-592. http://dx.doi.org/10.1007/s00213-008-1178-8 [194] Kim, G.W.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Ther., 2014, 95, 53-66. http://dx.doi.org/10.1038/clpt.2013.204 [195] Prinssen, E.P.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2000, 388, 57-67. http://dx.doi.org/10.1016/ S0014-2999(99)00859-6 [196] Cunningham, K.A.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropharmacology, 2011, 61, 513-523. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuro- psychopharmacology, 2012, 37, 1177-1191. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psycho- pharmacology, 2012, 219, 377-386. http://dx.doi.org/10.1007/ s00213-011-2517-8 [199] White, C.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2000, 68, 715-722. http://dx.doi.org/10.1016/ S0031-9384(99)00243-7 [200] White, C.L.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obesity, 2007, 15, 624-631. http://dx.doi.org/10.1038/oby.2007.579 [201] Dill, M.J.; Shaw, J.; Cramer, J.; Sindelar, D.K.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2013, 112, 1-8. http://dx.doi.org/10.1016/j.pbb.2013.09.003 [202] Sargent.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2011, 11, 52-58. http://dx.doi.org/10.1016/j.coph.2011.01.005 [203] Teff, K.L.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2011, 104, 590-508. http://dx.doi.org/10.1016/j.physbeh.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://dx.doi.org/10.3389/fnsys.2012.,Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2005, 164, 67-72. http://dx.doi.org/ 10.1016/j.bbr.2005.06.004 [206] Ali, A.H.; Yanoff, L.B.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2010, 92, 1290-1297. http://dx.doi.org/10.3945/ajcn.110.001586 [207] Valdés, J.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2010, 31, 2073-2085. http://dx.doi.org/10.1111/j.1460-9568.2010.07241.x [208] Hartfield, A.W.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2003, 76, 251-258. http://dx.doi.org/ 10.1016/S0091-3057(03)00221-1 [209] Yamada, M.; Miyakawa, T.; Duttaroy, A.; Yamanaka, A.; Moriguchi, T.; Makita, R.; Ogawa, M.; Chou, C.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nature, 2001, 410, 207-212. http://dx.doi.org/10.1038/35065604 [210] Mineur, Y.S.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Science, 2011, 332, 1330-1332. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2011, 221, 481-487. http://dx.doi.org/10.1016/j.bbr.2011.01.047",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychol., 2014, 5, 553. http://dx.doi.org/10.3389/fpsyg.2014.00553 [213] Zoli, M.; Picciotto, M.R.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 2012, 14, 1270-1290. http://dx.doi.org/10.1093/ ntr/nts159 [214] Avena, N.M.; Rada, P.V.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2012, 106, 332-336. http://dx.doi.org/10.1016/j.physbeh.2012.03.020 [215] Pratt, W.E., Kelley, A.E.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psycho- pharmacology, 2006, 186, 113-121. http://dx.doi.org/10.1007/ s00213-006-0352-0 [217] Perry, M.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2010, 124, 44-54. http://dx.doi.org/10.1037/ a0018283 [218] Shabani, S.;, Foster, R.; Gubner, N.; Phillips, T.J.; Mark, G.P.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroscience, 2010, 170, 559-569. http://dx.doi.org/10.1016/j.neuroscience.2010.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroscience, 2010, 171, 1180-1186. http://dx.doi.org/10.1016/ j.neuroscience.2010.10.005 [220] Ostlund, S.B.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropsycho- pharmacology, 2014, 39, 1490-1497. http://dx.doi.org/10.1038/ npp.2013.348 [221] Taraschenko, O.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2008, 201, 339-350. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2011, 215, 247-256. http://dx.doi.org/10.1007/s00213-010-2132-0 [223] Taraschenko, O.D.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2011, 102, 126-131. http://dx.doi.org/10.1016/j.physbeh.2010.10.010 [224] Audrain-McGovern, J.; Benowitz, N.L.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Ther., 2011, 90, 164-168. http://dx.doi.org/10.1038/clpt.2011.105 [225] Geha, P.Y.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2013, 97, 15-22. http://dx.doi.org/10.3945/ajcn.112.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 2007, 31, 1891-1899. http://dx.doi.org/10.1111/j.1530-0277.2007.00519.x [227] Nuttens, M.C.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Med., 1992, 231, 349-356. http://dx.doi.org/10.1111/j.1365-2796.1992.tb00943.x [228] Machulska, A.; Zlomuzica, A.; Adolph, D.; Rinck, M.; Margraf, J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"gov/pmc/articles/PMC4333198/ (Accessed May 28, 2015) http://dx.doi.org/10.1371/journal.pone.0116464 [229] Suliburska, J.; Bogdański, P. Smoking and dietary intake in the patients with metabolic diseases and nervous system disorders (in Polish).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Drug Alcohol Depend., 2012, 124, 299-306. http://dx.doi.org/10.1016/j.drugalcdep.2012.01.025 [231] Chen, H.; Parker, S.L.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2005, 22, 380-388. http://dx.doi.org/10.1111/j.1460-9568.2005.04229.x [232] Grimm, J.W.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Biol., 2012, 17, 623-633. http://dx.doi.org/10.1111/j.1369-1600.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Health Dis., 2011, 2, 162-167. http://dx.doi.org/10.1017/ S204017441100016X [234] Lee, K.W.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"J. Psychiatry Neurosci., 2015, 40, 38-45. http://dx.doi.org/10.1503/jpn.130263 [235] Chiolero, A.; Faeh, D.; Paccaud, F.; Cornuz, J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Assoc., 1996, 96, 1150-1155. http://dx.doi.org/10.1016/S0002-8223(96) 00296-9 [237] Spring, B.; Pagoto, S.; McChargue, D.; Hedeker, D.; Werth, J. Altered reward value of carbohydrate snacks for female smokers withdrawn from nicotine.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2003, 76, 351-360. http://dx.doi.org/10.1016/j.pbb.2003.08.008 [238] Stadler, M.; Tomann, L.; Storka, A.; Wolzt, M.; Peric, S.; Bieglmayer, C.; Pacini, G.; Dickson, S.L.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinol., 2014, 170, 219-217. http://dx.doi.org/10.1530/EJE-13-0590 [239] Allen, S.S.; Hatsukami, D.; Brintnell, D.M.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 1990, 21, 161-167. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Cell, 2015, 160, 516-527. http://dx.doi.org/10.1016/j.cell.2014.12.026 [242] Cansell, C.; Denis, R.G.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinol., 2012, 3, 169. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3530831/pdf/fendo-03-00169.pdf (Accessed June 22, 2015)http://dx.doi.org/10.3389/fendo.2012.00169 [243] Kamatchi, G.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2012, 51, 19-26. http://dx.doi.org/10.3164/jcbn.11-85 [244] Covelo, I.R.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2014, 270, 316-325. http://dx.doi.org/ 10.1016/j.bbr.2014.05.032",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 1977, 7, 537-541. http://dx.doi.org/10.1016/0091-3057(77)90250-7 [246] Ito, Y.; Banno, R.; Shibata, M.; Adachi, K.; Hagimoto, S.; Hagiwara, D.; Ozawa, Y.; Goto, M.; Suga, H.; Sugimura, Y.; Bettler, B.; Oiso, Y.; Arima, H. GABA type B receptor signaling in proopiomelanocortin neurons protects against obesity, insulin resistance, and hypothalamic inflammation in male mice on a high-fat diet.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2013, 33, 17166-17173. http://dx.doi.org/ 10.1523/JNEUROSCI.0897-13.2013 [247] Sato, I1.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"581, 4857-48564. http://dx.doi.org/10.1016/j.febslet.2007.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Med., 2010, 49, 2043-2047. http://dx.doi.org/10.2169/internalmedicine.49.3918 [249] Foltin, R.W.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2005, 82, 608-614. http://dx.doi.org/ 10.1016/j.pbb.2005.10.016 [250] Ebenezer, I.S.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2007, 569, 90-93. http://dx.doi.org/10.1016/j.ejphar.2007.05.022 [251] Higgs, S.; Barber, D.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychiatry, 2004, 28, 405-408. http://dx.doi.org/10.1016/j.pnpbp.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2008, 593, 68-72. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2005, 86, 176-184. http://dx.doi.org/10.1016/j.physbeh.2005.07.020 [254] Wojnicki, F.H.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2006, 84, 197-206. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2008, 89, 581-590. http://dx.doi.org/10.1016/ j.pbb.2008.02.013 [256] Berner, L.A.; Bocarsly, M.E.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2009, 20, 631-634. http://dx.doi.org/ 10.1097/FBP.0b013e328331ba47 [257] Wang, Y.1,.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2011, 57, 628-634. http://dx.doi.org/ 10.1016/j.appet.2011.08.002 [258] Wojnicki, F.H.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2014, 25, 166-172. http://dx.doi.org/10.1097/FBP.0000000000000031 [259] Wojnicki, F.H.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2013, 64, 62-70. http://dx.doi.org/10.1016/j.appet.2013.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psycho- pharmacol.. 2014, 22, 460-467. http://dx.doi.org/10.1037/a0037223 [261] Bradbury, M.J1.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Ther., 2005, 313, 395-402. http://dx.doi.org/10.1124/jpet.104.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nature, 2015, 518, 197-206. http://dx.doi.org/10.1038/nature14177 [263] Brownley, K.A.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Drugs, 2015, 75, 9-32. http://dx.doi.org/10.1007/s40265-014-0327-0 [264] Stratford, T.R.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 1998, 93, 43-50. http://dx.doi.org/10.1016/S0166-4328(97)00140-X [265] Guyenet, S.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Metab., 2013, 2, 116-122. http://dx.doi.org/ 10.1016/j.molmet.2013.02.001 [266] Rosa, C.B.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Rec., 2011, 294, 1226-1232. http://dx.doi.org/10.1002/ar.21419 [267] Bisaga, A.1.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropsychopharmacol., 2008, 18, 794-802. http://dx.doi.org/ 10.1016/j.euroneuro.2008.05.004 [268] Bossert, J.M.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2006, 173, 148-152. http://dx.doi.org/10.1016/j.bbr.2006.06.008 [269] Tapiero, H.; Mathé, G.; Couvreur, P.; Tew, K.D.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacother., 2002, 56, 446-457. http://dx.doi.org/10.1016/S0753-3322(02)00285-8 [270] Tsai, P.J1.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://dx.doi.org/10.3945/ajcn.2009.,Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Gastroenterol., 2013, 48, 442-451. http://dx.doi.org/10.1007/s00535-013-0778-1 [274] Masic, U.; Yeomans, M.R.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2014, 100, 532-538. http://dx.doi.org/10.3945/ajcn.113.080929 [275] Dermiki, M.; Prescott, J.; Sargent, L.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2015, 90, 108-113. http://dx.doi.org/10.1016/j.appet.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2007, 48, 29-36. http://dx.doi.org/10.1016/j.appet.2006.06.002 [277] Ren, X.; Ferreira, J.G.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Digestion, 2011, 83, Suppl 1, 32-36. http://dx.doi.org/10.1159/000323405 [278] Tordoff, M.G.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2012, 107, 338-345. http://dx.doi.org/10.1016/j.physbeh.2012.07.006 [279] Boutry, C.; Bos, C.; Matsumoto, H.; Even, P.; Azzout-Marniche, D.; Tome, D.; Blachier, F. Effects of monosodium glutamate supplementation on glutamine metabolism in adult rats.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Biosci., 2011, 3, 279-290. http://dx.doi.org/10.2741/e243 [280] Bellisle, F. Experimental studies of food choices and palatability responses in European su bjects expos ed to the Umami taste.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2014, 79, 158-165. http://dx.doi.org/10.1016/j.appet.2014.04.011 [282] Carter, B.E.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2011, 106, 1441-1448. http://dx.doi.org/ 10.1017/S0007114511001759 [283] Kondoh, T.; Torii, K. MSG intake suppresses weight gain, fat deposition, and plasma leptin levels in male Sprague-Dawley rats.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2008, 95, 135-144. http://dx.doi.org/10.1016/ j.physbeh.2008.05.010 [284] Luscombe-Marsh, N.D.; Smeets, A.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2009, 102, 929-937. http://dx.doi.org/10.1017/S0007114509297212 [285] Brosnan, J.T.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Amino Acids, 2014, 46, 2075-2087. http://dx.doi.org/10.1007/s00726-014-1771-6 [286] Punjabi, M.; Arnold, M.; Geary, N.; Langhans, W.; Pacheco-López, G. Peripheral glucagon-like peptide-1 (GLP-1) and satiation.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2011, 105, 71-76. http://dx.doi.org/10.1016/j.physbeh.2011.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Gut Liver, 2012, 6, 10-20. http://dx.doi.org/10.5009/gnl.2012.6.1.10 [288] Trapp, S.; Richards, J.E.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2013, 13, 964-969. http://dx.doi.org/10.1016/ j.coph.2013.09.006 [289] van Bloemendaal, L.; IJzerman, R.G.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Diabetes, 2014, 63, 4186-4196. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"2 Bojanowska and Ciosek Pharmacother., 2014, 15, 2487-2500. http://dx.doi.org/10.1517/ 14656566.2014.965678 [291] Ladenheim, E.E.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Ther., 2015, 9, 1867-1875. http://dx.doi.org/ 10.2147/DDDT.S58459 [292] Martin, K.A.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2012, 32, 4812-4820. http://dx.doi.org/10.1523/JNEUROSCI.6326-11.2012 [294] Dossat, A.M.; Diaz, R.; Gallo, L.; Panagos, A.; Kay, K.; Williams, D.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1152/ajpregu.00179.2014 [296] Alhadeff, A.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropsychopharmacology, 2014, 2233-2243. http://dx.doi.org/10.1038/npp.2014.74 [297] van Bloemendaal, L.; Veltman, D.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Metab., 2015, http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obes., 2006, 30, 1332-1340. http://dx.doi.org/10.1038/sj.ijo.0803284 [299] Lamont, B.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Diabetes, 2008, 57, 190-198. http://dx.doi.org/10.2337/db07-1202 [300] Washington, M.C.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2010, 1344, 124-133. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obesity, 2011, 19, 1342-1349. http://dx.doi.org/ 10.1038/oby.2011.50 [302] Yang, Y.; Moghadam, A.A.; Cordner, Z.A.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinology, 2014, 155, 3473-3483. http://dx.doi.org/ 10.1210/en.2014-1052 [303] Swick, J.C.; Alhadeff, A.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuro- psychopharmacology, 2015, 40, 2001-2014. http://dx.doi.org/ 10.1038/npp.2015.50 [304] Peters, C.T.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Metab., 2013, 15, 958-962. http://dx.doi.org/10.1111/dom.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Peptides, 2013, 47, 115-123. http://dx.doi.org/10.1016/j.peptides.2013.07.015 [307] Inoue, K.; Maeda, N.; Kashine, S.; Fujishima, Y.; Kozawa, J.; Hiuge-Shimizu, A.; Okita, K.; Imagawa, A.; Funahashi, T.; Shimomura, I.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Diabetol., 2011, 10, 109. http://www.cardiab.com/content/10/1/109 (Accessed June 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1186/1475-2840-10-109 [308] Fujishima, Y.; Maeda, N.; Inoue, K.; Kashine, S.; Nishizawa, H.; Hirata, A.; Kozawa, J.; Yasuda, T.; Okita, K.; Imagawa, A.; Funahashi, T.; Shimomura, I. Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Diabetol., 2012, 11, 107. http://www.cardiab.com/ content/11/1/107 (Accessed June 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/ 10.1186/1475-2840-11-107 [309] Hansen, H.H.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2014, 741, 254-263. http://dx.doi.org/10.1016/j.ejphar.2014.08.010 [310] Lean, M.E.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obes., 2014, 38, 689-697. http://dx.doi.org/10.1038/ ijo.2013.149 [311] Pénicaud, L.; Meillon, S.; Brondel, L. Leptin and the central control of feeding behavior.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Biochimie, 2012, 94, 2069-2074. http://dx.doi.org/10.1016/j.biochi.2012.04.013 [312] Dalamaga, M.; Chou, S.H.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Cell Metab., 2013, 18, 29-42. http://dx.doi.org/ 10.1016/j.cmet.2013.05.010 [313] Murray, S.; Tulloch, A.; Gold, M.S.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinol., 2014, 10, 540-552. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Metabolism, 2015, 64, 24-34. http://dx.doi.org/10.1016/j.metabol.2014.08.004 [315] Sáinz, N.; González-Navarro, C.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Targets, 2015, 19, 893-909. http://dx.doi.org/ 10.1517/14728222.2015.1018824 [316] Kanoski, S.E.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropsychopharmacology, 2014, 39, 605-613. http://dx.doi.org/ 10.1038/npp.2013.235 [317] Sánchez, J.; Priego, T.; Palou, M.; Tobaruela, A.; Palou, A.; Picó, C. Oral supplementation with physiological doses of leptin during lactation in rats improves insulin sensitivity and affects food preferences later in life.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinology, 2008, 149, 733-740. http://dx.doi.org/10.1210/en.2007-0630 [318] Farooqi, I.S.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/ 10.1530/JOE-14-0480 [319] Farr, O.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinol., 2014, 2014, 120286. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980779/ pdf/IJE2014-120286.pdf (Accessed June 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2011, 14, 1562-1568. http://dx.doi.org/10.1038/nn.2977",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2004, 83, 65-72. http://dx.doi.org/ 10.1016/S0031-9384(04)00311-7 [323] Licinio, J.; Milane, M.; Thakur.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2007, 49, 594-599. http://dx.doi.org/10.1016/j.appet.2007.03.228 [324] van den Heuvel, J.K.; Eggels, L.; van Rozen, A.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroendocrinol., 2014, 26, 377-385. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Scientifica, 2013, 2013:518909. http://dx.doi.org/10.1155/2013/ 518909 (Accessed June 22, 2015).",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Dev., 2013, 25, 101-111. http://dx.doi.org/10.1159/000346058 [328] Pradhan, G.; Samson, S.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Care., 2013, 16, 619-624. http://dx.doi.org/10.1097/MCO.0b013e328365b9be [329] Heppner, K.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1530/EJE-14-0183 [330] Perello, M.; Dickson, S.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroendocrinol., 2015, 27, 424-434. http://dx.doi.org/10.1111/ jne.12236 [331] Guan, X.M.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 1997, 48, 23-29. http://dx.doi.org/10.1016/S0169-328X(97)00071-5 [332] Menyhért, J.; Wittmann, G.; Hrabovszky, E.; Szlávik, N.; Keller, E.; Tschöp, M.; Liposits, Z.; Fekete, C. Distribution of ghrelin-immunoreactive neuronal networks in the human hypothalamus.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2006, 1125, 31-36. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Brain Res., 2008, 1196, 59-64. http://dx.doi.org/ 10.1016/j.brainres.2007.12.055 [334] Zigman, J.M.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Invest., 2005, 115, 3564-3572. http://dx.doi.org/10.1172/JCI26002 [335] Labarthe, A.; Fiquet, O.; Hassouna, R.; Zizzari, P.;, Lanfumey, L.; Ramoz, N.; Grouselle, D.; Epelbaum, J.; Tolle, V. Ghrelin-derived peptides: a link between appetite/reward, GH axis, and psychiatric disorders?",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinol., 2014, 5, 163. http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://dx.doi.org/10.3389/fendo.2014.,Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"2, 329-336. http://dx.doi.org/10.1016/j.molmet.2013.08.003 [337] Egecioglu, E.; Jerlhag, E.; Salomé, N.; Skibicka, K.P.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Biol., 2010, 15, 304-311. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroscience, 2011, 180, 129-137. http://dx.doi.org/10.1016/j.neuroscience.2011.02.016 [339] Davis, J.F.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2012, 62, 598-604. http://dx.doi.org/10.1016/j.yhbeh.2012.08.009 [340] Sun, Y.; Ahmed, S.; Smith, R.G.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Cell Biol., 2003, 23, 7973-7981. http://dx.doi.org/10.1128/MCB.23.22.7973-7981.2003 [341] McCoull, W.; Barton, P.; Brown, A.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Chem., 2014, 57, 6128-6140. http://dx.doi.org/10.1021/jm500610n [342] Sárvári, M.; Kocsis, P.; Deli, L.; Gajári, D.; Dávid, S.; Pozsgay, Z.; Hegedűs, N.; Tihanyi, K.; Liposits, Z. Ghrelin modulates the fMRI BOLD response of homeostatic and hedonic brain centers regulating energy balance in the rat.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022590/pdf/pone.0097651.pdf (Accessed June 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1371/ journal.pone.0097651 [343] Landgren, S.; Simms, J.A.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063250/pdf/pone.0018170.pdf (Accessed June 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1371/ journal.pone.0018170 [344] Disse, E.; Bussier, A.L.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2010, 101, 277-281. http://dx.doi.org/10.1016/j.physbeh.2010.05.017 [345] Stevenson, J.; Buirkle, J.M.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2015, 147, 23-29. http://dx.doi.org/10.1016/j.physbeh.2015.04.001 [346] Kola, B.; Farkas, I.; Christ-Crain, M.; Wittmann, G.; Lolli, F.; Amin, F.; Harvey-White, J.; Liposits, Z.; Kunos, G.; Grossman, A.B.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC2258435/pdf/pone.0001797.pdf (Accessed June 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropsychopharmacology, 2015, 40, 327-337. http://dx.doi.org/ 10.1038/npp.2014.175 [350] Kanoski, S.E.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropsychopharmacology, 2011, 36, 1859-1870. http://dx.doi.org/10.1038/npp.2011.70 [351] Xu, T.R.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Cell Signal., 2013, 25, 2413-2423. http://dx.doi.org/ 10.1016/j.cellsig.2013.07.025 [352] Matsuo, E.; Mochizuki, A.; Nakayama, K.; Nakamura, S.; Yamamoto, T.; Shioda, S.; Sakurai, T.; Yanagisawa, M.; Shiuchi, T.; Minokoshi, Y.; Inoue, T. Decreased intake of sucrose solutions",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neurosci., 2011, 43, 217-224. http://dx.doi.org/10.1007/s12031-010-9475-1 [353] Cason, A.M.; Aston-Jones, G. Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Psychopharmacology, 2013, 228, 499-507. http://dx.doi.org/10.1007/s00213-013-3051-7 [354] Cason, A.M.; Aston-Jones, G.. Role of orexin/hypocretin in conditioned sucrose-seeking in female rats.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuropharmacology, 2014, 86, 97-102. http://dx.doi.org/10.1016/j.neuropharm.2014.07.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Pharmacol., 2013, 4, 165. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3874552/pdf/fphar-04-00165.pdf (Accessed June 22, 2015).",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.3389/fphar.2013.00165 [356] Sabatier, N.; Leng, G.; Menzies, J. Oxytocin, feeding, and satiety.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinol., 2013, 4, 35. http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3603288/pdf/fendo-04-00035.pdf (Accessed June 22, 2015).",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Obesity, 2015, 23, 950-956. http://dx.doi.org/10.1002/ oby.21069 [358] Morton, G.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://dx.doi.org/10.1152/ajpregu.00441.,Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1152/ajpregu.00344.2014 [361] Maejima, Y.; Rita, R.S.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroendocrinology, 2015, 101, 35-44. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"http://dx.doi.org/10.1152/ajpregu.00228.2007 [363] Olszewski, P.K.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Endocrinology, 2010, 151, 4736-4744. http://dx.doi.org/10.1210/en.2010-0151 [364] Herisson, F.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Neuroreport, 2014, 25, 909-914. http://dx.doi.org/10.1097/WNR.0000000000000201 [365] Sinclair, M.S.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Behav., 2015, 141, 103-110. http://dx.doi.org/10.1016/ j.physbeh.2014.12.048 [366] Ott, V.; Finlayson, G.; Lehnert, H.; Heitmann, B.; Heinrichs, M.; Born, J.; Hallschmid, M. Oxytocin reduces reward-driven food intake in humans.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Diabetes, 2013, 62, 3418-3425. http://dx.doi.org/ 10.2337/db13-0663 [367] Kozuka, C.; Yabiku, K.; Takayama, C.; Matsushita, M.; Shimabukuro, M. Natural food science based novel approach toward prevention and treatment of obesity and type 2 diabetes: recent studies on brown rice and γ-oryzanol.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
http://dx.doi.org/10.1016/j.orcp.,OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Nutr., 2014, 111, 310-320. http://dx.doi.org/10.1017/S0007114513002432 [369] Kozuka, C.; Yabiku, K.; Sunagawa, S.; Ueda, R.; Taira, S.; Ohshiro, H.; Ikema, T.; Yamakawa, K.; Higa, M.; Tanaka, H.; Takayama, C.; Matsushita, M.; Oyadomari, S.; Shimabukuro, M.; Masuzaki, H. Brown rice and its component, γ-oryzanol, attenuate the preference for high-fat diet by decreasing hypothalamic endoplasmic reticulum stress in mice.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Diabetes, 2012, 61, 3084-3093. http://dx.doi.org/10.2337/db11-1767 [370] Zaru, A.; Maccioni, P.; Riva, A.; Morazzoni, P.; Bombardelli, E.; Gessa, G.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 2013, 27, 944-947. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Fitoterapia, 2013, 85, 14-19. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2014, 81, 295-304. http://dx.doi.org/10.1016/j.appet.2014.06.101 [373] Stenblom, E.L.; Egecioglu, E.; Landin-Olsson, M.; Erlanson-Albertsson, C. Consumption of thylakoid-rich spinach extract reduces hunger, increases satiety and reduces cravings for palatable food in overweight women.",Non-OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Appetite, 2015, 91, 209-219. http://dx.doi.org/10.1016/j.appet.2015.04.051 [374] Ogawa, N.; Ito, M.; Yamaguchi, H.; Shiuchi, T.; Okamoto, S.; Wakitani, K.; Minokoshi, Y.; Nakazato, M. Intestinal fatty acid infusion modulates food preference as well as calorie intake via the vagal nerve and midbrain-hypothalamic neural pathways in rats.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Metabolism, 2012, 61, 1312-1320. http://dx.doi.org/10.1016/ j.metabol.2012.02.011 [375] Harden, C.J.",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Res., 2014, 34, 17-24. http://dx.doi.org/10.1016/j.nutres.2013.10.004   Received: June 29, 2015 Revised: September 19, 2015 Accepted: October 31, 2015",OADS,/arxiv_data1/oa_pdf/e8/79/CN-14-118.PMC4825944.pdf
"Trends Genet., 2015, 31(3), 140-149. http://dx.doi.org/ 10.1016/j.tig.2015.01.004 [2] Mahalingam, S. and Levy, L.M.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neuroradiol., 2014, 35(6), 1070-2. http://dx.doi.org/ 10.3174/ajnr.A3772 [3] Gray, M.W.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
http://dx.doi.org/10.1101/cshperspect.,Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Sci., 2007, 95(1), 196-204. http://dx.doi.org/10.1093/toxsci/kfl133 [5] Swomley, A.M., Förster, S., Keeney, J.T., Triplett, J., Zhang, Z., Sultana R., Butterfield, D.A.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Acta, 2014, 1842(8), 1248-57. http://dx.doi.org/10.1016/j.bbadis.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Nature, 1998, 392(6676), 605-8. http://dx.doi.org/ 10.1038/33416 [7] Valente, E.M., Abou-Sleiman, P.M., Caputo, V., Muqit, M.M., Harvey, K., Gispert S., Ali, Z., Del Turco, D., Bentivoglio, A.R., Healy, D.G., Albanese, A., Nussbaum, R., González-Maldonado, R., Deller, T., Salvi, S., Cortelli, P, Gilks W.P., Latchman, D.S., Harvey, R.J., Dallapiccola, B., Auburger, G., Wood, N.W.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"S c i e n c e, 2004, 304(5674) 1158-60. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurol., 2002, 51(3), 296-301. http://dx.doi.org/10.1002/ana.10113 [9] Humphrey, D.M., Parsons, R.B., Ludlow, Z.N., Riemensperger, T, Esposito, G., Verstreken, P., Jacobs, H.T., Birman, S., Hirth, F. Alternative oxidase rescues mitochondria-mediated dopaminergic cell loss in Drosophila.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Genet., 2012, 21(12), 2698-712. http://dx.doi.org/10.1093/hmg/dds096 [10] Bloom, G.S.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"JAMA Neurol., 2014, 71(4), 505-8. http://dx.doi.org/10.1001/jamaneurol.2013.5847 [11] Delabio, R., Rasmussen, L., Mizumoto, I., Viani, G.A., Chen, E., Villares, J., Costa, I.B., Turecki, G., Linde, S.A., Smith, M.C., Payão, S.L.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Cell, 1993, 72(6), 971-83. http://dx.doi.org/10.1016/0092-8674(93)90585-E [13] Burgunder, J.M.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Today, 2014, 19(7), 985-9. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Mutat., 2010, 31(7), 763-80. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Int., 2014, 2014, 37, 1256. http://dx.doi.org/10.1371/journal.pone.0101392 [17] Chen, C.M., Chen, I.C., Huang, Y.C., Juan, H.F., Chen, Y.L., Chen, YC, Lin, C.H., Lee, L.C., Lee, C.M., Lee-Chen, G.J., Lai, Y.J., Wu, Y.R.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"http://dx.doi.org/10.1371/journal.pone.0101392 [18] Illingworth, M.A., Meyer, E., Chong, W.K., Manzur, A.Y., Carr, L.J., Younis, R., Hardy, C., McDonald, F., Childs, A.M., Stewart, B., Warren, D., Kneen, R., King, M.D., Hayflick, S.J., Kurian, M.A.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Metab., 2014, 112(2), 183-9. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Genet, 2014, 23(17), 4621-38. http://dx.doi.org/10.1093/hmg/ ddu178 [20] Chartier-Harlin, M.C., Dachsel, J.C., Vilariño-Güell, C., Lincoln, S.J., Leprêtre, F., Hulihan, M.M., Kachergus, J., Milnerwood, A.J., Tapia, L., Song, M.S., Le Rhun, E., Mutez, E., Larvor, L., Duflot, A., Vanbesien-Mailliot, C., Kreisler, A., Ross, O.A., Nishioka, K., Soto-Ortolaza, A.I., Cobb, S.A., Melrose, H.L., Behrouz, B., Keeling, B.H., Bacon, J.A., Hentati, E., Williams, L., Yanagiya, A., Sonenberg, N., Lockhart, P.J., Zubair, A.C., Uitti, R.J., Aasly, J.O., Krygowska-Wajs, A., Opala, G., Wszolek, Z.K., Frigerio, R., Maraganore, D.M., Gosal, D., Lynch, T., Hutchinson, M., Bentivoglio A.R., Valente, E.M., Nichols, W.C., Pankratz, N., Foroud, T., Gibson R.A., Hentati, F., Dickson, D.W., Destée, A., Farrer, M.J.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Genet., 2011, 89(3), 398-406. http://dx.doi.org/10.1016/j.ajhg.2011.08.009 [21] Bonifati, V. Genetics of Parkinson's disease--state of the art.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Disord., 2014, 20 S u p p l  1 ,  S 2 3-8. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Chem., 2015, 290, 9690-700. http://dx.doi.org/10.1074/jbc.M114.626713 [23] Jakobs, B.S., van den Heuvel, L.P., Smeets, R.J., de Vries, M.C., Hien, S., Schaible, T., Smeitink, J.A., Wevers, R.A., Wortmann, S.B., Rodenburg, R.J. A novel mutation in COQ2 leading to fatal infantile multisystem disease.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Sci., 2013, 326(1-2), 24-8. http://dx.doi.org/10.1016/j.jns.2013.01.004",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Res., 2012, 43(8), 622-31. http://dx.doi.org/10.1016/j.arcmed.2012.10.017 [26] Karch, C.M., Cruchaga, C. and Goate, A.M. Alzheimer's disease genetics: from the bench to the clinic.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neuron, 2014, 83(1), 11-26. http://dx.doi.org/10.1016/j.neuron.2014.05.041 [27] Zheng, Z. and Diamond, M.I.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Sci., 2012, 107, 189-214. http://dx.doi.org/10.1016/B978-0-12-385883-2.00010-2 [28] Parkinson, G .",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Aging Sci., 2014, 7(3), 155-60. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Dis., 2014, 70, 214-23. http://dx.doi.org/10.1016/j.nbd.2014.06.014 [30] Lin, M.T., Cantuti-Castelvetri, I., Zheng, K., Jackson, K.E., Tan, Y.B., Arzberger, T., Lees, A.J., Betensky, R.A., Beal, M.F., Simon, D.K.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurol., 2012, 71(6), 850-4. http://dx.doi.org/10.1002/ana.23568 [31] Simon, D.K., Pankratz, N., Kissell, D.K., Pauciulo M.W., Halter, C.A., Rudolph, A., Pfeiffer, R.F., Nichols, W.C., Foroud, T. Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Genet., 2010, 11, 53. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Sci., 2014, 346(1-2), 11-9. http://dx.doi.org/10.1016/j.jns.2014.07.067 [33] Coskun, P., Wyrembak, J., Schriner, S.E., Chen, H.W., Marciniack, C, Laferla, F., Wallace, D.C. A mitochondrial etiology of Alzheimer and Parkinson disease.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Acta, 2012, 1820(5), 553-64. http://dx.doi.org/10.1016/j.bbagen.2011.08.008 [34] Hudson, G, Nalls, M., Evans, J.R., Breen, D.P., Winder-Rhodes, S., Morrison, K.E., Morris, H.R., Williams-Gray, C.H., Barker, R.A., Singleton, A.B., Hardy, J., Wood, N.E., Burn, D.J., Chinnery, P.F.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurology, 2013, 80(22), 2042-8. http://dx.doi.org/10.1212/WNL.0b013e318294b434 [35] Iacobazzi, V., Castegna, A., Infantino, V., Andria, G. Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Metab., 2013, 110(1-2), 25-34. http://dx.doi.org/ 10.1016/j.ymgme.2013.07.012 [36] Gerschütz, A., Heinsen, H., Grünblatt, E., Wagner, A.K., Bartl, J., Meissner, C., Fallgatter, A.J., Al-Sarraj, S., Troakes, C., Ferrer, I., Arzberger, T., Deckert, J., Riederer, P., Fischer, M., Tatschner, T., Monoranu, C.M.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Alzheimer Res., 2013, 10(10), 1041-6. http://dx.doi.org/10.2174/15672050113106660166 [37] Yan, M.H., W a n g ,  X .",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Med., 2013, 62, 90-101. http://dx.doi.org/10.1016/ j.freeradbiomed.2012.11.014 [38] Phillips, N.R., Simpkins, J.W.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Alzheimers Dement., 2014, 10(3), 393-400. http://dx.doi.org/10.1016/j.jalz.2013.04.508 [39] Fachal, L., Mosquera-Miguel, A., Pastor, P., Ortega-Cubero, S., Lorenzo, E., Oterino-Durán, A., Toriello, M., Quintáns, B., Camiña-Tato, M., Sesar, A., Vega, A., Sobrido, M.J., Salas, A.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Genet., 2015, 168B(1), 54-65. http://dx.doi.org/10.1002/ajmg.b.32276 [40] Hudson, G., Sims.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurology, 2012, 78(14), 1038-42. http://dx.doi.org/10.1212/ WNL.0b013e31824e8f1d [41] Arning, L., Haghikia, A., Taherzadeh-Fard, E., Saft, C., Andrich, J., Pula, B., Höxtermann, S., Wieczorek, S., Akkad, D.A., Perrech, M., Gold, R., Epplen, J.T., Chan, A. Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"(Berl)., 2010, 88(4), 431-6. http://dx.doi.org/10.1007/ s00109-010-0589-2 [42] Mancuso, M., Kiferle, L., Petrozzi, L., Nesti, C, Rocchi, A., Ceravolo R., Orsucci, D., Maluccio, M.R., Bonuccelli, U., Filosto, M., Siciliano, G., Murri, L. M i t o c h o n d r i a l  D N A  h a p l o g r o u p s  d o  not influence the Huntington's disease phenotype.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Lett., 2008, 444(1), 83-6. http://dx.doi.org/10.1016/j.neulet.2008.08.013 [43] Wang, J.Q., Chen, Q., Wang, X., Wang, Q.C., Wang, Y., Cheng, H.P., Guo, C., Sun, Q., Chen, Q., Tang, T.S.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Chem., 2013, 288(5), 3070-84. http://dx.doi.org/10.1074/ jbc.M112.407726 [44] Siddiqui, A., Rivera-Sánchez, S., Castro, M.R., Acevedo-Torres, K., Rane, A., Torres-Ramos, C.A., Nicholls, D.G., Andersen, J.K., Ayala-Torres, S. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Med., 2012, 53(7), 1478-88. http://dx.doi.org/10.1016/ j.freeradbiomed.2012.06.008 [45] Xun, Z., Rivera-Sánchez, S., Ayala-Peña, S., Lim, J., Budworth, H., Skoda, E.M., Robbins, P.D., Niedernhofer, L.J., Wipf, P., McMurray, C.T.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Cell Rep., 2012, 2(5), 1137-42. http://dx.doi.org/10.1016/j.celrep.2012.10.001 [46] Lin, M.T., Beal, M.F.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Nature, 2006, 443(7113), 787-95. http://dx.doi.org/10.1038/nature05292 [47] Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A.Y., Miljan, EA, Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., Deas, E., Downward, J., Mansfield, L., Jat, P., Taylor, J., Heales, S., Duchen, M.R., Latchman, D., Tabrizi, S.J., Wood, N.W.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Trends Cell Biol., 2013, 23(2), 64-71. http://dx.doi.org/10.1016/j.tcb.2012.10.006 [50] Zhao, J., Liu, T., Jin S, Wang X, Qu, M., Uhlén, P., Tomilin, N., Shupliakov, O., Lendahl, U., Nistér, M. Human MIEF1 recruits Drp1 to mitochondrial outer membranes and promotes mitochondrial fusion rather than fission.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"http://dx.doi.org/10.1101/cshperspect.a009332 [52] Chen, H., Detmer, S.A., Ewald, A.J., Griffin EE, Fraser, S.E., Chan, D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Cell Biol., 2003, 160(2), 189-200. http://dx.doi.org/10.1083/ jcb.200211046 [53] Iijima-Ando, K., S e k i y a ,  M., Maruko-Otake, A., Ohtake, Y., Suzuki, E., Lu, B., Iijima, K.M.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"http://dx.doi.org/10.1371/journal.pgen.1002918 [54] Ashrafi, G., Schlehe, J.S., LaVoie, M.J., Schwarz, T.L.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Cell Biol., 2014, 206(5), 655-70. http://dx.doi.org/10.1083/jcb.201401070",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Chem., 2009, 284(20), 13843-55. http://dx.doi.org/10.1074/jbc.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Genet., 2011, 20(7), 1438-55. http://dx.doi.org/10.1093/hmg/ ddr024 [58] Deng, H., Dodson, M.W., Huang, H., Guo, M. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurochem., 2012, 122(2), 404-14. http://dx.doi.org/ 10.1111/j.1471-4159.2012.07769.x [60] Rojas-Charry, L., Cookson, M.R., Niño, A., Arboleda, H., Arboleda, G. Downregulation of Pink1 influences mitochondrial fusion-fission machinery and sensitizes to neurotoxins in dopaminergic cells.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurosci., 2009, 29(28), 9090-103. http://dx.doi.org/10.1523/JNEUROSCI.1357-09.2009 [62] Selfridge, J.E., E. L., Lu, J., Swerdlow, R.H. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Dis., 2013, 51, 3-12. http://dx.doi.org/10.1016/j.nbd.2011.12.057 [63] Manczak, M. and Reddy, P.H.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Genet., 2012, 21(11), 2538-47. http://dx.doi.org/10.1093/hmg/dds072 [64] Ziv, I., Melamed, E., Nardi, N., Luria, D., Achiron, A., Offen, D., Barzilai, A. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons--a possible novel pathogenetic mechanism in Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Lett., 1994, 170(1), 136-40. http://dx.doi.org/10.1016/0304-3940(94)90258-5 [65] Indran, I.R., Tufo, G., Pervaiz, S., Brenner, C. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Acta, 2011, 1807(6), 735-45. http://dx.doi.org/ 10.1016/j.bbabio.2011.03.010 [66] Perier, C., Tieu, K., Guégan, C., Caspersen, C., Jackson-Lewis, V., Carelli, V., Martinuzzi, A., Hirano, M., Przedborski, S., Vila, M. Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Toxicol., 2015, 55, 553-72. http://dx.doi.org/10.1146/ annurev-pharmtox-010814-124414 [68] Luo, D.J., Feng, Q., Wang, Z.H., Sun, D.S., Wang, Q., Wang, J.Z., Liu GP K n o c k d o w n  o f  p h o s p h o t y r o s y l  p h o s p h a t a s e  a c t i v a t o r  induces apoptosis via mitochondrial pathway and the attenuation by simultaneous tau hyperphosphorylation.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurochem., 2014, 130(6), 816-25. http://dx.doi.org/10.1111/jnc.12761 [69] Sunita, M., Masahide, O., Masashi, T., Jun, H., and Yasuyoshi, S. Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neuroreport, 1997, 8(6), 1499-502. http://dx.doi.org/ 10.1097/00001756-199704140-00035 [71] Kang, M.H., Kawai, Y., Naito, M., Osawa, T. Dietary defatted sesame flour decreases susceptibility to oxidative stress in hypercholesterolemic rabbits.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurobiol., 2002, 28(5), 390-6. http://dx.doi.org/10.1046/j.1365-2990.2002.00414.x [73] Tabrizi, S.J., Cleeter, M.W., Xuereb, J., Taanman, J.W., Cooper, J.M., Schapira, A.H. Biochemical abnormalities and excitotoxicity in Huntington's disease brain.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurol., 1999, 45(1), 25-32. http://dx.doi.org/10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E [74] Kincaid, B., and Bossy-Wetzel, E. Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Aging Neurosci., 2013, 5, 48. http://dx.doi.org/10.3389/ fnagi.2013.00048 [75] Langston, J.W., Ballar, d P., Tetrud, J.W., Irwin, I.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Science, 1983, 219(4587), 979-80. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Brain, 2005, 128(Pt 12), 2760-2. http://dx.doi.org/10.1093/brain/awh676 [77] Oliveras-Salvá, M., Macchi, F., Coessens, V., Deleersnijder, A., Gérard M., Van der Perren, A., Van den Haute, C., Baekelandt, V. Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Aging, 2014, 35(11), 2625-36. http://dx.doi.org/10.1016/j.neurobiolaging.2014.04.032 [78] Devi, L., Raghavendran, V., Prabhu, B.M., Avadhani, N.G., Anandatheerthaverada, H.K.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Chem., 2008, 283(14), 9089-100. http://dx.doi.org/10.1074/jbc.M710012200 [79] Parganlija, D., Klinkenberg, M., Domínguez-Bautista, J., Hetzel, M., Gispert, S., Chimi, M.A., Dröse, S., Mai, S., Brandt, U., Auburger, G., Jendrach, M. Loss of PINK1 impairs stress-induced autophagy and cell survival.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"http://dx.doi.org/10.1371/journal.pone.0095288 [80] Clarimon, J., Kulisevsky, J. Parkinson's disease: from genetics to clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Genom., 2013, 14(8), 560-7. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Autophagy, 2013, 9(6), 936-8. http://dx.doi.org/10.4161/auto.24397 [83] Tong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kellehe, R.J. 3rd, Shen, J.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"U. S. A., 2010, 107(21), 9879-84. http://dx.doi.org/ 10.1073/pnas.1004676107 [84] Gan, X., Wu, L., Huang, S., Zhong, C., Shi, H., Li, G., Yu, H., Howard, S., R., Xi, C. J., Yan, S.S. Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Med., 2014, 75, 230-40. http://dx.doi.org/10.1016/ j.freeradbiomed.2014.07.021 [85] Zhao, Y. and Zhao, B. Oxidative stress and the pathogenesis of Alzheimer's disease.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Biomembr., 2014, 46(5), 371-6. http://dx.doi.org/10.1007/s10863-014-9567-7 [87] Mattson, M.P.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Invest., 2001, 107(3), 247-54. http://dx.doi.org/10.1172/JCI11916 [88] Pimentel, C., Batista-Nascimento, L., Rodrigues-Pousada, C., Menezes, R.A. Oxidative stress in Alzheimer's and Parkinson's diseases: insights from the yeast Saccharomyces cerevisiae.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Other Demen., 2014, 29(8), 732-4. http://dx.doi.org/10.1177/ 1533317514536599 [90] Nygaard, H.B., Lippa, C.F., Mehdi, D., Baehring, J.M.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Other Demen., 2014, 29(5), 433-435. http://dx.doi.org/10.1177/1533317513518653 [91] Kukreja, L., Kujoth, G.C., Prolla, T.A., Van Leuven, F., Vassar, R. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurodegener., 2014, 9, 16. http://dx.doi.org/10.1186/1750-1326-9-16 [92] Damiano, M., Galvan, L., Déglon, N., Brouillet, E. Mitochondria in Huntington's disease.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Acta, 2010, 1802(1), 52-61. http://dx.doi.org/10.1016/j.bbadis.2009.07.012 [93] Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D., Richardson, E.P.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Neurol., 1985, 44(6), 559-77. http://dx.doi.org/10.1097/00005072-198511000-00003 [94] Yamamoto, A., Lucas, J.J. and Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Cell, 2000, 101(1), 57-66. http://dx.doi.org/10.1016/S0092-8674(00)80623-6 [95] Mochel, F. and Haller, R.G.",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Invest., 2011, 121(2) 493-9. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Genet., 2013, 22(19), 3869-82. http://dx.doi.org/10.1093/hmg/ddt242 [97] Tsunemi, T., Ashe, T.D., Morrison, B.E., Soriano, K.R., Au, J., Roque R.A., Lazarowski, ER, Damian, V.A., Masliah, E., La Spada, AR PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
http://dx.doi.org/10.1126/ scitranslmed.3003799 [98] Li.,Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Commun., 2012, 421(4), 727-30. http://dx.doi.org/10.1016/ j.bbrc.2012.04.070 [99] Ribeiro, M., Rosenstock, T.R., Oliveira, A., Oliveira, C.R., Carvalho, R. A.C. Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells.",Non-OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Med., 2014, 74, 129-44. http://dx.doi.org/10.1016/j.freeradbiomed.2014.06.023   Received: September 10, 2014 Revised: January 20, 2015 Accepted: July 02, 2015",OADS,/arxiv_data1/oa_pdf/55/a4/CN-14-143.PMC4825945.pdf
"Lancet Neurol., 2011, 10(3), 253-263. http://dx.doi.org/10.1016/ S1474-4422(11)70015-1 [2] Eikelenboom, P.; Hoozemans, J.J.; Veerhuis, R.; van Exel, E.; Rozemuller, A.J.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Ther., 2012, 4(3), 15. http://dx.doi.org/10.1186/alzrt118 [3] Blandini, F. Neural and immune mechanisms in the pathogenesis of Parkinson’s disease.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"J. Neuroimmune Pharmacol., 2013, 8(1), 189-201. http://dx.doi.org/10.1007/s11481-013-9435-y [4] Evans, M.C.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2013, 53, 34-41. http://dx.doi.org/10.1016/j.mcn.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurol., 2013, 9(1), 25-34. http://dx.doi.org/10.1038/nrneurol.2012.236 [6] Murta, V.; Ferrari, C.C.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2013, 53, 6-13. http://dx.doi.org/10.1016/j.mcn.2012.06.004 [7] Amor, S.; Peferoen, L.A.; Vogel, D.Y.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immunology, 2014, 142(2), 151-166. http://dx.doi.org/ 10.1111/imm.12233 [8] Heneka, M.T.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immunol., 2014, 14(7), 463-477. http://dx.doi.org/10.1038/nri3705 [9] Pasqualetti, G.; Brooks, D.J.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Rep., 2015, 15(4), 17. http://dx.doi.org/10.1007/s11910-015-0531-7 [10] Luterman, J.D.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurol., 2000, 57(8), 1153-1160. http://dx.doi.org/10.1001/ archneur.57.8.1153 [11] Serrano-Pozo, A.; Mielke, M.L.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Pathol., 2011, 179(3), 1373-1384. http://dx.doi.org/ 10.1016/j.ajpath.2011.05.047 [12] McGeer, P.L.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Acta Neuropathol., 2013, 126(4), 479-497. http://dx.doi.org/10.1007/ s00401-013-1177-7 [13] Exalto, L.G.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Gerontol., 2012, 47(11), 858-864. http://dx.doi.org/ 10.1016/j.exger.2012.07.014 [14] Ledesma, M.D.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Biosci., 2012, 4, 181-194. http://dx.doi.org/10.2741/E368 [15] Misiak, B.; Leszek, J.; Kiejna, A. metabolic syndrome, mild cognitive impairment and Alzheimer´s disease – the emerging role of systemic low-grade inflammation and adiposity.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Bull., 2012, 89(3-4), 144-149. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuroimmunol., 2014, 273(1-2), 8-21. http://dx.doi.org/10.1016/j.jneuroim.2014.06.004 [18] Holmes, C.; Cotterell, D. Role of infection in the pathogenesis of Alzheimer´s disease: implications for treatment.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"CNS Drugs, 2009, 23(12), 993-1002. http://dx.doi.org/10.2165/11310910-000000000-00000 [19] Holmes, C. Review: systemic inflammation and Alzheimer´s disease.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurobiol., 2013, 39(1), 51-68. http://dx.doi.org/10.1111/j.1365-2990.2012.01307.x",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Des., 2012, 18(1), 34-42. http://dx.doi.org/10.2174/ 138161212798919057 [22] Qin, L.; Wu, X.; Block, M.L.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Glia, 2007, 55(5), 453-462. http://dx.doi.org/10.1002/glia.20467 [23] Erickson, M.A.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immun., 2011, 25(8), 1637-1648. http://dx.doi.org/ 10.1016/j.bbi.2011.06.006 [24] Park, S.M.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Bull., 35(9), 1546-1552. http://dx.doi.org/10.1248/bpb.b12-00393 [25] Biesmans, S.; M e e r t ,  T .",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Dis., 2003, 14, 133-145. http://dx.doi.org/10.1016/S0969-9961(03) 00069-X [27] Kitazawa, M.; Oddo, S.; Yamasaki, T.R.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2005, 25(39), 8843-8853. http://dx.doi.org/10.1523/JNEUROSCI.2868-05.2005 [28] Schwartz, M.; Kipnis, J.; Rivest, S.; Prat, A.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2013, 33(45), 17587-17596. http://dx.doi.org/10.1523/ JNEUROSCI.3241-13.2013 [29] Nayak, D.; Roth, T.L.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Cell, 2015, 32(4), 469-477. http://dx.doi.org/10.1016/ j.devcel.2015.01.018 [31] Benakis, C.; Garcia-Bonilla, L.; Iadecola, C.; Anrather, J.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neyrosci., 2015, 8, 461. http://dx.doi.org/10.3389/ fncel.2014.00461 [32] Tremblay, M.E.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2011, 31(45), 16064-16069. http://dx.doi.org/10.1523/ JNEUROSCI.4158-11.2011 [33] Sy, M.; Kitazawa, M.; Medeiros, R.; Whitman, L.; Cheng, D.; Lane, T.E.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Pathol., 2011, 178(6), 2811-2822. http://dx.doi.org/10.1016/j.ajpath.2011.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuroinflamm., 2012, 9, 197. http://dx.doi.org/10.1186/1742-2094-9-197 [35] Okuyama, S.; Makihata, N.; Yoshimura, M.; Amakura, Y.; Yoshida, T.; Nakajima, M.; Furukawa, Y. Oenothein B suppresses lipopolysaccharide (LPS)-induced inflammation in mouse brain.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Sci., 2013, 14, 9767-9778. http://dx.doi.org/10.3390/ ijms14059767 [36] Jin, M.; Jang, E.; Suk, K. Lipocalin-2 acts as a neuroinflammatogen in lipopolysaccharide-injected mice.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurobiol., 2014, 23(2), 155-162. http://dx.doi.org/10.5607/en.2014.23.2.155 [37] Cunningham, C.; Wilcockson, D. C.; Campion, S.; Lunnon, K.; Perry, V. H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2005, 25(40), 9275-9284. http://dx.doi.org/10.1523/JNEUROSCI.2614-05.2005 [38] Chen, Z.; Jalabi, W.; Shpargel, K.B.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2012, 32(34), 11706-11715. http://dx.doi.org/10.1523/JNEUROSCI.0730-12.2012 [39] Elmquist, J.K.; Scammell, T.E.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Trends Neurosci., 1997, 20(12), 565-570. http://dx.doi.org/ 10.1016/S0166-2236(97)01138-7 [40] Vallieres, L.; Rivest, S. Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and proinflammatory cytokine interleukin -1beta.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
",  1997, 69(4), 1668-1683. http://dx.doi.org/10.1046/j.1471-4159.1997.69041668.x [41] Lacroix, S.; Rivest, S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurochem., 1998, 70(2), 452-466. http://dx.doi.org/10.1046/ j.1471-4159.1998.70020452.x [42] Laye, S.; Parnet, P.; Goujon, E.; Dantzer, R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Brain Res., 1994, 27(1), 157-162. http://dx.doi.org/10.1016/ 0169-328X(94)90197-X [43] Brugg, B.; Dubreuil, Y.L.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"USA, 1995, 92(7), 3032-3035. http://dx.doi.org/10.1073/ pnas.92.7.3032 [44] Gabellec, M.M.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
",  1995, 31(1-2), 122-130. http://dx.doi.org/10.1016/0169-328X(95)00042-Q [45] Pitossi, F.; del Rey, A.; Kabiersch, A.; Besedovsky, H. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Res., 1997, 48(4), 287-298. http://dx.doi.org/10.1002/ (SICI)1097-4547(19970515)48:4%3C287::AID-JNR1%3E3.0.CO;2-7 [46] Ban, E.; Haour, F.; Lenstra, R. Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Cytokine, 1992, 4(1), 48-54. http://dx.doi.org/10.1016/1043-4666(92)90036-Q [47] Takao, T.; Culp, S.G.; De Souza, E.B.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Health A., 1998, 53(5), 357-373. http://dx.doi.org/ 10.1080/009841098159222 [49] Brochu, S.; Olivier, M.; Rivest, S. Neuronal activity and transcription of proinflammatory cytokines, IkappaBalpha, and iNOS in the mouse brain during acute endotoxemia and  chronic infection with Trypanosoma brucei brucei.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Res., 1999, 57(6), 801-816. http://dx.doi.org/10.1002/(SICI)1097-4547(19990915)57:6%3C801::AID-JNR5%3E3.0.CO;2-B [50] Godbout, J.P.; Chen, J.; Abraham, J.; Richwine, A.F.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immun., 2008, 22, 301-311. http://dx.doi.org/10.1016/j.bbi.2007.08.014 [52] Henry, C.J.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immun., 2009, 23, 309-317. http://dx.doi.org/10.1016/j.bbi.2008.09.002 [53] Ip, J.P.; Nocon, A.L.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"J. Neuro- inflammation, 2011, 8, 124. http://dx.doi.org/10.1186/1742-2094-8-124 [54] Fu, Y.Y.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurobiol., 2014, 34(5), 651-657. http://dx.doi.org/10.1007/ s10571-014-0039-8 [55] Cazareth, J.; Guyon, A.; Heurteaux, C.; Chabry, J.; Petit-Paitel, A. Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/ CCL2 signaling.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Brain, 2014, 7(1), 56. http://dx.doi.org/10.1186/s13041-014-0056-z [57] Wohleb, E.S.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Psyconeuroendocrinology, 2012, 37(9), 1491-1505. http://dx.doi.org/10.1016/j.psyneuen.2012.02.003 [58] Biesmans, S.; Acton, P.D.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Glia, 2015, 63, 1126-1137. http://dx.doi.org/10.1002/glia.22804 [59] Hopkins, W.; Gendron-Fitzpatrick, A.; McCarthy, D.O.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Shock, 1998, 10(5), 319-323. http://dx.doi.org/10.1097/00024382-199811000-00002 [61] Yang, I.V.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Genome, 2011, 22(9-10), 518-529. http://dx.doi.org/10.1007/s00335-011-9340-8 [62] Yang, I.V.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Biol., 2011, 45(2), 393-402. http://dx.doi.org/10.1165/rcmb.2010-0342OC [63] Hsiao, K.; Chapman, P.; Nilsen, S.; Eckman, C.; Harigaya, Y.; Younkin, S.; Yang, F.; Cole, G. Correlative memory deficits,  Abeta elevation, and amyloid plaques in transgenic mice.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Science, 1996, 274(5284), 99-102. http://dx.doi.org/10.1126/science.274.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurol., 1997, 56(9), 965-973. http://dx.doi.org/ 10.1097/00005072-199709000-00002 [65] Johnson-Wood, K.; Lee, M.; Motter, R.; Hu, K.; Gordon, G.; Barbour, R.; Khan, K.; Gordon, M.; Tan, H.; Games, D.; Leiberburg, I.; Schenk, D.; Seubert, P.; McConlogue, L. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Suppl., 2000, 59, 175-183. http://dx.doi.org/10.1007/978-3-7091-6781-6_20 [67] Oddo, S.; Caccamo, A.; Shepherd, J.D.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuron, 2003, 39(3), 409-421. http://dx.doi.org/10.1016/S0896-6273(03)00434-3 [68] German, D.C.; Nelson, O.; Liang, F.; Liang, C.L.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurol., 2005, 492(4), 469-476. http://dx.doi.org/10.1002/cne.20744 [69] Meredith, G.E.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"http://dx.doi.org/10.1016/j.parkreldis.2008.04.012 [70] Crews, L.; Rockenstein, E.; masliah, E. APP transgenic modeling of Alzheimer´s disease: mechanisms of neurodegeneration and aberrant neurogenesis.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuroscience, 2012, 211, 51-76. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurotherapeutics, 2012, 9(2), 297-314. http://dx.doi.org/10.1007/s13311-012-0104-2 [73] Chaboub, L.S.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2012, 34(5), 379-388. http://dx.doi.org/10.1159/ 000343723 [74] Sofroniew, M.V.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2015, 16(5), 249-263. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"http://dx.doi.org/10.1101/cshperspect.a020420 [76] Kang, W.; Hebert, J.M.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuron, 2014, 81(2), 229-248. http://dx.doi.org/10.1016/j.neuron.2013.12.034 [78] Camara , M.L.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuropsycopharmacology, 2015, 40, 502-512. http://dx.doi.org/10.1038/npp.2014.199 [79] Dubois, R.N.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuroimmunol., 2001, 114(1-2), 8-18. http://dx.doi.org/10.1016/S0165-5728(01)00246-6 [81] Minghetti, L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Exp.Neurol., 2004, 63(9), 901-910. http://dx.doi.org/10.1093/jnen/63.9.901 [82] Brown, G.C.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Trans., 2007, 35, 1119-1121. http://dx.doi.org/10.1042/BST0351119 [83] Doherty, G.H.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Bull., 2011, 27(6), 366-382. http://dx.doi.org/10.1007/s12264-011-1530-6 [84] Lassmann, H. Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer´s disease.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Transm., 2011, 118(5), 747-752. http://dx.doi.org/10.1007/s00702-011-0607-8 [85] Drechsel, D.A.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Res., 2012, 22(4), 251-264. http://dx.doi.org/10.1007/s12640-012-9322-y [86] Nathan, C.; Calingasan, N.; Nezezon, J.; Ding, A.; Lucia, M.S.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Med., 2005, 202(9), 1163-1169. http://dx.doi.org/10.1084/jem.20051529 [87] Tomaz, V.S.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuroscience, 2014, 268, 236-246. http://dx.doi.org/10.1016/j.neuroscience.2014.03.025 [88] Sapirstein, A.; Saito, H.; Texel, S.J.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"http://dx.doi.org/10.1152/ajpregu.00815.2004 [89] Dunn, A.J.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuroimmunomodulation, 2006, 13(2), 96-104. http://dx.doi.org/10.1159/000096291 [90] Czapski, G.A.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Brain Res., 2010, 1356, 85-94. http://dx.doi.org/10.1016/j.brainres.2010.07.096 [91] Chung, D.W.; Yoo, K.Y.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurobiol., 2010, 30(4), 531-541. http://dx.doi.org/10.1007/s10571-009-9477-0 [92] Song, J.H.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuroimmunomodulation, 1996, 3(6), 364-370. http://dx.doi.org/10.1159/000097297 [95] Palin, K.; Bluthe, R.M.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immun., 2004, 18(3), 223-230. http://dx.doi.org/10.1016/j.bbi.2003.09.002 [96] Sparkman, N.L.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2006, 26(42), 10709-10716. http://dx.doi.org/10.1523/ JNEUROSCI.3376-06.2006 [97] Mandolesi, G.; Grasseli, G.; Musumeci, G.; Centonze, D. Cognitive deficits in experimental autoimmune encephalomyelitis: neuro- inflammation and synaptic degeneration.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"http://dx.doi.org/10.1007/s10072-010-0369-3 [98] Jain, N.K.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Res., 2002, 133, 369-376. http://dx.doi.org/10.1016/S0166-4328(02)00025-6 [99] Sparkman, N.L.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Brain Res., 2005, 159, 145-151. http://dx.doi.org/10.1016/j.bbr.2004.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Lett., 2007, 429(1), 69-73. http://dx.doi.org/10.1016/j.neulet.2007.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immun., 2007, 21, 824-835. http://dx.doi.org/10.1016/j.bbi.2007.01.009 [102] Ormerod, B.K.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immun., 2013, 29, 28-38. http://dx.doi.org/10.1016/j.bbi.2012.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosci., 2014, 8, 83. http://dx.doi.org/10.3389/fnins.2014.00083 [104] Choi, D.K.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Molecules, 2011, 16(2), 1021-1043. http://dx.doi.org/10.3390/molecules16021021 [105] Ray, B.; Chauhan, N.B.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Chem., 2011, 18(22), 3306-3313. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Res., 2012, 37(9), 1829-1842. http://dx.doi.org/10.1007/s11064-012-0799-9 [107] Spencer, J.P.; Vafeiadou, K.; Williams, R.J.; vauzour, D. Neuroinflammation: modulation by flavonoids and mechanisms of action.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Aspects Med., 2012, 33(1), 83-97. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Food Agric., 2014, 94, 1042-1056. http://dx.doi.org/10.1002/jsfa.6473 [109] Rege, S.D.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Aging Neurosci., 2014, 6, 218. http://dx.doi.org/ 10.3389/fnagi.2014.00218 [110] Poulsen, M.M.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Acta, 2015, 1852, 6, 1124-1136. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Acta, 2015, 1852, 6, 1209-1218. http://dx.doi.org/10.1016/j.bbadis.2015.01.012 [112] Abraham, J.; Johnson, R.W.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Rejuvenation Res., 2009, 12(6), 445-453. http://dx.doi.org/10.1089/rej.2009.0888 [113] Sebai, H.; Sani, M.; Ghanem-Boughanmi, N.; Aouani, E. Prevention of lipopolysaccharide-induced mouse lethality by resveratrol.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Biol., 2015, 822, 107-108. http://dx.doi.org/10.1007/978-3-319-08927-0_12 [115] Noorafshan, A.; Ashkani-Esfahani, S.A review on therapeutic effects of curcumin.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Des., 2013, 19(11), 2032-2046. http://dx.doi.org/10.2174/1381612811319110006 [116] Lee, W.H.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuropharmacol., 2013, 11(4), 338-378. http://dx.doi.org/ 10.2174/1570159X11311040002 [117] Furst, R.; Zundorf, I. Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progress.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Molecules, 2015, 20(2), 2728-2769. http://dx.doi.org/10.3390/molecules20022728 [119] Vallianou, N.G.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Ther., 2008, 326(1), 196-208. http://dx.doi.org/10.1124/jpet.108.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Brain Res., 2014, 274, 282-290. http://dx.doi.org/10.1016/j.bbr.2014.08.018 [122] Zhuang, X.; Xiang, X.; Grizzle, W.; Sun, D.; Zhang, S.; Axtell., R.; Ju, S.; Mu, J.; Zhang, L.; Steinman, L.; Miller, D.; Zhang, H.G.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Ther., 2011, 19(10), 1769-1779. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Physiol., 2014, 5, 98. http://dx.doi.org/10.3389/ fphys.2014.00098 [124] Chen, W.Z.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Bull., 2015, 38(2), 239-247. http://dx.doi.org/10.1248/ bpb.b14-00599 [125] Guan, N.; Huo, X.; Zhang, Z.; Zhang, S.; Luo, J.; Guo, W. Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Res., 2013, 27, 1270-1276. http://dx.doi.org/10.1002/ptr.4852 [128] Ni, Y.F.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"http://dx.doi.org/10.1016/j.jss.2010.10.004 [129] Ming, L.J.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"http://dx.doi.org/10.1007/s10753-015-0133-1 [131] Schepetkin, I.A.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immunol., 2009, 183(10), 6754-6766. http://dx.doi.org/10.4049/ jimmunol.0901827 [132] Kiss, A.K.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Allergy  Drug Targets, 2012, 11(3), 207-221. http://dx.doi.org/10.2174/ 187152812800392715 [134] Suk, K. Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neurosignals, 2005, 14, 23-33. http://dx.doi.org/10.1159/000085383 [135] Vafeiadou, K.; Vauzour, D.; Spencer, J.P. Neuroinflammation  and its modulation by flavonoids.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Drug Targets, 2007, 7(3), 211-224. http://dx.doi.org/10.2174/ 187153007781662521 [136] Ha, S.K.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Res., 2012, 37, 1560-1567. http://dx.doi.org/10.1007/s11064-012-0751-z [137] Lee, Y.J.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Biochem., 2013, 24, 298-310. http://dx.doi.org/10.1016/j.jnutbio.2012.06.011 [138] Wang, Y.J.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Int., 2010, 56, 424-430. http://dx.doi.org/10.1016/j.neuint.2009.11.016 [139] Mestas, J.; Hughes, C.C.W.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Immunol., 2004, 172, 2731-2738. http://dx.doi.org/10.4049/jimmunol.172.5.2731 [140] Seok, J.; Warren, H.S.",OADS,/arxiv_data1/oa_pdf/b5/c0/CN-14-155.PMC4825946.pdf
"Neuropharmacology, 2014, 77, 131-144. doi: http://dx.doi.org/10.1016/j.neuropharm.2013.09.021  [75] Deussing, J.M.",Non-OADS,/arxiv_data1/oa_pdf/9e/aa/CN-14-165.PMC4825947.pdf
"Aging, 2007, 28 ( 7 ) ,  9 8 7-994. http://dx.doi.org/10.1016/j.neurobiolaging.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neurol., 2005, 62 (2), 192-195. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neurosci., 2003, 6 ( 4 ) ,  3 4 5-351. http://dx.doi.org/10.1038/nn0403-345 [4] Vignini, A.; Giulietti, A.; Nanetti, L.; Raffaelli, F.; Giusti, L.; Mazzanti, L.; Provinciali, L. Alzheimer’s Disease and Diabetes: New Insights and Unifying Therapies.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Diabetes Rev.2013, 9 (3), 218-227. http://dx.doi.org/10.2174/1573399811309030003 [5] Lopes da Silva, S.; Vellas, B.; Elemans, S.; Luchsinger, J.; Kamphuis, P.; Yaffe, K.; Sijben, J.; Groenendijk, M.; Stijnen, T. Plasma Nutrient Status of Patients with Alzheimer’s Disease: Systematic Review and Meta-Analysis.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Dement.2014, 10 (4), 485-502. http://dx.doi.org/10.1016/j.jalz.2013.05.1771 [6] Lopes da Silva, S.; Elemans, S.; Kamphuis, P.; Sijben, J.; Groenendijk, M. Plasma Nutrient Status of Alzheimer’s Disease Patients Compared to Cognitive Intact Elderly Controls: A Systematic Review and Meta-Analysis.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"http://dx.doi.org/10.1016/j.jalz.2012.05.2004 [7] Jeandel, C.; Nicolas, M. B.; Dubois, F.; Nabet-Belleville, F.; Penin, F.; Cuny, G. Lipid Peroxidation and Free Radical Scavengers in Alzheimer’s Disease.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Gerontology, 1989, 35 ( 5-6), 275-282. http://dx.doi.org/10.1159/000213037 [8] Olde Rikkert, M. G. M.; Verhey, F. R.; Sijben, J. W. C.; Bouwman, F. H.; Dautzenberg, P. L. J.; Lansink, M.; Sipers, W. M. W.; van Asselt, D. Z.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Health Aging, 2014, 18 (9), 800-805. http://dx.doi.org/10.1007/s12603-014-0552-y [10] Han, J.-Y.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"2014, 29 ( 7 ) ,  8 8 6-892. http://dx.doi.org/10.3346/jkms.2014.29.7.886 [11] Ogawa, S. Nutritional Management of Older Adults with Cognitive Decline and Dementia.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Int., 2014, 14 Suppl 2, 17-22. http://dx.doi.org/10.1111/ggi.12252 [12] Polidori, M. C.; Nelles, G. Antioxidant Clinical Trials in Mild Cognitive Impairment and Alzheimer’s Disease - C h a l l e n g e s  a n d  Perspectives.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Des., 2014, 20 ( 1 8 ) ,  3 0 8 3-3092. http://dx.doi.org/10.2174/13816128113196660706 [13] Rijpma, A.; Meulenbroek, O.; Olde, R., M. G. M. Cholinesterase Inhibitors and Add-on Nutritional Supplements in Alzheimer’s Disease: A Systematic Review o f  R a n d o m i z e d  C o n t r o l l e d  T r i a l s .",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Rev., 2014, 16, 105-112. http://dx.doi.org/10.1016/ j.arr.2014.06.002 [14] Grodstein, F.; O’Brien, J.; Kang, J. H.; Dushkes, R.; Cook, N. R.; Okereke, O.; Manson, J. E.; Glynn, R. J.; Buring, J. E.; Gaziano, M.; Sesso, H. D. Long-Term Multivitamin Supplementation and Cognitive Function in Men: A Randomized Trial.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Med., 2013, 159 ( 1 2 ) ,  8 0 6-814. http://dx.doi.org/10.7326/0003-4819-159-12-201312170-00006 [15] Mi, W.; van Wijk, N.; Cansev, M.; Sijben, J. W. C.; Kamphuis, P. J. G. H. Nutritional Approaches in the Risk Reduction and Management of Alzheimer’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Nutrition, 2013, 29 ( 9 ) ,  1080-1089. http://dx.doi.org/10.1016/j.nut.2013.01.024 [16] Morris, M. C. The Role of Nutrition in Alzheimer’s Disease: Epidemiological Evidence.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neurol., 2009, 16 Suppl 1, 1-7. http://dx.doi.org/10.1111/j.1468-1331.2009.02735.x [17] Shah, R. The Role of Nutrition and Diet in Alzheimer Disease: A Systematic Review.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Assoc., 2013, 14 ( 6 ) ,  3 9 8-402. http://dx.doi.org/10.1016/j.jamda.2013.01.014 [18] Parletta, N.; Milte, C. M.; Meyer, B. J. Nutritional Modulation of Cognitive Function and Mental Health.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Biochem., 2013, 24 (5), 725-743. http://dx.doi.org/10.1016/j.jnutbio.2013.01.002 [19] Mohajeri, M. H.; Troesch, B.; Weber, P. Inadequate Supply of Vitamins and DHA in the Elderly: Implications for Brain Aging and Alzheimer-Type Dementia.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Nutrition, 2015, 31 ( 2 ) ,  2 6 1-275. http://dx.doi.org/10.1016/j.nut.2014.06.016 [20] Oxidative Stress and Free Radical Damage in Neurology; Gadoth, N., Göbel, H. H., Eds.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Aging, 2002, 23 ( 5 ) ,  7 4 7-769. http://dx.doi.org/10.1016/S0197-4580(02)00079-9",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Sci.,1999, 890, 356-364. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Med., 2005, 142 ( 1 ) ,  3 7-46. http://dx.doi.org/10.7326/0003-4819-142-1-200501040-00110 [39] Aquilano, K.; Baldelli, S.; Rotilio, G.; Ciriolo, M. R. Role of Nitric Oxide Synthases in Parkinson’s Disease: A Review on the Antioxidant and Anti-Inflammatory Activity of Polyphenols.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Res., 2008, 33 ( 1 2 ) ,  2 4 1 6-2426. http://dx.doi.org/ 10.1007/s11064-008-9697-6 [40] Subash, S.; Essa, M. M.; Al-Asmi, A.; Al-Adawi, S.; Vaishnav, R. Chronic Dietary Supplementation of 4% Figs on the Modification of Oxidative Stress in Alzheimer’s Disease Transgenic Mouse Model.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neurosci., 2014, http://dx.doi.org/10.1179/ 1476830514Y.0000000131 [42] Subash, S.; Essa, M. M.; Al-Adawi, S.; Memon, M. A.; Manivasagam, T.; Akbar, M. Neuroprotective Effects of Berry Fruits on Neurodegenerative Diseases.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Res., 2014, 9 (16), 1557-1566. http://dx.doi.org/10.4103/1673-5374.139483 [43] Vingtdeux, V.; Dreses-Werringloer, U.; Zhao, H.; Davies, P.; Marambaud, P. Therapeutic Potential of Resveratrol in Alzheimer’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"http://dx.doi.org/ 10.1186/1471-2202-9-S2-S6 [44] Bastianetto, S.; Ménard, C.; Quirion, R. Neuroprotective Action of Resveratrol.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Age (Dordr)., 2013, 35 (5), 1851-1865. http://dx.doi.org/10.1007/s11357-012-9489-4 [46] Noguer, M. A.; Cerezo, A.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Res., 2012, 65 (6), 609-614. http://dx.doi.org/10.1016/j.phrs.2012.03.003 [47] Pietri, S.; Maurelli, E.; Drieu, K.; Culcasi, M. Cardioprotective and Anti-Oxidant Effects of the Terpenoid Constituents of Ginkgo Biloba Extract (EGb 761).",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Cardiol.1997, 29 (2), 733-742. http://dx.doi.org/10.1006/jmcc.1996.0316 [48] Luo, Y.; Smith, J. V; Paramasivam, V.; Burdick, A.; Curry, K. J.; Buford, J. P.; Khan, I.; Netzer, W. J.; Xu, H.; Butko, P. Inhibition of Amyloid-Beta Aggregation and Caspase-3 Activation by the Ginkgo Biloba Extract EGb761.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Maturitas, 2013, 76 (2), 113-117. http://dx.doi.org/10.1016/j.maturitas.2013.06.011 [51] Yamagishi, K.; Iso, H.; Yatsuya, H.; Tanabe, N.; Date, C.; Kikuchi, S.; Yamamoto, A.; Inaba, Y.; Tamakoshi, A. Dietary Intake of Saturated Fatty Acids and Mortality from Cardiovascular Disease in Japanese: The Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Nutr., 2010, 92 ( 4), 7 5 9-765. http://dx.doi.org/10.3945/ajcn.2009.29146 [52] Kalmijn, S.; van Boxtel, M. P. J.; Ocké, M.; Verschuren, W. M. M.; Kromhout, D.; Launer, L. J. Dietary Intake of Fatty Acids and Fish in Relation to Cognitive Performance at Middle Age.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neurology, 2004, 62 ( 2 ) ,  2 7 5-280. http://dx.doi.org/10.1212/01.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"2009, 29, 59-87. http://dx.doi.org/10.1146/annurev-nutr-080508-141059 [67] Huss, M.; Völp, A.; Stauss-Grabo, M. Supplementation of Polyunsaturated Fatty Acids, Magnesium and Zinc in Children Seeking Medical Advice for Attention-Deficit/hyperactivity Problems - a n  O b s e r v a t i o n a l  C o h o r t  S t u d y .",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Psychopharmacol., 2013, 33 (2), 199-205. http://dx.doi.org/10.1097/JCP.0b013e3182825bfd [89] Cumbo, E.; Ligori, L. D. Differential Effects of Current Specific Treatments on Behavioral and Psychological Symptoms in Patients with Alzheimer’s Disease: A 12-Month, Randomized, Open-Label Trial.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Disord., 2011, 25 (4), 333-340. http://dx.doi.org/10.1097/WAD.0b013e318212ab7a",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Psychopharmacol., 2013, 28 ( 6 ) ,  3 4 6-348. http://dx.doi.org/10.1097/YIC.0b013e328364f58d [92] Zhong, Y.; Z h e n g ,  X .",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Sci., 2013, 345 ( 3 ) ,  2 2 2-226. http://dx.doi.org/10.1097/MAJ.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neurology, 2009, 73 (10), 761-767. http://dx.doi.org/10.1212/WNL.0b013e3181b6bbe3 [94] Albani, D.; Martinelli Boneschi, F.; Biella, G.; Giacalone, G.; Lupoli, S.; Clerici, F.; Benussi, L.; Ghidoni, R.; Galimberti, D.; Squitti, R.; Mariani, S.; Confaloni, A.; Bruno, G.; Mariani, C.; Scarpini, E.; Binetti, G.; Magnani, G.; Franceschi, M.; Forloni, G. Replication Study to Confirm the Role of CYP2D6 Polymorphism rs1080985 on Donepezil Efficacy in Alzheimer’s Disease Patients.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"BMC Geriatr., 2013, 13, 56. http://dx.doi.org/10.1186/ 1471-2318-13-56 [96] Christensen, D. D. Higher-Dose (23 Mg/day) Donepezil Formulation for the Treatment of Patients with Moderate-to-Severe Alzheimer’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Med., 2012, 124 ( 6 ) ,  1 1 0-116. http://dx.doi.org/10.3810/pgm.2012.11.2589 [97] Yang, Y.-H.; Chen, C.-H.; Chou, M.-C.; Li, C.-H.; Liu, C.-K.; Chen, S.-H.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Psychopharmacol., 2013, 33 ( 3 ) ,  351-355. http://dx.doi.org/10.1097/JCP.0b013e31828b5087 [98] Tariot, P.; Salloway, S.; Yardley, J.; Mackell, J.; Moline, M. Long-Term Safety and Tolerability of Donepezil 23 Mg in Patients with Moderate to Severe Alzheimer’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Disord., 2012, 33 (2-3), 164-173. http://dx.doi.org/10.1159/000338236 [100] Lo, D.; Grossberg, G. T. Use of Memantine for the Treatment of Dementia.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neurother., 2011, 11 ( 1 0 ) ,  1 3 5 9-1370. http://dx.doi.org/10.1586/ern.11.132 [101] Lipton, S. A. Paradigm Shift in Neuroprotection by NMDA Receptor Blockade: Memantine and Beyond.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Drug Discov., 2006, 5 (2), 160-170. http://dx.doi.org/10.1038/nrd1958 [102] Bakchine, S.; Loft, H. Memantine Treatment in Patients with Mild to Moderate Alzheimer’s Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Psychiatry, 2006, 14 ( 8 ) ,  7 0 4-715. http://dx.doi.org/10.1097/01.JGP.0000224350.82719.83 [104] Zhang, N.; Wei, C.; Du, H.; Shi, F.-D.; Cheng, Y.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Disord., 2015, 40 ( 1-2), 85-93. http://dx.doi.org/10.1159/000430808 [105] Clements, J. D.; Lester, R. A.; Tong, G.; Jahr, C. E.; Westbrook, G. L. The Time Course of Glutamate in the Synaptic Cleft.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Science, 1992, 258 ( 5 0 8 7 ) ,  1 4 9 8-1501. http://dx.doi.org/10.1126/science.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Cell Death Differ., 2003, 11 (1), 18-20. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"FEBS Lett., 2004, 566 ( 1-3), 261-269. http://dx.doi.org/10.1016/ j.febslet.2004.04.047 [109] Tariot, P. N.; Farlow, M. R.; Grossberg, G. T.; Graham, S. M.; McDonald, S.; Gergel, I. Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil: A Randomized Controlled Trial.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Ther., 2015, 7 (1), 28. http://dx.doi.org/10.1186/s13195-015-0109-2 [111] Matsunaga, S.; Kishi, T.; Iwata, N. Combination Therapy  with Cholinesterase Inhibitors and Memantine for Alzheimer’s Disease: A Systematic Review and Meta-Analysis.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"http://dx.doi.org/10.1093/ijnp/ pyu115 [112] Creţu, O.; Szalontay, A. S.; Chiriţă, R.; Chiriţă, V. Effect of Memantine Treatment on Patients with Moderate-to-Severe Alzheimer’s Disease Treated with Donepezil.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Alzheimer Res., 2008, 5 ( 1 ) ,  8 3-89. http://dx.doi.org/10.2174/ 156720508783884576 [114] Modrego, P. J.; Fayed, N.; Errea, J. M.; Rios, C.; Pina, M. A.; Sarasa, M. Memantine versus Donepezil in Mild to Moderate Alzheimer’s Disease: A Randomized Trial with Magnetic Resonance Spectroscopy.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neurol., 2010, 17 ( 3 ) ,  4 0 5-412. http://dx.doi.org/10.1111/j.1468-1331.2009.02816.x [115] Ritchie, C. W.; Bajwa, J.; Coleman, G.; Hope, K.; Jones, R. W.; Lawton, M.; Marven, M.; Passmore, P. Souvenaid®: A New Approach to Management of Early Alzheimer’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Health Aging, 2014, 18 ( 3 ) ,  2 9 1-299. http://dx.doi.org/10.1007/ s12603-013-0411-2 [116] Thaipisuttikul, P.; Galvin, J. E. Use of Medical Foods and Nutritional Approaches in the Treatment of Alzheimer’s Disease.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"(Lond)., 2012, 9 ( 2 ) ,  1 9 9-209. http://dx.doi.org/ 10.2217/cpr.12.3 [117] De Waal, H.; Stam, C. J.; Lansbergen, M. M.; Wieggers, R. L.; Kamphuis, P. J. G. H.; Scheltens, P.; Maestú, F.; van Straaten, E. C. W. The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"http://dx.doi.org/10.1371/journal.pone.0086558 [118] Scheltens, P.; Twisk, J. W. R.; Blesa, R.; Scarpini, E.; von Arnim, C. A. F.; Bongers, A.; Harrison, J.; Swinkels, S. H. N.; Stam, C. J.; de Waal, H.; Wurtman, R. J.; Wieggers, R. L.; Vellas, B.; Kamphuis, P. J. G. H. Efficacy of Souvenaid in Mild Alzheimer’s Disease: Results from a Randomized, Controlled Trial.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Aging, 2015, 36 (1), 344-351. http://dx.doi.org/10.1016/ j.neurobiolaging.2014.07.021 [120] Scheltens, P.; Kamphuis, P. J. G. H.; Verhey, F. R. J.; Olde Rikkert, M. G. M.; Wurtman, R. J.; Wilkinson, D.; Twisk, J. W. R.; Kurz, A. Efficacy of a Medical Food in Mild Alzheimer’s Disease: A Randomized, Controlled Trial.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"http://dx.doi.org/10.1016/j.jalz.2009.10.003 [121] Shah, R. C.; Kamphuis, P. J.; Leurgans, S.; Swinkels, S. H.; Sadowsky, C. H.; Bongers, A.; Rappaport, S. a; Quinn, J. F.; Wieggers, R. L.; Scheltens, P.; Bennett, D. a.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Ther., 2013, 5 (6), 59. http://dx.doi.org/10.1186/alzrt224",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Res., 2012, 37 (12), 2706-2714. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neurol., 2006, 63 ( 1 0 ) ,  1402-1408. http://dx.doi.org/10.1001/archneur.63.10.1402 [126] Cornelli, U.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Dis., 2010, 7 (1-3), 193-202. http://dx.doi.org/10.1159/000295663 [127] Sun, Y.; Lu, C.-J.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Ther., 2007, 29 ( 1 0 ) ,  2 2 0 4-2214. http://dx.doi.org/10.1016/ j.clinthera.2007.10.012 [128]  Vedin, I.; Cederholm, T.; Freund-Levi, Y.; Basun, H.; Garlind, A.; Irving, G. F.; Eriksdotter-Jönhagen, M.; Wahlund, L. O.; Dahlman, I.; Palmblad, J.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"PloS One, 2012, 7(4), 1-8. http://dx.doi.org/10.1371/journal.",Non-OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
"Neuroscience, 2007, 149(2), 286-302. http://dx.doi.org/10.1016/j.neuroscience.2007.08.",OADS,/arxiv_data1/oa_pdf/69/70/CN-14-177.PMC4825948.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Lancet, 2003, 361, 653-661. http://dx.doi.org/10.1016/ S0140-6736(03)12599-8 [3] Fava, M. Diagnosis and definition of treatment-resistant depression.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Psychiat., 2003, 53, 649-659. http://dx.doi.org/ 10.1016/S0006-3223(03)00231-2 [4] Rozensweig-Lipson, S.; Beyer, C.E.",OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Ther., 2007, 113, 134-143. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Neuropharmacology, 2013, 70, 338-347. http://dx.doi.org/ 10.1016/j.neuropharm.2013.02.024 [11] Citrome, L. Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - w h a t  i s  t h e  n u m b e r  n e e d e d  t o  t r e a t ,  number needed to harm and likelihood to be helped or harmed?",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Pract., 2013, 67, 1089-1104. http://dx.doi.org/10.1111/ijcp.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Drugs, 2013, 73, 1639-1645. http://dx.doi.org/10.1177/0897190013516504 [13] Saraceni, M.M.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Pharmacol., 2014, 7, 137-145. http://dx.doi.org/10.1586/ 17512433.2014.889563 [15] Palmer, E.C.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Pharmacother., 2014, 48, 1030-1039. http://dx.doi.org/10.1177/1060028014535074 [16] Sansone, R.A.; Sansone, L.A. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"CNS Drugs, 2014, 28, 1071-1082. http://dx.doi.org/10.1007/s40263-014-0203-1 [18] Deardorff, W.J.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Pharmacother., 2014, 15, 2525-2542. http://dx.doi.org/10.1517/14656566.2014.960842 [19] Asnis, G.M.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Treat., 2015, 11, 125-135. http://dx.doi.org/10.2147/NDT.S54710 [20] Stahl, S.M.",OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Neuro- psychopharmacology, 2001, 25, 8 7 1-880. http://dx.doi.org/10.1016/ S0893-133X(01)00298-6 [22] Vaishnavi, S.N.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Ther., 2006, 318, 657-665. http://dx.doi.org/10.1124/jpet.106.103382 [24] Chen, L.; Periclou, A.; Ghahramani, P.; Greenberg, W.M.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Drug Investig., 2014, 34, 351-359. http://dx.doi.org/10.1007/ s40261-014-0182-5",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"CNS Drugs, 2012, 26, 39-67. http://dx.doi.org/10.2165/11594710-000000000-00000 [28] Montgomery, S.A.; Mansuy, L.; Ruth, A.; et al.",OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Psychiatry, 2013, 74(4), 363-369. http://dx.doi.org/10.4088/JCP.12m08141 [29] Asnis, G.M.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Psychiatry, 2013, 74(3), 242-248. http://dx.doi.org/10.4088/JCP.12m08197 [30] Bakish, D.; Bose, A.; Gommoll, C.; Chen, C., Nunez, R., Greenberg, W.M., Liebowitz, M., Khan, A.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"J. Psychiatry Neurosci., 2014, 39(1), 40-49. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Psychopharmacol., 2014, 34(1), 1-10. http://dx.doi.org/10.1097/JCP.0000000000000060 [32] Gommoll, C.P.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Drug Investig., 2013, 33(10), 761-771. http://dx.doi.org/10.1007/s40261-013-0126-5 [34] Shiovitz, T.; Greenberg, W.M.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Psychopharmacol., 2014, 29, 26-35. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Psychopharmacol., 2014, 29, 197-205. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Disord., 2015, 170, 230-236. http://dx.doi.org/10.1016/j.jad.2014.09.005 [39] Acquadro, C.; Berzon, R.; Dubois, D.; Leidy, N.K.",OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Value Health, 2003, 6(5), 522-531. http://dx.doi.org/10.1046/j.1524-4733.2003.65309.x [40] Thase, M.E.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Psychiatry, 2009, 70 (Suppl 6), 4-9. http://dx.doi.org/10.4088/JCP.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"http://dx.doi.org/10.1097/00005650-198903001-00012 [42] Patrick, D.L.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Psychopharmacol., 2013, 27, 740-758. http://dx.doi.org/10.1177/ 0269881113494937 [45] Sansone, R.A.; Sansone, L.A. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison.",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Ther., 2011, 1 7(6), 723-732. http://dx.doi.org/10.1111/j.1755-5949.2010.00217.x   Received: April 18, 2015 Revised: November 04, 2015 Accepted: November 11, 2015",Non-OADS,/arxiv_data1/oa_pdf/65/ce/CN-14-191.PMC4825949.pdf
"Brain, 2006, 129 ( P t  7 ) ,  1 6 5 9-73. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurobiol., 2001, 24 (1-3), 107-29. http://dx.doi.org/10.1385/MN:24:1-3:107 [4] Zadori, D.; Klivenyi, P.; Szalardy, L.; Fulop, F.; Toldi, J.; Vecsei, L. Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: novel therapeutic strategies for neurodegenerative disorders.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Sci., 2012, 322 ( 1-2), 187-91. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Drug Targets, 2001, 2 (3), 241-71. http://dx.doi.org/10.2174/1389450013348335 [7] Lipton, S. A.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"NeuroRx, 2004, 1 ( 1 ) ,  1 0 1-10. http://dx.doi.org/10.1602/ neurorx.1.1.101 [8] Chen, L.; Yamada, K.; Nabeshima, T.; Sokabe, M. alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 2006, 50 ( 2 ) ,  2 5 4-68. http://dx.doi.org/ 10.1016/j.neuropharm.2005.09.018 [9] Parsons, C. G.; Stoffler, A.; Danysz, W. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 2007, 53 ( 6 ) ,  699-723. http://dx.doi.org/10.1016/j.neuropharm.2007.07.013 [10] Lipton, S. A.; Chen, H. S. Paradigm shift in neuroprotective drug development: clinically tolerated NMDA receptor inhibition by memantine.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Cell Death Differ., 2004, 11 ( 1 ) ,  1 8-20. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Drug Discov., 2004, 3 ( 2 ) ,  1 0 9-10. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 1989, 166 (3), 591-2. http://dx.doi.org/10.1016/0014-2999(89)90385-3 [13] Kornhuber, J.; Bormann, J.; Retz, W.; Hubers, M.; Riederer, P. Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human f r o n t a l  c o r t e x .",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"J. Pharmacol.,1989, 166 (3), 589-90. http://dx.doi.org/10.1016/0014-2999(89)90384-1 [14] Danysz, W.; Parsons, C. G.; Mobius, H. J.; Stoffler, A.; Quack, G. Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurotox Res., 2000, 2 (2-3), 85-97. http://dx.doi.org/10.1007/BF03033787 [15] Parsons, C. G.; Danysz, W.; Quack, G. Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 1999, 38 ( 6 ) ,  735-67. http://dx.doi.org/10.1016/S0028-3908(99)00019-2 [16] Parsons, C. G.; Gruner, R.; Rozental, J.; Millar, J.; Lodge, D. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3, 5-dimethyladamantan).",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 1993, 32 (12), 1337-50. http://dx.doi.org/10.1016/0028-3908(93)90029-3 [17] Johnson, J. W.; Kotermanski, S. E. Mechanism of action of memantine.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Lett., 1995, 195 (2), 137-9. http://dx.doi.org/10.1016/0304-3940(95)11785-U [19] Sonkusare, S. K.; Kaul, C. L.; Ramarao, P. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Res., 2005, 51 ( 1 ) ,  1-17. http://dx.doi.org/10.1016/j.phrs.2004.05.005 [20] Sobolevsky, A. I.; Koshelev, S. G.; Khodorov, B. I. Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Physiol., 1998, 512 (Pt 1), 47-60. http://dx.doi.org/10.1111/j.1469-7793.1998.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 2002, 61 ( 3 ) ,  5 3 3-45. http://dx.doi.org/10.1124/mol.61.3.533 [22] Chen, H. S.; Pellegrini, J. W.; Aggarwal, S. K.; Lei, S. Z.; Warach, S.; Jensen, F. E.; Lipton, S. A. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 2007, 53 (3), 415-20. http://dx.doi.org/10.1016/j.neuropharm.2007.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 2009, 56 (5), 866-75. http://dx.doi.org/10.1016/j.neuropharm.2009.01.012 [25] Glodzik, L.; King, K. G.; Gonen, O.; Liu, S.; De Santi, S.; de Leon, M. J. Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Psychiatry, 2008, 32 ( 4 ) ,  1 0 0 5-12. http://dx.doi.org/10.1016/j.pnpbp.2008.01.016 [26] van Wageningen, H.; Jorgensen, H. A.; Specht, K.; Hugdahl, K. A 1H-MR spectroscopy study of changes in glutamate and glutamine (Glx) concentrations in frontal spectra after administration of memantine.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Cerebral Cortex, 2010, 20 (4), 79 8-803. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 1991, 198 ( 2-3), 215-7. http://dx.doi.org/10.1016/0014-2999(91)90625-Z [28] Osborne, N. N.; Quack, G. Memantine stimulates inositol phosphates production in neurones and nullifies N-methyl-D-aspartate-induced destruction of retinal neurones.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Int., 1992, 21 (3), 329-36. http://dx.doi.org/10.1016/0197-0186(92) 90183-R [29] Weller, M.; Finiels-Marlier, F.; Paul, S. M. NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Brain Res., 1993, 613 ( 1 ) ,  1 4 3-8. http://dx.doi.org/10.1016/0006-8993(93)90464-X [30] Barnes, C. A.; Danysz, W.; Parsons, C. G. Effects of the uncompetitive NMDA receptor antagonist memantine on",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurosci., 1996, 8 (3), 565-71. http://dx.doi.org/10.1111/j.1460-9568.1996.tb01241.x [31] Frankiewicz, T.; Parsons, C. G. Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 1999, 38 ( 9 ) ,  1 2 5 3-9. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 1997, 36 ( 7 ) ,  9 6 1-71. http://dx.doi.org/ 10.1016/S0028-3908(97)00070-1 [33] Schmitt, F.; Ryan, M.; Cooper, G. A brief review of the pharmacologic and therapeutic aspects of memantine in Alzheimer's disease.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Toxicol., 2007, 3 (1), 135-41. http://dx.doi.org/10.1517/17425255.3.1.135 [34] Song, M. S.; Rauw, G.; Baker, G. B.; Kar, S. Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurosci., 2008, 28 (10), 1989-2002. http://dx.doi.org/10.1111/j.1460-9568.2008.06498.x [35] Martinez-Coria, H.; Green, K. N.; Billings, L. M.; Kitazawa, M.; Albrecht, M.; Rammes, G.; Parsons, C. G.; Gupta, S.; Banerjee, P.; LaFerla, F. M. Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pathol., 2010, 176 ( 2 ) ,  8 7 0-80. http://dx.doi.org/10.2353/ajpath.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Suppl., 2004, (68), 117-22. http://dx.doi.org/10.1007/978-3-7091-0579-5_14 [37] Aarsland, D.; Ballard, C.; Walker, Z.; Bostrom, F.; Alves, G.; Kossakowski, K.; Leroi, I.; Pozo-Rodriguez, F.; Minthon, L.; Londos, E. Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Lancet Neurol., 2009, 8 ( 7 ) ,  6 1 3-8. http://dx.doi.org/10.1016/S1474-4422(09)70146-2 [38] Li, W.; Zhao, J. H.; Sun, S. G.; Zhang, J. W.; Suo, A. Q.; Ma, M. M. [Clinical rehabilitative effect of memantine on cognitive and motor disorders in patients with Parkinson's disease].",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Disord., 2009, 24 ( 8 ) ,  1 2 1 7-21. http://dx.doi.org/10.1002/mds.22495 [40] Moreau, C.; Delval, A.; Tiffreau, V.; Defebvre, L.; Dujardin, K.; Duhamel, A.; Petyt, G.; Hossein-Foucher, C.; Blum, D.; Sablonniere, B.; Schraen, S.; Allorge, D.; Destee, A.; Bordet, R.; Devos, D. Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Psychiat., 2013, 84 ( 5 ) ,  5 5 2-5. http://dx.doi.org/10.1136/jnnp-2012-303182 [41] Varanese, S.; Howard, J.; Di Rocco, A. NMDA antagonist memantine improves levodopa-induced dyskinesias and ""on-off"" phenomena in Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Disord., 2010, 25 (4), 508-10. http://dx.doi.org/10.1002/mds.22917 [42] Vidal, E. I.; Fukushima, F. B.; Valle, A. P.; Villas Boas, P. J.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Soc., 2013, 61 ( 1 ) ,  170-2. http://dx.doi.org/10.1111/jgs.12058 [43] Bigal, M.; Rapoport, A.; Sheftell, F.; Tepper, D.; Tepper, S. Memantine in the preventive treatment of refractory m i g r a i n e .",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Headache, 2008, 48 (9), 1337-42. http://dx.doi.org/10.1111/j.1526-4610.2008.01083.x [44] Spengos, K.; Theleritis, C.; Paparrigopoulos, T. Memantine and NMDA antagonism for chronic migraine: a potentially novel therapeutic approach?",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Headache, 2008, 48 ( 2 ) ,  2 8 4-6. http://dx.doi.org/10.1111/j.1526-4610.2007.01016.x [45] Chen, S. R.; Samoriski, G.; Pan, H. L. Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 2013, 721 ( 1-3), 382-90. http://dx.doi.org/10.1016/ j.ejphar.2013.06.020 [47] Pickering, G.; Morel, V.; Joly, D.; Villatte, C.; Roux, D.; Dubray, C.; Pereira, B.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Trials, 2014, 15, 331. http://dx.doi.org/10.1186/1745-6215-15-331 [48] Lipton, S. A. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 1999, 128 ( 8 ) ,  1 7 5 4-60. http://dx.doi.org/10.1038/ sj.bjp.0702940 [50] Rodriguez-Martinez, E.; Camacho, A.; Maldonado, P. D.; Pedraza-Chaverri, J.; Santamaria, D.; Galvan-Arzate, S.; Santamaria, A.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Brain Res., 2000, 858 ( 2 ) ,  4 3 6-9. http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Res., 1991, 16 ( 1 0 ) ,  1 1 3 9-43. http://dx.doi.org/10.1007/BF00966592 [52] Connick, J. H.; Stone, T. W. Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro a n d  in vivo.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 1988, 93 (4), 868-76. http://dx.doi.org/10.1111/j.1476-5381.1988.tb11474.x [53] Tavares, R. G.; Tasca, C. I.; Santos, C. E.; Alves, L. B.; Porciuncula, L. O.; Emanuelli, T.; Souza, D. O. Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Int., 2002, 40 ( 7 ) ,  6 2 1-7. http://dx.doi.org/10.1016/S0197-0186(01)00133-4 [54] Perkins, M. N.; Stone, T. W. Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurol., 1985, 88 (3), 570-9. http://dx.doi.org/10.1016/0014-4886(85)90072-X [55] Swartz, K. J.; During, M. J.; Freese, A.; Beal, M. F. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 1988, 154 (1), 85-7. http://dx.doi.org/10.1016/0014-2999(88)90367-6 [57] Kessler, M.; Terramani, T.; Lynch, G.; Baudry, M. A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurochem., 1989, 52 ( 4 ) ,  1 3 1 9-28. http://dx.doi.org/10.1111/ j.1471-4159.1989.tb01881.x [58] Hilmas, C.; Pereira, E. F.; Alkondon, M.; Rassoulpour, A.; Schwarcz, R.; Albuquerque, E. X.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurochem., 2002, 80 ( 6 ) ,  1 0 7 1-8. http://dx.doi.org/ 10.1046/j.0022-3042.2002.00805.x [60] Carpenedo, R.; Pittaluga, A.; Cozzi, A.; Attucci, S.; Galli, A.; Raiteri, M.; Moroni, F. Presynaptic kynurenate-sensitive receptors inhibit glutamate release.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurosci., 2001, 13 (11), 2141-7. http://dx.doi.org/10.1046/j.0953-816x.2001.01592.x [61] Prescott, C.; Weeks, A. M.; Staley, K. J.; Partin, K. M. Kynurenic acid has a dual action on AMPA receptor responses.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Lett., 2006, 402 ( 1-2), 108-12. http://dx.doi.org/10.1016/j.neulet.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"J. Neural Transm., 2008, 115 ( 8 ) ,  1 0 8 7-91. http://dx.doi.org/10.1007/s00702-008-0052-5 [63] Csapo, E.; Majlath, Z.; Juhasz, A.; Roosz, B.; Hetenyi, A.; Toth, G. K.; Tajti, J.; Vecsei, L.; Dekany, I.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"B. Biointerfaces, 2014, 123, 924-9. http://dx.doi.org/10.1016/j.colsurfb.2014.10.046 [64] Wang, J.; Simonavicius, N.; Wu, X.; Swaminath, G.; Reagan, J.; Tian, H.; Ling, L. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Chem., 2006, 281 (31), 22021-8. http://dx.doi.org/10.1074/jbc.M603503200 [65] Tajti, J.; Majlath, Z.; Szok, D.; Csati, A.; T o l d i ,  J .",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Des., 2015, 21, 2 2 5 0-8. http://dx.doi.org/10.2174/1381612821666150105163055 [66] Mo, X.; Pi, L.; Yang, J.; Xiang, Z.; Tang, A. Serum indoleamine 2, 3-dioxygenase and kynurenine aminotransferase enzyme activity in patients with ischemic stroke.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurosci., 2014, 21 (3), 482-6. http://dx.doi.org/10.1016/j.jocn.2013.08.020 [67] Widner, B.; Leblhuber, F.; Walli, J.; Tilz, G. P.; Demel, U.; Fuchs, D. Tryptophan degradation and immune activation in Alzheimer's disease.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"J. Neural Transm., 2000, 107 ( 3 ) ,  3 4 3-53. http://dx.doi.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurobiol., 2005, 31 ( 4 ) ,  3 9 5-404. http://dx.doi.org/10.1111/j.1365-2990.2005.00655.x [69] Guillemin, G. J.; Smythe, G. A.; Veas, L. A.; Takikawa, O.; Brew, B. J.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuroreport, 2003, 14 ( 1 8 ) ,  2 3 1 1-5. http://dx.doi.org/10.1097/00001756-200312190-00005 [70] Rahman, A.; Ting, K.; Cullen, K. M.; Braidy, N.; Brew, B. J.; Guillemin, G. J.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"http://dx.doi.org/10.1371/journal.pone.0006344 [71] Szalardy, L.; Klivenyi, P.; Zadori, D.; Fulop, F.; Toldi, J.; Vecsei, L. Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Chem., 2012, 19 ( 1 3 ) ,  1 8 9 9-920. http://dx.doi.org/10.2174/ 092986712800167365 [72] Stone, T. W.; Forrest, C. M.; Stoy, N.; Darlington, L. G. Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"J. Neural Transm., 2012, 119 (2), 261-74. http://dx.doi.org/10.1007/s00702-011-0676-8 [73] Klein, C.; Patte-Mensah, C.; Taleb, O.; Bourguignon, J. J.; Schmitt, M.; Bihel, F.; Maitre, M.; Mensah-Nyagan, A. G. The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 2013, 70, 254-60. http://dx.doi.org/10.1016/j.neuropharm.2013.02.006 [74] Graham, W. C.; Robertson, R. G.; Sambrook, M. A.; Crossman, A. R. Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Life Sci., 1990, 47 ( 1 8 ) ,  P L 9 1-7. http://dx.doi.org/10.1016/0024-3205(90)90376-3 [75] Carrillo-Mora, P.; Mendez-Cuesta, L. A.; Perez-De La Cruz, V.; Fortoul-van Der Goes, T. I.; Santamaria, A.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Brain Res., 2010, 210 (2), 240-50. http://dx.doi.org/10.1016/j.bbr.2010.02.041 [76] Silva-Adaya, D.; Perez-De La Cruz, V.; Villeda-Hernandez, J.; Carrillo-Mora, P.; Gonzalez-Herrera, I. G.; Garcia, E.; Colin-Barenque, L.; Pedraza-Chaverri, J.; Santamaria, A.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Teratol., 2011, 33 (2), 303-12. http://dx.doi.org/10.1016/j.ntt.2010.10.002 [77] Pineda-Farias, J.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pain, 2013, 17 ( 9 ) ,  1 3 6 5-73. http://dx.doi.org/10.1002/j.1532-2149.2013.00305.x [78] Zwilling, D.; Huang, S. Y.; Sathyasaikumar, K. V.; Notarangelo, F. M.; Guidetti, P.; Wu, H. Q.; Lee, J.; Truong, J.; Andrews-Zwilling, Y.; Hsieh, E. W.; Louie, J. Y.; Wu, T.; Scearce-Levie, K.; Patrick, C.; Adame, A.; Giorgini, F.; Moussaoui, S.; Laue, G.; Rassoulpour, A.; Flik, G.; Huang, Y.; Muchowski, J. M.; Masliah, E.; Schwarcz, R.; Muchowski, P. J. Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Cell, 2011, 145 (6), 8 63-74. http://dx.doi.org/10.1016/j.cell.2011.05.020 [79] Gregoire, L.; Rassoulpour, A.; Guidetti, P.; Samadi, P.; Bedard, P. J.; Izzo, E.; Schwarcz, R.; Di Paolo, T. Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Brain Res., 2008, 186 (2), 161-7. http://dx.doi.org/10.1016/j.bbr.2007.08.007 [80] Ouattara, B.; Belkhir, S.; Morissette, M.; Dridi, M.; Samadi, P.; Gregoire, L.; Meltzer, L. T.; Di Paolo, T. Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurosci., 2009, 38 (2), 128-42. http://dx.doi.org/10.1007/ s12031-008-9137-8 [81] Acuna-Castroviejo, D.; Tapias, V.; Lopez, L. C.; Doerrier, C.; Camacho, E.; Carrion, M. D.; Mora, F.; Espinosa, A.; Escames, G. Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced parkinsonism in mice.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Bull., 2011, 85 ( 3-4), 133-40. http://dx.doi.org/10.1016/ j.brainresbull.2011.03.008 [82] Wu, H. Q.; Lee, S. C.; Schwarcz, R. Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 2000, 390 ( 3 ) ,  2 6 7-74. http://dx.doi.org/10.1016/S0014-2999(00)00024-8 [83] Zadori, D.; Nyiri, G.; Szonyi, A.; Szatmari, I.; Fulop, F.; Toldi, J.; Freund, T. F.; Vecsei, L.; Klivenyi, P. Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"J. Neural Transm., 2011, 118 ( 6 ) ,  8 6 5-75. http://dx.doi.org/10.1007/s00702-010-0573-6 [84] Gellert, L.; Fuzik, J.; Goblos, A.; Sarkozi, K.; Marosi, M.; Kis, Z.; Farkas, T.; Szatmari, I.; Fulop, F.; Vecsei, L.; Toldi, J. Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 2011, 667 (1-3), 182-7. http://dx.doi.org/10.1016/j.ejphar.2011.05.069 [85] Marosi, M.; Nagy, D.; Farkas, T.; Kis, Z.; Rozsa, E.; Robotka, H.; Fulop, F.; Vecsei, L.; Toldi, J.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"J. Neural Transm., 2010, 117 ( 2 ) ,  1 8 3-8. http://dx.doi.org/ 10.1007/s00702-009-0346-2 [86] Knyihar-Csillik, E.; Mihaly, A.; Krisztin-Peva, B.; Robotka, H.; Szatmari, I.; Fulop, F.; Toldi, J.; Csillik, B.; Vecsei, L. The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase o f  c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Res., 2008, 61 (4), 429-32. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuropharmacology, 2009, 57 ( 4 ) ,  4 2 5-9. http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Chem., 2011, 19 (24), 7590-6. http://dx.doi.org/10.1016/j.bmc.2011.10.029 [89] Justinova, Z.; Mascia, P.; Wu, H. Q.; Secci, M. E.; Redhi, G. H.; Panlilio, L. V.; Scherma, M.; Barnes, C.; Parashos, A.; Zara, T.; Fratta, W.; Solinas, M.; Pistis, M.; Bergman, J.; Kangas, B. D.; Ferre, S.; Tanda, G.; Schwarcz, R.; Goldberg, S. R. Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neurosci., 2013, 16 (11), 1652-61. http://dx.doi.org/10.1038/nn.3540 [90] Gellert, L.; Varga, D.; Ruszka, M.; Toldi, J.; Farkas, T.; Szatmari, I.; Fulop, F.; Vecsei, L.; Kis, Z. Behavioural studies with a newly developed neuroprotective KYNA-amide.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"J. Neural Transm., 2012, 119 (2), 165-72. http://dx.doi.org/10.1007/s00702-011-0692-8 [91] Demeter, I.; Nagy, K.; Farkas, T.; Kis, Z.; Kocsis, K.; Knapp, L.; Gellert, L.; Fulop, F.; Vecsei, L.; Toldi, J. Paradox effects of kynurenines on LTP induction in the Wistar rat.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Lett., 2013, 553, 138-41. http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Drug Discov., 2013, 12 (1), 64-82. http://dx.doi.org/10.1038/nrd3793 [93] Li, F.; Tsien, J.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Med., 2009, 361 (3), 302-3. http://dx.doi.org/10.1056/NEJMcibr0902052 [94] Winn, P.; Stone, T. W.; Latimer, M.; Hastings, M. H.; Clark, A. J.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Pharmacol., 1991, 102 (4), 904-8. http://dx.doi.org/10.1111/j.1476-5381.1991.tb12274.x [95] Szalardy, L.; Zadori, D.; Toldi, J.; Fulop, F.; Klivenyi, P.; Vecsei, L. Manipulating kynurenic acid levels in the brain - o n  t h e  e d g e  between neuroprotection and cognitive dysfunction.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Chem., 2012, 12 ( 1 6 ) ,  1 7 9 7-806. http://dx.doi.org/10.2174/ 156802612803989264 [96] Wesnes, K. A.; Aarsland, D.; Ballard, C.; Londos, E. Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"J. Geriatric Psychiatry, 2015, 30 (1), 46-54. http://dx.doi.org/10.1002/gps.4109 [97] Anitha, M.; Nandhu, M. S.; Anju, T. R.; Jes, P.; Paulose, C. S. Targeting glutamate mediated excitotoxicity in Huntington's disease: neural progenitors and partial glutamate antagonist--memantine.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Hypotheses, 2011, 76 ( 1 ) ,  138-40. http://dx.doi.org/10.1016/j.mehy.2010.09.003 [98] Milnerwood, A. J.; Kaufman, A. M.; Sepers, M. D.; Gladding, C. M.; Zhang, L.; Wang, L.; Fan, J.; Coquinco, A.; Qiao, J. Y.; Lee, H.; Wang, Y. T.; Cynader, M.; Raymond, L. A. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Dis., 2012, 48 ( 1 ) ,  4 0-51. http://dx.doi.org/10.1016/ j.nbd.2012.05.013 [99] Sulkowski, G.; Dabrowska-Bouta, B.; Salinska, E.; Struzynska, L. Modulation of glutamate transport and receptor binding by glutamate receptor antagonists in EAE rat brain.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"http://dx.doi.org/10.1371/journal.pone.0113954 [100] Zaitsev, A. V.; Kim, K.; Vasilev, D. S.; Lukomskaya, N. Y.; Lavrentyeva, V. V.; Tumanova, N. L.; Zhuravin, I.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Res., 2015, 93 ( 3 ) ,  4 5 4-65. http://dx.doi.org/10.1002/jnr.23500 [101] Miranda, A. F.; Boegman, R. J.; Beninger, R. J.; Jhamandas, K. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Neuroscience, 1997, 78 ( 4 ) ,  9 6 7-75. http://dx.doi.org/10.1016/ S0306-4522(96)00655-0 [102] Heyliger, S. O.; Goodman, C. B.; Ngong, J. M.; Soliman, K. F. The analgesic effects of tryptophan and its metabolites in the rat.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Res., 1998, 38 ( 4 ) ,  2 4 3-50. http://dx.doi.org/10.1006/ phrs.1998.0362 [103] Platten, M.; Ho, P. P.; Youssef, S.; Fontoura, P.; Garren, H.; Hur, E. M.; Gupta, R.; Lee, L. Y.; Kidd, B.",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Science, 2005, 310 (5749), 850-5. http://dx.doi.org/10.1126/science.1117634 [104] Kloc, R.; Luchowska, E.; Wielosz, M.; Owe-Larsson, B.; Urbanska, E. M. Memantine increases brain production of kynurenic acid via protein kinase A-dependent mechanism.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Lett., 2008, 435 ( 2 ) ,  1 6 9-73. http://dx.doi.org/10.1016/ j.neulet.2008.02.027 [105] D'Andrea, M. R.; Nagele, R. G. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Des., 2006, 12 (6), 677-84. http://dx.doi.org/10.2174/138161206775474224 [106] Turski, W. A.; Malaczewska, J.; Marciniak, S.; Bednarski, J.; Turski, M. P.; Jablonski, M.; Siwicki, A. K. On the toxicity of kynurenic acid in vivo and in vitro.",OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Rep., 2014, 66 (6), 1127-33. http://dx.doi.org/10.1016/j.pharep.2014.07.013   Received: March 02, 2015 Revised: April 22, 2015 Accepted: December 03, 2015",Non-OADS,/arxiv_data1/oa_pdf/4c/07/CN-14-200.PMC4825950.pdf
"Sao Paulo 2016;58:25 http://dx.doi.org/10.1590/S1678-9946201658025 ORIGINAL ARTICLE Candida albicans  PROTEIN PROFILE CHANGES IN RESPONSE TO THE BUTANOLIC EXTRACT OF  Sapindus saponaria  L. Adriana FIORINI(1), Fabio Rogério ROSADO(2), Eliane Martins da Silva BETTEGA(1), Kátia Cristina Sibin MELO(1), Caroline KUKOLJ(3),   Patrícia de Souza BONFIM-MENDONÇA(1), Cristiane Suemi SHINOBU-MESQUITA(1), Luciana Dias GHIRALDI(1), Paula Aline Zanetti CAMPANERUT(1),   Isis Regina Grenier CAPOCI(1), Janine Silva Ribeiro GODOY(1), Izabel Cristina Piloto FERREIRA(4) & Terezinha Inez Estivalet SVIDZINSKI(1) SUMMARY Candida albicans  is an opportunistic human pathogen that is capable of causing superficial and systemic infections in  immunocompromised patients.",Non-OADS,/arxiv_data1/oa_pdf/66/ec/0036-4665-rimtsp-00025.PMC4826078.pdf
"Mass spectra (MS) were acquired  using a MALDI-TOF/TOF Autoflex II spectrometer (Bruker Daltonics,  Germany) with the MASCOT search engine (Matrix Science Ltd., UK)  against the “Fungi” subset of the SwissProt database (http://www.expasy.",OADS,/arxiv_data1/oa_pdf/66/ec/0036-4665-rimtsp-00025.PMC4826078.pdf
ch/sprot/) or NCBInr (http://www.ncbi.nlm.nih.gov/).,Non-OADS,/arxiv_data1/oa_pdf/66/ec/0036-4665-rimtsp-00025.PMC4826078.pdf
Sao Paulo 2016;58:26 http://dx.doi.org/10.1590/S1678-9946201658026 ORIGINAL ARTICLE CD19 LYMPHOCYTE PROLIFERATION INDUCED BY Bifidobacterium animalis  subsp.,Non-OADS,/arxiv_data1/oa_pdf/3f/23/0036-4665-rimtsp-00026.PMC4826079.pdf
"Sao Paulo 2016;58:27 http://dx.doi.org/10.1590/S1678-9946201658027 ORIGINAL ARTICLE MALARIA DIAGNOSIS BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) IN THAILAND Ronja OCKER(1), Yongyut PROMPUNJAI(2), Salakchit CHUTIPONGVIV ATE(2) & Panagiotis KARANIS(3) SUMMARY The loop-mediated isothermal amplification method (LAMP) is a recently developed molecular technique that amplifies nucleic  acid under isothermal conditions.",Non-OADS,/arxiv_data1/oa_pdf/6d/75/0036-4665-rimtsp-00027.PMC4826080.pdf
Available from: http://www.who.int/malaria/publications/world_malaria_ report_2014/wmr-2014-no-profiles.pdf?ua=1 2.,Non-OADS,/arxiv_data1/oa_pdf/6d/75/0036-4665-rimtsp-00027.PMC4826080.pdf
Available from: http://www.who.int/malaria/areas/diagnosis/en/  5.,Non-OADS,/arxiv_data1/oa_pdf/6d/75/0036-4665-rimtsp-00027.PMC4826080.pdf
Available from: http://www.who.int/malaria/diagnosis_treatment/arcp/ focused_screening/en/  24.,Non-OADS,/arxiv_data1/oa_pdf/6d/75/0036-4665-rimtsp-00027.PMC4826080.pdf
Available  from: http://graphpad.com/quickcalcs/index.cfm,OADS,/arxiv_data1/oa_pdf/6d/75/0036-4665-rimtsp-00027.PMC4826080.pdf
Available from: http://www.finddiagnostics.,OADS,/arxiv_data1/oa_pdf/6d/75/0036-4665-rimtsp-00027.PMC4826080.pdf
"Sao Paulo 2016;58:28 http://dx.doi.org/10.1590/S1678-9946201658028 ORIGINAL ARTICLE ISOLATION AND GENOTYPING OF Toxoplasma gondii  IN SERONEGATIVE URBAN RATS AND  PRESENCE OF ANTIBODIES IN COMMUNICATING DOGS IN BRAZIL Bruno Bergamo RUFFOLO(1), Roberta dos Santos TOLEDO(1), Felippe Danyel Cardoso MARTINS(1), Felipe Monteiro BUGNI(1),Letícia da COSTA(1),   Elizabete Regina Marangoni MARANA(2), Italmar Teodorico NA V ARRO(2), João Luis GARCIA(2), Chunlei SU(3) & Roberta Lemos FREIRE(2) SUMMARY The role of rodents in the epidemiology of toxoplasmosis was investigated in Londrina , Paraná  State, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/d7/f4/0036-4665-rimtsp-00028.PMC4826081.pdf
"Sao Paulo 2016;58:29 http://dx.doi.org/10.1590/S1678-9946201658029 ORIGINAL ARTICLE VISCERAL LEISHMANIASIS IN PETROLINA , STATE OF PERNAMBUCO , BRAZIL, 2007-2013 Andreina de Carvalho ARAUJO(1), Nara Nagle Vieira Matos GONÇALVES(1), Filipe DANTAS-TORRES(2), Fernando FERREIRA(3) & Mauricio Claudio HORTA(1) SUMMARY Visceral leishmaniasis is a life-threatening disease of great public health relevance in Brazil.",Non-OADS,/arxiv_data1/oa_pdf/7c/7a/0036-4665-rimtsp-00029.PMC4826082.pdf
Available from: http://www.cidades.,Non-OADS,/arxiv_data1/oa_pdf/7c/7a/0036-4665-rimtsp-00029.PMC4826082.pdf
Available from: http://dtr2004.saude.gov.br/sinanweb/.,Non-OADS,/arxiv_data1/oa_pdf/7c/7a/0036-4665-rimtsp-00029.PMC4826082.pdf
"Sao Paulo 2016;58:30 http://dx.doi.org/10.1590/S1678-9946201658030 ORIGINAL ARTICLE PRELIMINARY REPORT ON THE PUTATIVE ASSOCIATION OF IL10 -3575 T/A GENETIC  POLYMORPHISM WITH MALARIA SYMPTOMS Wilson DOMINGUES(1), Kelly Aparecida KANUNFRE(1,2), Jonatas Cristian RODRIGUES(1,2), Leandro Emidio TEIXEIRA(1),   Lidia YAMAMOTO(1) & Thelma Suely OKAY(1) SUMMARY Only a small percentage of individuals living in endemic areas develop severe malaria suggesting that host genetic factors may play  a key role.",Non-OADS,/arxiv_data1/oa_pdf/1f/44/0036-4665-rimtsp-00030.PMC4826083.pdf
To determine if the genotype frequencies were in Hardy–Weinberg  equilibrium (HW) we used the equation available at http://www.oege.,OADS,/arxiv_data1/oa_pdf/1f/44/0036-4665-rimtsp-00030.PMC4826083.pdf
Available from: http://bvsms.saude.,Non-OADS,/arxiv_data1/oa_pdf/1f/44/0036-4665-rimtsp-00030.PMC4826083.pdf
Sao Paulo 2016;58:31 http://dx.doi.org/10.1590/S1678-9946201658031 ORIGINAL ARTICLE HIGH PREVALENCE OF Blastocystis spp.,Non-OADS,/arxiv_data1/oa_pdf/b2/83/0036-4665-rimtsp-00031.PMC4826084.pdf
Available from: http://cod.ibge.gov.br/239YT  11.,Non-OADS,/arxiv_data1/oa_pdf/b2/83/0036-4665-rimtsp-00031.PMC4826084.pdf
Sao Paulo 2016;58:32 http://dx.doi.org/10.1590/S1678-9946201658032 ORIGINAL ARTICLE INFECTION BY Rickettsia felis  IN OPOSSUMS ( Didelphis sp.),Non-OADS,/arxiv_data1/oa_pdf/89/50/0036-4665-rimtsp-00032.PMC4826085.pdf
"Sao Paulo 2016;58:33 http://dx.doi.org/10.1590/S1678-9946201658033 REVIEW CONTRIBUTIONS TO RICKETTSIOSES RESEARCH IN COLOMBIA (1917-1943),  LUIS B.  PATIÑO CAMARGO Álvaro  A. FACCINI-MARTÍNEZ(1,2,3,4), Carlos A. BOTERO-GARCÍA(5) & Marylin HIDALGO(6) SUMMARY Colombian physician Luis Benigno Patiño Camargo was one of the pioneers in the study of rickettsioses in South America,  demonstrating for the first time in Colombia the presence of Rickettsia rickettsii  as the etiological agent of a highly deadly exanthematic  febrile syndrome in the 1930s.",Non-OADS,/arxiv_data1/oa_pdf/99/9d/0036-4665-rimtsp-00033.PMC4826086.pdf
2015.  http://dx.doi.org/10.1016/j.infect.2015.04.006   36.,OADS,/arxiv_data1/oa_pdf/99/9d/0036-4665-rimtsp-00033.PMC4826086.pdf
"Sao Paulo 2016;58:34 http://dx.doi.org/10.1590/S1678-9946201658034 CASE REPORT  BRAIN ABSCESS DUE TO Staphylococcus aureus  OF CRYPTOGENIC SOURCE IN AN HIV-1  INFECTED PATIENT IN USE OF ANTIRETROVIRAL THERAPY Anna Paula Romero de OLIVEIRA(1), Mara Cristina PAPPALARDO(1), Daniel DANTAS(1), Diogo LINS(1) & José Ernesto VIDAL(1,2) SUMMARY The spectrum of neurological complications associated with human immunodeficiency virus type 1 (HIV-1) infection is broad.",Non-OADS,/arxiv_data1/oa_pdf/7b/8b/0036-4665-rimtsp-00034.PMC4826087.pdf
"Sao Paulo 2016;58:35 http://dx.doi.org/10.1590/S1678-9946201658035 CASE REPORT Rhipicephalus sanguineus  (ACARI: IXODIDAE) BITING A HUMAN BEING IN PORTO  ALEGRE  CITY,  RIO GRANDE DO SUL , BRAZIL Márcia Bohrer MENTZ(1), Marcelo TROMBKA(2) Guilherme Liberato da SILV A(1,3) & Carlos Eugênio SILV A(1 ) SUMMARY We report the finding of a female brown dog tick, Rhipicephalus sanguineus  (Acari: Ixodidae) on the scalp of a male patient in  Porto Alegre, Rio Grande do Sul , Brazil.",Non-OADS,/arxiv_data1/oa_pdf/05/f4/0036-4665-rimtsp-00035.PMC4826088.pdf
"ﬁ Submitted: 04/30/2015 Revised: 08/31/2015Accepted: 09/15/2015http://dx.doi.org/10.1080/19490976.2015.1096486 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gut 2007; 56:1770-98; PMID:17488783; http://dx.doi.org/ 10.1136/gut.2007.119446 2.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gastroenterology 2006; 130:1480-91; PMID:16678561;http://dx.doi.org/10.1053/j.gastro.2005.11.061 3.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
N Engl J Med 2012; 367:1626-35; PMID:23094724; http://dx.doi.org/10.1056/ NEJMra1207068 4.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gastroenterology 2010; 138:1276-85; PMID:20176021; http://dx.doi.org/10.1053/j.gastro.2010.02.037 5.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gut 2012; 61:1284-90; PMID:22234979; http://dx.doi.org/ 10.1136/gutjnl-2011-300474 6.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gut 2013; 62:159-76;PMID:22730468; http://dx.doi.org/10.1136/gutjnl- 2012-302167 7.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Am J Gastroenterol 2015; 110:278-87; PMID:25623659; http://dx.doi.org/10.1038/ajg.2014.427 8.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Microbiology 2010; 156:3205-15;PMID:20705664; http://dx.doi.org/10.1099/ mic.0.043257-0 9.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Curr Opin Clin Nutr Metab Care 2011; 14:581-7; PMID:21892075; http://dx.doi.org/10.1097/MCO.0b013e32834b8082 10.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Am J Gastroenterol 2012; 107:28-35; quiz 6; PMID:22045120; http://dx.doi.org/10.1038/ajg.2011.355 11.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Nat Rev Gastro Hepat 2014; 11:256-66; http://dx.doi.org/10.1038/nrgastro.2013.259 12.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gastroenterology 2009; 136:1979-88; PMID:19457422; http://dx.doi.org/10.1053/j.gastro.2009.02.074 15.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Nature communications 2014; 5:4344;PMID:25003530; http://dx.doi.org/10.1038/ ncomms5344 18.,OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gut 2014; 63:1737-45; PMID:24310267; http://dx.doi.org/10.1136/gutjnl-2013-305994 19.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Environ Microbiol 2009; 11:1736-51; PMID:19508560; http://dx.doi.org/10.1111/j.1462-2920.2009.01900.x 20.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
PLoS ONE 2009; 4:e6669; PMID:19693277; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gut 2012; 61:997-1006; PMID:22180058; http://dx.doi.org/10.1136/gutjnl- 2011-301501 22.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Aliment Phar- macol Ther 2015; 41:449-58; PMID:25586008;http://dx.doi.org/10.1111/apt.13074 23.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Aliment Pharmacol Ther 2015; 41:342- 51; PMID:25521822; http://dx.doi.org/10.1111/apt.13055 24.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
J Microbiol Methods 2010; 81:127-34; PMID:20171997; http://dx.doi.org/10.1016/j.mimet.2010.02.007 25.,OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gut microbes 2014; 5:165-75; PMID:24637601; http://dx.doi.org/10.4161/ gmic.27923 28.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Neurogastroenterol Motil 2012; 24:31-9;PMID:22070725; http://dx.doi.org/10.1111/j.1365- 2982.2011.01803.x 30.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
J Med Microbiol2011; 60:817-27; PMID:21330412; http://dx.doi.org/ 10.1099/jmm.0.028126-0 31.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gas-troenterology 2011; 141:1792-801; PMID:21820992; http://dx.doi.org/10.1053/j.gastro.2011.07.043 32.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
mBio 2014; 5(5):e0212-14; PMID:25227462; http://dx.doi.org/10.1128/mBio.01212-14 34.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Gastroenterology 2014; 147:1363- 77 e17; PMID:25172014; http://dx.doi.org/10.1053/j.gastro.2014.08.033 36.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Nat Immunol 2010; 11:76-83; PMID:19855381; http://dx.doi.org/10.1038/ni.1825 368 Volume 6 Issue 6 Gut Microbes,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Curr Opin Microbiol 2012; 15:57-62; PMID:22177113; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
PlosOne 2014; 9(4): e94863; http://dx.doi.org/10.1371/ journal.pone.009486340.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Transfusion 1996; 36:362-74; PMID:8623141; http://dx.doi.org/10.1046/j.1537-2995.1996.36496226154.x 41.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
J Clin Invest 2015; 125:926-38;PMID:25689247; http://dx.doi.org/10.1172/ JCI76304 43.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
Societal costs for irritable bowel syndrome - a population based study.Scandinavian Journal of Gastroenterology 2010; 45:582-91; PMID:20166844; http://dx.doi.org/ 10.3109/00365521003637211 44.,Non-OADS,/arxiv_data1/oa_pdf/18/d0/kgmi-06-06-1096486.PMC4826089.pdf
"Channels 2015; 9(3):129–38; PMID: 25891132; http://dx.doi.org/10.1080/ 19336950.2015.1040966 Martin D Bootman* and Katja Rietdorf; Department of Life, Health and Chemical Sciences; The Open University; Milton Keynes, UK; *Correspondence to: Martin D Bootman; Email: martin.bootman@open.ac.uk; http://dx.doi.org/10.1080/15384101.2015.1086203; /C211Martin D Bootman and Katja Rietdorf.",Non-OADS,/arxiv_data1/oa_pdf/28/a9/kchl-09-05-1086203.PMC4826100.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-on-ommercial License (http://creativecommons.org/licenses/by c/3.0/), which permits unrestricted nonommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/a9/kchl-09-05-1086203.PMC4826100.pdf
Channels 2015; 9:129-38; PMID:25891132; http://dx.doi.org/10.1080/19336950.2015.1040966.,Non-OADS,/arxiv_data1/oa_pdf/28/a9/kchl-09-05-1086203.PMC4826100.pdf
Nature 2002; 415:198-205; PMID:11805843; http://dx.doi.org/10.1038/415198a.,OADS,/arxiv_data1/oa_pdf/28/a9/kchl-09-05-1086203.PMC4826100.pdf
Biochimica et biophysica acta 2011; 1813:922-34; PMID:21295621; http://dx.doi.org/ 10.1016/j.bbamcr.2011.01.030.,OADS,/arxiv_data1/oa_pdf/28/a9/kchl-09-05-1086203.PMC4826100.pdf
Experimental physiology 2009; 94:509-19; PMID:19297389; http://dx.doi.org/ 10.1113/expphysiol.2008.043984.,Non-OADS,/arxiv_data1/oa_pdf/28/a9/kchl-09-05-1086203.PMC4826100.pdf
PloS one 2014; 9:e88649; PMID:24586364; http://dx.doi.org/10.1371/journal.pone.0088649.,Non-OADS,/arxiv_data1/oa_pdf/28/a9/kchl-09-05-1086203.PMC4826100.pdf
"Cardiomyocytes contain a small but measurable pool of free Zn 2Cin the cyto- sol reported to be »100 pM.4Since small changes in the Zn2Clevel will have a marked effect on RyR2 activity, this becomes highly relevant when we considerthat concentrations of Zn 2Chave recently been reported to be transiently elevated to»50 nM during Zn 2C-signaling events.5 Live-cell detection of intracellular Zn2C and Ca2Cusing selective ﬂuorophores reveal that intracellular Zn2Cconcentra- tions are altered during cardiac EC cou- pling and that spatio-temporalﬂuctuations in free Zn 2Clevels are compa- rable to those of Ca2C.6Extracellular Zn2Ccan also enter cardiomyocytes through the L-type Ca2Cchannel in a sim- ilar manner to Ca2C.7These Zn2Cﬂuctu- ations may serve to modulate RyR2 activity highlighting a potential role for Zn2Cin ﬁne-tuning graded Ca2C-release events to control the force and duration of© Alan J Stewart and Samantha J Pitt *Correspondence to: Samantha J Pitt; Email: sjp24@st-andrews.ac.uk Submitted: 07/15/2015Accepted: 07/20/2015http://dx.doi.org/10.1080/19336950.2015.1075784 This is an Open Access article distributed under the terms of the Creative Commons Attribution License(http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the originalwork is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
J Biol Chem 2015; 290(28):17599-610; PMID: 26041778; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
PMID:10830164. http://dx.doi.org/10.1016/ S00928674(00)80847-82.,OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
PMID:20950764. http://dx.doi.org/10.1016/j.nut.2010.,OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
PMID:26041778. http://dx.doi.org/10.1074/jbc.M115.,OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
PMID:25011072. http://dx.doi.org/10.1021/ cb50040645.,OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
PMID:25615666. http://dx.doi.org/10.1038/nchem.2133 6.,OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
PMID:21062918. http://dx.doi.org/10.1093/cvr/cvq352 7.,OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
PMID:7852308. http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
PMID:16214842. http://dx.doi.org/10.1152/ajpheart.00754.2005 www.tandfonline.com 229 Channels,Non-OADS,/arxiv_data1/oa_pdf/46/95/kchl-09-05-1075784.PMC4826112.pdf
"22The EF-hand Ca2C-binding domains (together with the SAM domains) of STIMs are responsible forsensing [Ca 2C] in the lumen of the ER.8,10,23Ad e c r e a s ei nE R luminal Ca2Cconcentration results in dissociation of Ca2Cfrom the EF-hand domain which, in turn, triggers oligomerization andactivation of STIM1, a process that is reversed when luminal[Ca 2C] returns to resting level (that is, 250–600 mM).24The lumi- nal EF-hand domain of STIM1 binds Ca2Cwith an apparent dis- sociation constant (K d)o f»250mM, whereas the K dof STIM2 for Ca2Cis»500mM.24,25Hence, STIM2 is more sensitive to small changes in luminal [Ca2C] and partially active at resting ER© Robert Kraft Correspondence to: Robert Kraft; Email: robert.kraft@medizin.uni-leipzig.de Submitted: 06/17/2015; Revised: 07/07/2015; Accepted: 07/07/2015http://dx.doi.org/10.1080/19336950.2015.1071747 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Cold Spring Harb Perspect Biol 2010; 2:a003962; PMID:20861159; http://dx.doi.org/10.1101/ cshperspect.a003962 8.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Sci Signal 2009; 2:ra67; PMID:19843959; http://dx.doi.org/10.1126/ scisignal.2000522 20.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Nat Rev Mol Cell Biol 2012; 13:549-65; PMID:22914293;http://dx.doi.org/10.1038/nrm3414 21.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
"Stathopulos PB, Ikura M. Structural aspects of cal- cium-release activated calcium channel function.Channels (Austin) 2013; 7:344-53; PMID:24213636; http://dx.doi.org/10.4161/chan.26734 22.",OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Cell 2008; 135:110-22; PMID:18854159; http://dx.doi.org/10.1016/j.cell.2008.08.006 25.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Biochem Biophys Res Commun 2008;369:240-6; PMID:18166150; http://dx.doi.org/ 10.1016/j.bbrc.2007.12.129 26.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Biol Chem 2009; 284:728-32; PMID:19019825; http://dx.doi.org/10.1074/jbc.C800178200 28.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Nat Commun 2014; 5:3183; PMID:24492416; http://dx.doi.org/ 10.1038/ncomms4183 29.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Cell Calcium 2009; 46:227-32; PMID:19733393; http://dx.doi.org/10.1016/j.ceca.2009.08.003 31.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Mol Biol 2015; 427:77-93; PMID:25284754; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Channels (Austin) 2011;5:424-31; PMID:21747233; http://dx.doi.org/ 10.4161/chan.5.5.16471 37.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Immunol Rev 2009; 231:189-209; PMID:19754898; http://dx.doi.org/10.1111/j.1600-065X.2009.00818.x38.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Channels (Austin) 2013; 7:379-91; PMID:23511024;http://dx.doi.org/10.4161/chan.24302 39.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Nat Immunol 2008; 9:432-43; PMID:18327260; http://dx.doi.org/10.1038/ni1574 40.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Blood 2009; 113:1097-104; PMID:18941110; http://dx.doi.org/10.1182/blood-2008-05-158477 43.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Blood 2014; 123:2238-49; PMID:24493668; http://dx.doi.org/ 10.1182/blood-2012-08-450403 44.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Nat Cell Biol 2008; 10:688-97; PMID:18488020; http://dx.doi.org/ 10.1038/ncb1731 45.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Circ Res 2011; 109:534-42; PMID:21737791; http://dx.doi.org/10.1161/ CIRCRESAHA.111.246777 47.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
FASEB J 2013; 27:893-906; PMID:23159931; http://dx.doi.org/10.1096/fj.12- 215293 48.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Exp Med 2008; 205:1583-91; PMID:18559454;http://dx.doi.org/10.1084/jem.20080302 49.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Blood2009; 113:2056-63; PMID:18832659; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
PMID:23677809; http://dx.doi.org/10.1007/s12264- 013-1343-x 52.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Biochim Biophys Acta 2015;1853:1940-52; PMID:25646572; http://dx.doi.org/ 10.1016/j.bbamcr.2015.01.019 53.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Front Cell Neurosci 2015; 9:153; PMID:25964739; http://dx.doi.org/10.3389/ fncel.2015.00153 54.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Exp Neurol 2011; 232:185-94; PMID:21906591; http://dx.doi.org/10.1016/j.expneurol.2011.08.022 56.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Science 2015; 347:1260419; PMID:25613900; http://dx.doi.org/ 10.1126/science.1260419 59.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Neuron 2014; 82:79-93; PMID:24698269; http://dx.doi.org/10.1016/j.neuron.2014.02.019 61.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
PLoS One 2010; 5:e13465; PMID:20976103; http://dx.doi.org/10.1371/journal.pone.0013465 62.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Mol Biol Cell 2015; 26:1141-59; PMID:25609091; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Neuron 2014; 82:635- 44; PMID:24811382; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Sci Signal 2014; 7:ra51; PMID:24894994; http://dx.doi.org/10.1126/ scisignal.2005242 65.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Curr Top Membr 2013; 71:237-71; PMID:23890118; http://dx.doi.org/10.1016/B978-0-12-407870-3.00010-X 68.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Pﬂugers Arch 2010; 460:525-42; PMID:20229265; http://dx.doi.org/10.1007/s00424-010-0809-1 75.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
EMBO J 2012;31:1764-73; PMID:22343944; http://dx.doi.org/ 10.1038/emboj.2012.31 76.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Science 2010; 330:101-5; PMID:20929812; http://dx.doi.org/10.1126/science.1191027 77.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Science 2010; 330:105-9;PMID:20929813; http://dx.doi.org/10.1126/ science.1191086 78.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Stem Cell Res 2014; 12:452- 66; PMID:24424349; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Sci Signal 2014; 7:pe18; PMID:25056876; http://dx.doi.org/10.1126/scisignal.2005556 80.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Neurosci 2014;34:9107-23; PMID:24990931; http://dx.doi.org/ 10.1523/JNEUROSCI.0263-14.2014 81.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Neuron 2008; 59:392-8; PMID:18701065; http://dx.doi.org/10.1016/j.neuron.2008.06.009 83.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Cell Calcium 2012; 52:457-67; PMID:22944608; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Pﬂugers Arch 2013; 465:1249-60;PMID:23515871; http://dx.doi.org/10.1007/s00424- 013-1254-8 89.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Cell Calcium 2014; 55:219-29; PMID:24656753; http://dx.doi.org/ 10.1016/j.ceca.2014.02.016 90.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Am J Physiol Cell Physiol 2011; 300:C1502-12;PMID:21368296; http://dx.doi.org/10.1152/ ajpcell.00379.2010 92.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Glia 2008; 56:821-35; PMID:18338793; http://dx.doi.org/10.1002/glia.20656 93.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Neurosci 2010; 30:13116-29; PMID:20881130; http://dx.doi.org/10.1523/ JNEUROSCI.1890-10.2010 96.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Physiol Rev 2011; 91:461-553; PMID:21527731; http://dx.doi.org/ 10.1152/physrev.00011.2010 99.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Physiol 2008; 586:3061-73;PMID:18403424; http://dx.doi.org/10.1113/ jphysiol.2008.151365 107.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Neuroinﬂammation 2012; 9:250;PMID:23158496; http://dx.doi.org/10.1186/1742- 2094-9-250 108.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Cell Signal 2015; 27:177-86; PMID:25451082; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Immunol 2011; 186:3701-9;PMID:21317391; http://dx.doi.org/10.4049/ jimmunol.1000212 110.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Physiol 2013; 591:1433-45; PMID:23359669; http://dx.doi.org/10.1113/ jphysiol.2012.245399 114.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Sci Signal 2015; 8:ra3; PMID:25587190; http://dx.doi.org/ 10.1126/scisignal.2005748 115.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
FASEB J 2010; 24:2211-21; PMID:20179145; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Glia 2012; 60:1094-105; PMID:22488958; http://dx.doi.org/10.1002/ glia.22337 118.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
J Neurosci Res 2008; 86:1511-9; PMID:18183622; http://dx.doi.org/ 10.1002/jnr.21610 119.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Sci Signal 2010; 3: ra24; PMID:20354224; http://dx.doi.org/10.1126/ scisignal.2000672 120.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Channels (Austin) 2010; 4:398-410; PMID:20818184; http://dx.doi.org/10.4161/ chan.4.5.13226 122.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Neuro- therapeutics 2010; 7:338-53; PMID:20880499;http://dx.doi.org/10.1016/j.nurt.2010.07.006 124.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Science 2009; 323:1211-5; PMID:19251629; http://dx.doi.org/10.1126/science.1169096 125.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Neuron 2013;77:10-8; PMID:23312512; http://dx.doi.org/ 10.1016/j.neuron.2012.12.023 126.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Science 2013; 339:156-61; PMID:23307732; http://dx.doi.org/10.1126/science.1227901 127.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Acta Neuropathol Commun 2014; 2:142; PMID:25257319; http://dx.doi.org/10.1186/s40478-014-0142-6 129.,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Neuron 2012; 74:691-705;PMID:22632727; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
Acta Neuropathol 2014; 127:495-505; PMID:24407428; http://dx.doi.org/10.1007/s00401- 013-1242-2 252 Volume 9 Issue 5 Channels,Non-OADS,/arxiv_data1/oa_pdf/7d/1c/kchl-09-05-1071747.PMC4826113.pdf
"Thus, despite reduced GABA ARd subunit function, the increased impact on GABA ARg2subunits mediating I tonic may enable GAT blockade to reverse© Hyun-Woo Kim, Sudip Pandit, and Jin Bong Park *Correspondence to: Jin Bong Park; Email:jinbong@cnu.ac.kr Submitted: 07/09/2015Accepted: 07/10/2015 http://dx.doi.org/10.1080/19336950.2015.1074475 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecom mons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/2d/kchl-09-05-1074475.PMC4826118.pdf
The Journal of physiology 2007; 582: 539-51; PMID:17495040; http://dx.doi.org/10.1113/ jphysiol.2007.133223.,Non-OADS,/arxiv_data1/oa_pdf/9b/2d/kchl-09-05-1074475.PMC4826118.pdf
Journal of neurophysiology 2015; 114 (2):914–26; PMID:26063771; http://dx.doi.org/ 10.1152/jn.00080.2015 3.,Non-OADS,/arxiv_data1/oa_pdf/9b/2d/kchl-09-05-1074475.PMC4826118.pdf
The Journal of physiology 2007; 582:1163-78; PMID:17525114; http://dx.doi.org/ 10.1113/jphysiol.2007.134460.,Non-OADS,/arxiv_data1/oa_pdf/9b/2d/kchl-09-05-1074475.PMC4826118.pdf
Eur J Pharmacol 2003; 479:127; PMID:14612144; http://dx.doi.org/10.1016/j.ejphar.,OADS,/arxiv_data1/oa_pdf/9b/2d/kchl-09-05-1074475.PMC4826118.pdf
The Journal of physiology 2009; 587:4645-60; PMID:19703969; http://dx.doi.org/ 10.1113/jphysiol.2009.173435.,Non-OADS,/arxiv_data1/oa_pdf/9b/2d/kchl-09-05-1074475.PMC4826118.pdf
"American journal of physiology Regula- tory, integrative and comparative physiology 2010; 299:R129-39; PMID:20164200; http://dx.doi.org/10.1152/ ajpregu.00391.2009.",Non-OADS,/arxiv_data1/oa_pdf/9b/2d/kchl-09-05-1074475.PMC4826118.pdf
Trends Neurosci 2004; 27: 262-9; PMID:15111008; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9b/2d/kchl-09-05-1074475.PMC4826118.pdf
"In our recent publication,13we found that 75 newborn babies from the Singa-porean GUSTO birth cohort wentthrough a progression of gut microbiotaacquisition, similar to the studiesKeywords: adiposity, Caesarean section, deﬁning/proﬁling gut microbiome, gesta-tional age, gut microbiota, harnessing microbial strategies for treatment of human disease, immaturity, infancy, obe-sity, prematurity, vaginal delivery © Shaillay Dogra, Olga Sakwinska, Shu-E Soh, Catherine Ngom-Bru, Wolfram M Br €uck, Bernard Berger, Harald Br €ussow, Neerja Karnani, Yung Seng Lee, Fabian Yap, Yap-Seng Chong, Keith M Godfrey,and Joanna D Holbrook*Correspondence to: Joanna D Holbrook; Email: Joanna_Holbrook@sics.a-star.edu.sg Submitted: 06/12/2015Revised: 07/22/2015Accepted: 07/24/2015http://dx.doi.org/10.1080/19490976.2015.1078051 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproductionin any medium, provided the original work is prop-erly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
MBio2015 Feb 3;6(1); pii: e02419 –14; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
BMC Pediatr 2015; 15:64; PMID:26024884; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Sci Rep 2015; 5:10512;PMID:26015368; http://dx.doi.org/10.1038/ srep10512 5.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Pediatr Res 2014; 76:2-10; PMID:24732106; http://dx.doi.org/10.1038/ pr.2014.49 6.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
"Knights D, Ward TL, McKinlay CE, Miller H, Gonza- lez A, McDonald D, Knight R. Rethinking “enterotypes.” Cell Host Microbe 2014; 16:433-7;PMID:25299329; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Gut Microbes 2012; 3:352-65; PMID:22743759; http://dx.doi.org/ 10.4161/gmic.21215 8.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Gut Microbes2014; 5:192-201; PMID:24637795; http://dx.doi.org/ 10.4161/gmic.28442 10.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Proc Natl Acad Sci USA 2014; 111:12522- 7; PMID:25114261; http://dx.doi.org/10.1073/ pnas.1409497111 12.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Trends Micro- biol 2013; 21:167-73; PMID:23332725; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Cell Host Microbe2015; 17:690-703; PMID:25974306; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Gut 2014; 63:559-66; PMID:23926244; http://dx.doi.org/10.1136/gutjnl-2012-303249 18.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Microbiome 2014; 2:38; PMID:25332768; http://dx.doi.org/ 10.1186/2049-2618-2-38 20.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
J Pediatr Gastroenterol Nutr 2007; 44:577-82; PMID:17460489; http://dx.doi.org/10.1097/MPG.0b013e3180406b20 21.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Pediatr Res 2015; 77:726-31; PMID:25760550; http://dx.doi.org/10.1038/ pr.2015.54 22.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Cell Mol Life Sci 2011; 68:3699-712; PMID:21952827; http://dx.doi.org/10.1007/s00018-011-0831-2 23.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Dig Dis 2015; 33:131-6;PMID:25925913; http://dx.doi.org/10.1159/ 000369534 24.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
MucosalImmunol 2015; PMID:25921338; http://dx.doi.org/ 10.1038/mi.2015.27 25.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Am J Clin Nutr 2014; 100:1508-19; http://dx.doi.org/10.3945/ ajcn.114.09255126.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
J Endocrinol 1999; 162:227-35; PMID:10425460;http://dx.doi.org/10.1677/joe.0.1620227 27.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Cell 2014; 158:705-21; PMID:25126780; http://dx.doi.org/10.1016/j.cell.2014.05.052 28.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Int J Obes 2013; 37:16-23; PMID:22907693; http://dx.doi.org/10.1038/ ijo.2012.132 29.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Int J Obes 2014; 38:1290-8; http://dx.doi.org/10.1038/ijo.2014.119 30.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Pediatr Res 2014; 76:150-8; PMID:24819377; http://dx.doi.org/ 10.1038/pr.2014.69 31.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
J Pediatr 2015; 166:538-44; http://dx.doi.org/10.1016/j.jpeds.2014.09.041 32.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
"Ajslev TA, Andersen CS, Gamborg M, Sorensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-preg- nancy weight and early administration of antibiotics.Int J Obesity 2011; 35:522-9; http://dx.doi.org/ 10.1038/ijo.2011.27 34.",Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Clin Perinatol 2014; 41:815-31; PMID:25459776; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Arch Dis Child Fetal Neonatal Ed 2014; 99:F510-4; PMID:25135955; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
BMC Pregnancy Childbirth 2015; 15:94; PMID:25884808; http://dx.doi.org/10.1186/s12884-015-0518-z37.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Obes Rev 2015; 16:295-303; PMID:25752886; http://dx.doi.org/10.1111/obr.12267 38.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
J Pediatr Gastroenterol Nutri 2011; 52:90-5; http://dx.doi.org/10.1097/MPG.0b013e3181f3457f 41.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Cell 2015; 161:36-48; PMID:25815983; http://dx.doi.org/ 10.1016/j.cell.2015.03.013 42.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Clin Chim Acta 2015; PMID:25668229; http://dx.doi.org/10.1016/j.cca.2015.01.022 44.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Annu Rev Anim Biosci 2015; 3:419-45;PMID:25387230; http://dx.doi.org/10.1146/annurev- animal-022114-111112 45.,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Trends Mol Med 2015;21:109-17; PMID:25578246; http://dx.doi.org/ 10.1016/j.molmed.2014.12.002 47.,OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
Nat 2014; 515:423-6; PMID:25231861; http://dx.doi.org/ 10.1038/nature13738 www.tandfonline.com 325 Gut Microbes,Non-OADS,/arxiv_data1/oa_pdf/df/6d/kgmi-06-05-1078051.PMC4826121.pdf
"Thus, local activation of release in the nerve terminal was attributed to the pooling of Ca2Cnanodomains from large CaV clusters, generating a ’Ca2Cmicrodomain’ that overlapped and activated the SV-sensors.5,12 © Elise F Stanley *Correspondence to: Elise F Stanley; Email: elise.f.stanley@gmail.comSubmitted: 09/08/2015; Revised: 09/14/2015; Accepted: 09/16/2015 http://dx.doi.org/10.1080/19336950.2015.1098793 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
1967; 193:419-32; PMID:6065887; http://dx.doi.org/10.1113/ jphysiol.1967.sp008367 2.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Science2000; 289:953-7; PMID:10937999; http://dx.doi.org/ 10.1126/science.289.5481.953 4.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Biophys J 1985; 48:485-98; PMID:2412607; http://dx.doi.org/ 10.1016/S0006-3495(85)83804-2 6.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Nat Rev Neurosci 2009; 10:373-83; PMID:19377502; http://dx.doi.org/10.1038/ nrn2634 9.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Biophys J 1981;33:323-51; PMID:6261850; http://dx.doi.org/ 10.1016/S0006-3495(81)84899-0 10.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Biophys J 1984;45:993-99; PMID:6329349; http://dx.doi.org/ 10.1016/S0006-3495(84)84244-7 11.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
1986; 381:619-40; PMID:2442355; http://dx.doi.org/ 10.1113/jphysiol.1986.sp016347 12.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Biophys J 1985; 48:1003-7; PMID:2418887; http://dx.doi.org/ 10.1016/S0006-3495(85)83863-7 13.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Ann N Y Acad Sci 1989; 560:230-48;PMID:2545135; http://dx.doi.org/10.1111/j.1749- 6632.1989.tb24100.x 14.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
1990; 431:343- 64; PMID:1983120; http://dx.doi.org/10.1113/ jphysiol.1990.sp018333 15.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Neuron 1993; 11:1007-11; PMID:8274272; http://dx.doi.org/10.1016/0896-6273(93)90214-C 18.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Biophys J 1999; 76:735-50;PMID:9929478; http://dx.doi.org/10.1016/S0006- 3495(99)77240-1 www.tandfonline.com 331 Channels,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Neuroscience 2001; 104:137-51; PMID:11311538; http://dx.doi.org/10.1016/S0306-4522(01)00057-4 21.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Neurosci 2004; 24:2877-85;PMID:15044526; http://dx.doi.org/10.1523/ JNEUROSCI.1660-03.2004 22.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Eur J Neurosci 2005; 21:278-82; PMID: 15654866; http://dx.doi.org/10.1111/j.1460-9568.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Neurosci 2005; 25:11577-85; PMID:16354915; http://dx.doi.org/10.1523/JNEUROSCI.3411-05.2005 24.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Neurosci 2006; 26:13240-9; PMID:17182774; http://dx.doi.org/ 10.1523/JNEUROSCI.1418-06.2006 25.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Neuron 2008; 57:536-45; PMID:18304483; http://dx.doi.org/10.1016/j.neuron.2007.12.026 27.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Neurosci 2012; 32:18157-76; PMID:23238730; http://dx.doi.org/ 10.1523/JNEUROSCI.3827-12.2012 28.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Physiol 2013;591:3167-78; PMID:23459757; http://dx.doi.org/ 10.1113/jphysiol.2012.249482 29.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Trends Neurosci 2013; 36:14-22; PMID:23102681; http://dx.doi.org/10.1016/j.tins.2012.09.009 30.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"Nat Neurosci 2010; 13, 1348-50; PMID:20953196; http://dx.doi.org/10.1038/nn.2657 31.",Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Neurosci 2009; 29:12196-209; PMID:19793978;http://dx.doi.org/10.1523/JNEUROSCI.0263- 09.2009 33.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Neuron 1990; 5:773-9; PMID:1980068; http://dx.doi.org/10.1016/0896- 6273(90)90336-E 34.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"J Neurocytol 1974; 3, 109-31; PMID:4596345; http://dx.doi.org/10.1007/BF01111936 35.",Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Neurosci 2011; 31:11268-81; PMID:21813687; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"J Neurosci 2005; 25, 4131-40; PMID:15843616; http://dx.doi.org/10.1523/JNEUROSCI.",Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Neurosci 2008; 28:14450- 8; PMID:19118179; http://dx.doi.org/10.1523/ JNEUROSCI.4245-08.2008 42.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Physiol 2009; 587:3009-23; PMID:19403608; http://dx.doi.org/10.1113/ jphysiol.2009.172387 43.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"J Neuro- sci 2007; 27, 1725-37; PMID:17301180; http://dx.doi.org/10.1523/JNEUROSCI.4116-06.2007 46.",Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"J Neurosci 2006; 26, 5698-708; PMID:16723526; http://dx.doi.org/10.1523/ JNEUROSCI.4889-05.2006 47.",Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Physiol 2001; 534:861-71; PMID:11483715; http://dx.doi.org/10.1111/j.1469-7793.2001.00861.x 48.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Brain Res 1972; 36:101-15; PMID:5008374; http://dx.doi.org/10.1016/0006-8993(72)90769-X 49.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
1996;383:431-5; http://dx.doi.org/10.1038/383431a0 50.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Physiol 2007; 581:581-602; PMID:17347264; http://dx.doi.org/10.1113/jphysiol.2007.129833 51.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Neurosci 2013; 33:3668-78;PMID:23426693; http://dx.doi.org/10.1523/ JNEUROSCI.2921-12.2013 52.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Neuron 2015; 85:145-58; PMID:25533484; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Ann N Y Acad Sci 1993; 681:368-72; PMID:8102841; http://dx.doi.org/10.1111/j.1749-6632.1993.tb22915.x 54.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"Nat Neurosci 2012; 15, 998-1006;PMID:22683682; http://dx.doi.org/10.1038/nn.3129 55.",Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Trends Neurosci 2000;23:305-12; PMID:10856940; http://dx.doi.org/ 10.1016/S0166-2236(00)01580-0 56.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Cereb Cortex 2014; 24:1818-31; http://dx.doi.org/10.1093/cercor/bht032 57.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Mol Brain 2009; 2:36; PMID:19939269; http://dx.doi.org/10.1186/1756-6606-2-36 58.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Trends Neu-rosci 1997; 20:404-9; PMID:9292969; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Physiol 2008; 586:2263-75;http://dx.doi.org/10.1113/jphysiol.2007.142547 62.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Physiol (Lond) 1998; 509:419-23; PMID:9575291; http://dx.doi.org/10.1111/j.1469-7793.1998.419bn.x 63.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Biophys J 2000; 78:2222-40;PMID:10777722; http://dx.doi.org/10.1016/S0006- 3495(00)76770-1 65.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Neurophysiol 2005; 94:1912-9; PMID:15888526; http://dx.doi.org/ 10.1152/jn.00256.2005 67.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Science 2014; 343:665-70; PMID:24503854; http://dx.doi.org/10.1126/science.1244811 69.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Physiol 2004; 555:699-711; PMID:14645448; http://dx.doi.org/10.1113/jphysiol.2003.051136 70.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Neuron 2014; 83:1303-18; PMID:25233313; http://dx.doi.org/ 10.1016/j.neuron.2014.08.029 72.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"Proc Natl Acad Sci U S A 2015; 112, E1028- 37; PMID:25691754; http://dx.doi.org/10.1073/ pnas.1416424112 73.",OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Curr Biol 2013; 23:244-9; PMID:23273895; http://dx.doi.org/10.1016/j.cub.2012.12.007 74.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"Nat Neurosci 2010; 13, 19-21; PMID:20010820;http://dx.doi.org/10.1038/nn.2461 75.",Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
PLoS Comput Biol 2015; 11:e1004253; PMID:25951120; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
PLoS ONE 2013; 8: e69410; PMID:23894473; http://dx.doi.org/10.1371/journal.pone.0069410 77.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Comp Neurol 2009; 513:457- 68; PMID:19226520; http://dx.doi.org/10.1002/ cne.21975 78.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J PhysiolParis 1998; 92:75-8; PMID:9782447; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Ann N Y Acad Sci 1999; 868:144-59; PMID:10414292; http://dx.doi.org/10.1111/j.1749-6632.1999.tb11284.x 82.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"J Bioenerg Biomembr 1998; 30, 335-45; PMID:9758330; http://dx.doi.org/10.1023/ A:1021985521748 83.",OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Proc Natl Acad Sci U S A 1982; 79:2415-9; PMID:6954549; http://dx.doi.org/ 10.1073/pnas.79.7.2415 84.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Gen Physiol 2004; 124:445-61; PMID:15504896; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Biophys J 2015; 108:451-2; PMID:25650909;http://dx.doi.org/10.1016/j.bpj.2014.12.021 86.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
J Theor Biol 1980; 84:3-29; PMID:6106090; http://dx.doi.org/10.1016/S0022- 5193(80)81035-6 88.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Neuron 1994; 13:1275-80;PMID:7993621; http://dx.doi.org/10.1016/0896- 6273(94)90414-6 89.,OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
Eur J Neurosci2003; 18:2403-7; PMID:14622203; http://dx.doi.org/ 10.1046/j.1460-9568.2003.02948.x www.tandfonline.com 333 Channels,Non-OADS,/arxiv_data1/oa_pdf/73/12/kchl-09-05-1098793.PMC4826128.pdf
"© Armando Navarro *Correspondence to: Armando Navarro; Email: arnava@unam.mx Submitted: 10/02/2015; Accepted: 10/02/2015http://dx.doi.org/10.1080/21505594.2015.1104450Comment on: Ban E, Yoshida Y, Wakushima M, Wajima T, Hamabata T, Ichikawa N, Abe H, Horiguchi Y, Hara-Kudo Y, Kage-Nakadai E, Yamamoto T, Wada T, and Nishikawa Y.",Non-OADS,/arxiv_data1/oa_pdf/a4/e5/kvir-06-08-1104450.PMC4826131.pdf
"Characterization of unstable pEntYN10 from enterotoxigenic Escherichia coli (ETEC) O169:H41; http://dx.doi.org/10.1080/2150559 4.2015.1094606 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/e5/kvir-06-08-1104450.PMC4826131.pdf
Epidemiol Infect 2014; 142:616–23; PMID:23800632; http://dx.doi.org/10.1017/S0950268813001477 3 .,Non-OADS,/arxiv_data1/oa_pdf/a4/e5/kvir-06-08-1104450.PMC4826131.pdf
Epidemiol Infect 1998; 121:31–42; PMID:9747753; http://dx.doi.org/10.1017/S0950268898001046 4.,Non-OADS,/arxiv_data1/oa_pdf/a4/e5/kvir-06-08-1104450.PMC4826131.pdf
Emerg Infect Dis 2004;10:518–21; PMID:15109427; http://dx.doi.org/ 10.3201/eid1003.030268 5.,Non-OADS,/arxiv_data1/oa_pdf/a4/e5/kvir-06-08-1104450.PMC4826131.pdf
Am J Med 2006; 119:168-e7-10; PMID:16443428; http://dx.doi.org/ 10.1016/j.amjmed.2005.07.063 6.,OADS,/arxiv_data1/oa_pdf/a4/e5/kvir-06-08-1104450.PMC4826131.pdf
Emerg Infect Dis 1995; 1:61; PMID:8903162; http://dx.doi.org/10.3201/ eid0102.950206 8.,Non-OADS,/arxiv_data1/oa_pdf/a4/e5/kvir-06-08-1104450.PMC4826131.pdf
Jpn J Infect Dis 2013; 66:530–3; PMID:24270144; http://dx.doi.org/10.7883/yoken.66.530 9.,Non-OADS,/arxiv_data1/oa_pdf/a4/e5/kvir-06-08-1104450.PMC4826131.pdf
"For the opportunistic pathogen Can- dida albicans , the silkworm Bombyx mori or caterpillars of the tobacco hornwormManduca sexta had been established most © Sven Krappmann *Correspondence to: Sven Krappmann; Email: sven.krappmann@uk-erlangen.de Submitted: 09/24/2015; Accepted: 09/24/2015http://dx.doi.org/10.1080/21505594.2015.1103428 Comment on: Delarze, et al.",Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
"6(7): 684-93; http://dx.doi.org/10.1080/21505594.2015.1081330This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Science 2015;347:1414-6; PMID:25814567; http://dx.doi.org/ 10.1126/science.aaa6097 3.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Nature 2014; 516:165-6; PMID:25503219; http://dx.doi.org/10.1038/516165a 5.,OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Infect Immun 2010; 78:2512-21;PMID:20308295; http://dx.doi.org/10.1128/ IAI.01293-09 7.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Eukaryot Cell 2009; 8:1750-8; PMID:19666778; http://dx.doi.org/10.1128/ EC.00163-09 8.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Nat Protoc 2008;3:1925-31; PMID:19180076; http://dx.doi.org/ 10.1038/nprot.2008.193 9.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Environ Microbiol 2015; 17:2858- 69; PMID:25684622; http://dx.doi.org/10.1111/1462-2920.12808 10.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Infect Immun 2003; 71:4862-72;PMID:12933827; http://dx.doi.org/10.1128/ IAI.71.9.4862-4872.2003 11.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Methods Mol Biol 2012; 845:487-96; PMID:22328397; http://dx.doi.org/10.1007/978-1- 61779-539-8_34 14.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Cell 1996; 86:973-83;PMID:8808632; http://dx.doi.org/10.1016/S0092- 8674(00)80172-5 15.,OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
BMC Microbiol 2010; 10:186; PMID:20615207; http://dx.doi.org/ 10.1186/1471-2180-10-186 16.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Virulence 2012; 3:159-63; PMID:21921682; http://dx.doi.org/10.4161/ viru.17631 17.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Eukar- yot Cell 2008; 7:1640-8; PMID:18708562; http://dx.doi.org/10.1128/EC.00129-08 19.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
FEMS Immunol Med Microbiol 2000; 27:163- 9; PMID:10640612; http://dx.doi.org/10.1111/ j.1574-695X.2000.tb01427.x 20.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Dev Comp Immunol 2010; 34:1129-36; PMID:20558200; http://dx.doi.org/10.1016/j.dci.2010.06.005 21.,OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Can J Microbiol 2003; 49:514-24; PMID:14608387; http://dx.doi.org/10.1139/w03-064 22.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
FEMSImmunol Med Microbiol 2002; 34:153-7; PMID:12381467; http://dx.doi.org/10.1111/j.1574- 695X.2002.tb00617.x 23.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
J Med Micro- biol 2011; 60:189-96; PMID:20947665; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Infect Immun 2005; 73:3842-50; PMID:15972469; http://dx.doi.org/ 10.1128/IAI.73.7.3842-3850.2005 25.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Int J Microbiol 2012; 2012:956794; PMID:22121368; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Virulence 2012; 3:51-61;PMID:22286700; http://dx.doi.org/10.4161/ viru.3.1.18799 29.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Infect Immun 2009; 77:4847-58; PMID:19687206; http://dx.doi.org/10.1128/IAI.00223-09 30.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
BMC Microbiol 2010; 10:105; PMID:20377900; http://dx.doi.org/10.1186/1471-2180-10-105 32.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Virulence 2013; 4:250-4; PMID:23334179; http://dx.doi.org/10.4161/ viru.23529 34.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
PLoS Pathog 2014; 10:e1004179; PMID:25010008; http://dx.doi.org/10.1371/journal.ppat.1004179 35.,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Cell Microbiol 2014; 16:115-30; PMID:23962311; http://dx.doi.org/10.1111/ cmi.12184 36.,OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
Infect Immun2001; 69:3350-8; PMID:11292758; http://dx.doi.org/ 10.1128/IAI.69.5.3350-3358.2001 www.tandfonline.com 729 Virulence,Non-OADS,/arxiv_data1/oa_pdf/2b/6b/kvir-06-08-1103428.PMC4826133.pdf
"The current review therefore highlights recent progressin research on neurodegenerative diseases focusing on advancesof TRPM7 channel to various pathologies.© Yuyang Sun, Pramod Sukumaran, Anne Schaar, and Brij B Singh *Correspondence to: Brij Singh; Email: brij.singh@med.und.edu Submitted: 05/27/2015; Revised: 07/15/2015; Accepted: 07/17/2015http://dx.doi.org/10.1080/19336950.2015.1075675 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Cell Calcium 2005; 37:387-93; PMID:15820385; http://dx.doi.org/10.1016/j.ceca.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Cell 2007; 131:1047-58; PMID:18083096; http://dx.doi.org/ 10.1016/j.cell.2007.11.028.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
PLoS ONE 2014; 9:e101023; PMID:25013939; http://dx.doi.org/10.1371/journal.pone.0101023.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Neu- roinﬂammation 2014; 11:210; PMID:25539735; http://dx.doi.org/10.1186/s12974-014-0210-7.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Adv Exp Med Biol2011; 704:125-34; PMID:21290292; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Physiol Rev 2015; 95:1-46; PMID:25540137; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Nature 2011; 475:471-6; PMID:21796205; http://dx.doi.org/10.1038/nature10246.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Proc Natl Acad Sci U S A 2005; 102:662-6; PMID:15647355; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Arch Biochem Biophys 2007; 458:16-23; PMID:16750508; http://dx.doi.org/10.1016/j.abb.2006.03.026.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Bioessays 2005; 27:311-20; PMID:15714553; http://dx.doi.org/ 10.1002/bies.20183.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Nat Commun 2014; 5:4667; PMID:25135336; http://dx.doi.org/10.1038/ncomms5667.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Adv Exp Med Biol 2013;961:65-78; PMID:23224871; http://dx.doi.org/ 10.1007/978-1-4614-4756-6_7.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Hypertens 2009; 27:155-66; PMID:19145781; http://dx.doi.org/10.1097/ HJH.0b013e3283190582.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
CNS Neurol Dis- ord Drug Targets 2010; 9:94-104; PMID:20201820;http://dx.doi.org/10.2174/187152710790966650.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Biochim Biophys Acta 2007; 1772:958-67; PMID:17490865; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Adv Exp Med Biol 2011; 704:595-613; PMID:21290318;http://dx.doi.org/10.1007/978-94-007-0265-3_32.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Hum Genomics 2011; 5:108-16; PMID:21296744; http://dx.doi.org/10.1186/1479-7364-5-2-108.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Biol Chem 2012; 287:44345-60;PMID:23144458; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Handb Exp Pharmacol 2014; 222:489-502; PMID:24756718; http://dx.doi.org/ 10.1007/978-3-642-54215-2_19.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Handb Exp Pharmacol 2014; 222:503-20; PMID:24756719; http://dx.doi.org/10.1007/978-3-642-54215-2_20.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Handb Exp Pharmacol 2014; 222:521-46; PMID:24756720; http://dx.doi.org/10.1007/978-3-642-54215-2_21.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Handb Exp Pharmacol 2014; 222:387-402; PMID:24756714; http://dx.doi.org/10.1007/978-3-642-54215-2_15.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Adv Exp Med Biol 2011; 704:135-45; PMID:21290293; http://dx.doi.org/10.1007/978-94- 007-0265-3_7.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Recept Signal Transduct Res 2006; 26:179-98; PMID:16777714; http://dx.doi.org/10.1080/10799890600637522.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Circ Res 2004; 95:922-9; PMID:15472118; http://dx.doi.org/ 10.1161/01.RES.0000147311.54833.03.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Curr Opin Pharmacol 2015; 22C:18-23; http://dx.doi.org/10.1016/j.coph.2015.02.006.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Nature 2001; 411:590-5; PMID:11385574; http://dx.doi.org/10.1038/35079092.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
The channel kinases TRPM6 and TRPM7 are functionally nonredundant.J Biol Chem 2005; 280:37763-71; PMID:16150690; http://dx.doi.org/10.1074/jbc.M509175200.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Biol Chem 2005; 280:20793-803; PMID:15781465; http://dx.doi.org/10.1074/jbc.M413671200.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Biol Chem2004; 279:50643-6; PMID:15485879; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Bio- chemistry 2011; 50:2187-93; PMID:21280599; http://dx.doi.org/10.1021/bi101963h.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
EMBO J2006; 25:290-301; PMID:16407977; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Int J Biochem Cell Biol 2012; 44:1381- 4; PMID:22634382; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Cell Mol Life Sci 2014; 71:4853-67; PMID:24858416; http://dx.doi.org/10.1007/s00018-014-1647-7.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Proc Natl Acad Sci U S A 2004;101:6009-14; PMID:15069188; http://dx.doi.org/ 10.1073/pnas.0307565101.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Biophys J 2003; 84:922-7; PMID:12547774; http://dx.doi.org/ 10.1016/S0006-3495(03)74909-1.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Biol Chem 2013; 288:255- 63; PMID:23168410; http://dx.doi.org/10.1074/jbc.M112.393918.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Biol Chem 2007; 282:232-9; PMID:17095511; http://dx.doi.org/10.1074/jbc.M605300200.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Gen Physiol 2005; 126:137-50;PMID:16009728; http://dx.doi.org/10.1085/ jgp.200409185.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Antioxid Redox Signal 2011; 14:1815-27; PMID:20812867; http://dx.doi.org/10.1089/ ars.2010.3549.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Dev Cell 2012; 22:1149-62; PMID:22698280; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Cell 2014; 157:1061- 72; PMID:24855944; http://dx.doi.org/10.1016/j.cell.2014.03.046.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Sci Rep 2014;4:5718; PMID:25030553; http://dx.doi.org/ 10.1038/srep05718.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
BMC Genomics 2006; 7:159;PMID:16787531; http://dx.doi.org/10.1186/1471- 2164-7-159.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Biochem J 2012; 445:441-8; PMID:22587440; http://dx.doi.org/ 10.1042/BJ20120248.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Proc Natl Acad Sci U S A 2008; 105:8304-8; PMID:18539771; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Neuron 2006; 52:485-96; PMID:17088214; http://dx.doi.org/10.1016/j.neuron.2006.09.033.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Science 2008; 322:756- 60; PMID:18974357; http://dx.doi.org/10.1126/science.1163493.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
FEBS Lett 2011; 585:2275-8;PMID:21627970; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Mol Biol 2008; 378:790- 803; PMID:18394644; http://dx.doi.org/10.1016/j.jmb.2008.02.057.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Pharmacol Sci 2004; 95:403-19; PMID:15286426; http://dx.doi.org/10.1254/jphs.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Mol Neurobiol 2014; PMID:25502295; http://dx.doi.org/10.1007/s12035- 014-9032-y 64.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Cell Tissue Res 1997; 290:471-80; PMID:9369525; http://dx.doi.org/ 10.1007/s004410050955.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Free Radic Biol Med 2013; 62:90-101; PMID:23200807; http://dx.doi.org/10.1016/j.freeradbiomed.2012.11.014.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
CNS Neurol Disord Drug Targets 2007;6:411-23; PMID:18220780; http://dx.doi.org/ 10.2174/187152707783399201.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Antioxid Redox Signal 2014; 21:123-37; PMID:24512092; http://dx.doi.org/10.1089/ars.2013.5777.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Eur J Neurosci 2011; 34:437-47; PMID:21722208; http://dx.doi.org/10.1111/j.1460-9568.2011.07760.x.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Mol Immunol 2002; 38:713-21; PMID:11841831; http://dx.doi.org/ 10.1016/S0161-5890(01)00108-0.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Nat Commun 2014; 5:5318; PMID:25351853; http://dx.doi.org/ 10.1038/ncomms6318.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Dev Neurobiol 2012; 72:865-77;PMID:22102510; http://dx.doi.org/10.1002/ dneu.22001.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Neurosci Res 2005; 82:377-86; PMID:16211559; http://dx.doi.org/ 10.1002/jnr.20651.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Neurosci Res 2009; 63:72-5; PMID:18977253; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Neuropathology 2006; 26:115-28; PMID:16708544; http://dx.doi.org/10.1111/j.1440-1789.2006.00672.x.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Dev Biol 2014; 386:428-39; PMID:24291744; http://dx.doi.org/10.1016/j.ydbio.2013.11.015.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Neurol Neuro- surg Psychiatry 2005; 76:1046-57; PMID:16024877; http://dx.doi.org/10.1136/jnnp.2004.048652.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Neu- rology 1982; 32:107-26; PMID:7198738; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Brain 1961;84:662-79; PMID:13907610; http://dx.doi.org/ 10.1093/brain/84.4.662.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Curr Alzheimer Res 2006; 3:397-401; PMID:17017870; http://dx.doi.org/10.2174/156720506778249425.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Biochim Biophys Acta 2007; 1772:822- 35; PMID:17395433; http://dx.doi.org/10.1016/j.bbadis.2007.02.008.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Lancet 1972; 2:292-6; PMID:4115029; http://dx.doi.org/10.1016/S0140-6736(72)92903-0.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Ann Neurol 1984; 15:42-8; PMID:6546847; http://dx.doi.org/ 10.1002/ana.410150108.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Cell Calcium 2009; 45:300-9; PMID:19135721; http://dx.doi.org/10.1016/j.ceca.2008.11.009.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
PloS one 2012; 7:e33584; PMID:22438954; http://dx.doi.org/10.1371/journal.pone.0033584.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Mol Brain 2015; 8:11; PMID:25761704; http://dx.doi.org/10.1186/s13041- 015-0102-5.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Cell Signal 2012; 24:2070-5; PMID:22759789; http://dx.doi.org/10.1016/j.cellsig.2012.06.015.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Neurochem Res2000; 25:189-96; PMID:10786701; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
"Ma T, Chen Y, Vingtdeux V, Zhao H, Viollet B, Marambaud P, Klann E. Inhibition of AMP-activated protein kinase signaling alleviates impairments in hip-pocampal synaptic plasticity induced by amyloid b.J Neurosci 2014; 34:12230-8; PMID:25186765; http://dx.doi.org/10.1523/JNEUROSCI.1694-14.2014.",OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
FEBS J 2005; 272:4211-20;PMID:16098202; http://dx.doi.org/10.1111/j.1742- 4658.2005.04833.x.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Cell Signal 2011; 23:586-93; PMID:21112387; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Alzheimer Dement 2010; 6:118-24; http://dx.doi.org/10.1016/j.jalz.2009.05.663.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
CNS Neurol Disord Drug Targets 2015; 14:313-24; PMID:25714978; http://dx.doi.org/ 10.2174/1871527314666150225124928.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Pﬂugers Archiv 2005; 451:243-9; PMID:16044308; http://dx.doi.org/10.1007/s00424- 005-1439-x.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Biol Chem 2003; 278:21493-501; PMID:12672799; http://dx.doi.org/10.1074/jbc.M300945200.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Gen Physiol 2006; 127:525-537;PMID:16636202; http://dx.doi.org/10.1085/jgp.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Gen Physiol 2003; 121:49-60; PMID:12508053; http://dx.doi.org/10.1085/jgp.,Non-OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Expression proﬁle of the transient receptor potential (TRP) family in neutro- phil granulocytes: evidence for currents through long TRP channel 2 induced by ADP-ribose and NAD.Biochem J 2003; 371:1045-53; PMID:12564954; http://dx.doi.org/10.1042/BJ20021975.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Science 2001; 293:1327-30; PMID:11509734; http://dx.doi.org/ 10.1126/science.1062473.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Nature 2002; 416:52-8; PMID:11882888; http://dx.doi.org/10.1038/nature 719.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Biochem Biophys Res Commun 2005; 333:374-82;PMID:15950184; http://dx.doi.org/10.1016/j.bbrc.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Science 2004; 306:1374-7; PMID:15550671; http://dx.doi.org/10.1126/science.1098845.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
J Biol Chem 2005; 280:22899-906;PMID:15845551; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
Curr Biol 2003; 13:1153-8; PMID:12842017; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/79/87/kchl-09-05-1075675.PMC4826135.pdf
"8-10Moreover, although some studies have demonstrated a speciﬁc diversity ofbiﬁdobacterial species present in formula-fed infants is more like © Caroline Thum, Nicole C Roy, Warren C McNabb, Don E Otter, and Adrian L Cookson *Correspondence to: Adrian L Cookson; Email: adrian.cookson@agresearch.co.nzSubmitted: 05/22/2015; Revised: 07/23/2015; Accepted: 10/05/2015 http://dx.doi.org/10.1080/19490976.2015.1105425 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
"infantis ATCC15697ACJ53406 Blon_2348 394 35-368 None None B. breve ACS-071-V-Sch8b AEF27628 HMPREF9228_0182 763 325-730 None None B. biﬁdum PRL2010 ADP36806 BBPR_1793 1795 325-650 Between aa 39-40 Two between aa 17-39 and aa 1767-1789 B. biﬁdum PRL2010 ADP36807 BBPR_1794 834 190-510 Between aa 35-36 Two between aa 13-35 and aa 806-828 B) OriginPredicted localizationPrimer name SequenceAmplicon lengthRegion ampli ﬁed B. longum subsp infantis ATCC15697Intracellular Sialil-Inf F. 50-TACTGTGTGCGGCGCGAACC R. 50-CAGACAGCGGAAAACCGCCGA 1136bp 33-1168bp B. breve ACS-071-V-Sch8b Intracellular Sialil-Br F. 50-GCGGTGCGGTGGACATCTAT R. 50-CAGCCGACTTCACTCCGAA 1527bp 737-2263bp B. biﬁdum PRL2010 Extracellular Sialil-Bif5 F. 50-GCGACCACTCAGGACGGCAC R. 50-TCCGAGATCGCAACGCGACG 1198bp 448-1645bp B. biﬁdum PRL2010 Extracellular Sialil-Bif2 F. 50-GCTGCATGCGGTCGTCGTCA R. 50-TCGTGGCGTTGGCATTCGCA 1049bp 915-1963bp *66 yTMHMM Server v. 2.0, http://www.cbs.dtu.dk/services/TMHMM/ www.tandfonline.com 361 Gut Microbes",Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Nat Immunol 2013; 14:685-90; PMID:23778796; http://dx.doi.org/10.1038/ni.2608.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Clin Gastroenterol 2006; 40:235-43; PMID:16633129; http://dx.doi.org/10.1097/00004836-200603000-00015.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
NatRev Immunol 2004; 4:478-85; PMID:15173836; http://dx.doi.org/10.1038/nri1373.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Gut 2004;53:1388-9; PMID:15306608; http://dx.doi.org/ 10.1136/gut.2004.041640.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Proc Natl Acad Sci U S A 2010; 107:11971-5; PMID:20566857; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Proc Natl Acad Sci U S A 2011; 108 Suppl 1:4578-85; PMID:20668239; http://dx.doi.org/ 10.1073/pnas.1000081107.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Anaer- obe 2011; 17:478-82; PMID:21497661; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Microbiology 2011; 157:1385-92; PMID:21330436; http://dx.doi.org/10.1099/mic.0.042143-0.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Pediatr Gastroenterol Nutr 2010; 51:77-84; PMID:20479681; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Pediatr GastroenterolNutr 2000; 30:61-7; PMID:10630441; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
ApplEnviron Microbiol 2005; 71:2318-24; PMID:15870317; http://dx.doi.org/10.1128/AEM.71.5.2318-2324.2005.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Microbiology 2010; 156:3329-41; PMID:20864478; http://dx.doi.org/ 10.1099/mic.0.043224-0.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Anim Sci 2009; 87:26-34;PMID:19028867; http://dx.doi.org/10.2527/jas.2008- 1347.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Adv Food Nutr Res 2009; 55:101-61; PMID:18772103; http://dx.doi.org/ 10.1016/S1043-4526(08)00402-6.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Adv Nutr 2012; 3:422S-9S; PMID:22585921; http://dx.doi.org/ 10.3945/an.111.001420.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Nutr J 2012; 11:81; PMID:23035863; http://dx.doi.org/ 10.1186/1475-2891-11-81.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Infect Immun 2006; 74:6920-8; PMID:16982832; http://dx.doi.org/10.1128/IAI.01030-06.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Biol Chem 2011; 286:11909-18; PMID:21288901; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Int J Epidemiol 1999; 28:152-6; PMID:10195681; http://dx.doi.org/10.1093/ije/28.1.152.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Eur J Clin Nutr 2003;57:1351-69; PMID:14576748; http://dx.doi.org/ 10.1038/sj.ejcn.1601704.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Glycoconj J 2000; 17:485-99; PMID:11421344; http://dx.doi.org/10.1023/ A:1011062223612.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Appl EnvironMicrobiol 2006; 72:5204-10; PMID:16885266; http://dx.doi.org/10.1128/AEM.00146-06.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Biofactors 2012; 6:440-9; http://dx.doi.org/10.1002/biof.1043.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
PLoS One 2012; 7:e36957;PMID:22606315; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Glycobiology 2011; 21:437-47; PMID:21036948; http://dx.doi.org/10.1093/glycob/cwq175.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Appl Environ Microbiol 2006; 72:4497-9; PMID:16751577; http://dx.doi.org/10.1128/ AEM.02515-05.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Gut 1987; 28:1221- 7; PMID:3678950; http://dx.doi.org/10.1136/ gut.28.10.1221.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Eur J Nutr 2002; 41:i11-i6; PMID:12420111; http://dx.doi.org/10.1007/s00394-002-1102-7.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
PMID:17187590; http://dx.doi.org/10.1111/j.1365- 2982.2006.00853.x.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Proc Natl Acad Sci U S A 2004; 101:1045-50; PMID:14722361; http://dx.doi.org/10.1073/ pnas.2637002100.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Appl Micro- biol 2005; 99:201-12; PMID:15960680; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Arch Biochem Biophys 1954; 48:193-201; PMID:13125589; http://dx.doi.org/10.1016/0003- 9861(54)90323-9.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Appl Environ Microbiol 2010; 76:54-9; PMID:19854932; http://dx.doi.org/10.1128/ AEM.01683-09.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Appl Microbiol Biotech- nol 2009; 82:1079-88; PMID:19099301; http://dx.doi.org/10.1007/s00253-008-1795-5.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Genes Nutr 2011; 6:285-306; PMID:21484167; http://dx.doi.org/ 10.1007/s12263-010-0206-6.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Biol Chem 2011; 286:34583-92; PMID:21832085; http://dx.doi.org/10.1074/jbc.M111.248138.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Appl Environ Microbiol 2009; 75:7319-25; PMID:19801485; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Proc Natl Acad Sci U S A 2002;99:14422-7; PMID:12381787; http://dx.doi.org/ 10.1073/pnas.212527599.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Glycobiology 2009; 19:1010-7; PMID:19520709; http://dx.doi.org/ 10.1093/glycob/cwp082.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Biol Chem 2013; 288:25194-206; PMID:23843461; http://dx.doi.org/10.1074/jbc.M113.484733.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Appl Environ Microbiol 2010; 76:7373-81; PMID:20802066; http://dx.doi.org/10.1128/AEM.00675-10.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Can J Microbiol 2011; 57:857-65; PMID:21958046; http://dx.doi.org/10.1139/w11-077.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Appl Bac- teriol 1994; 77:412-20; PMID:7989269; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
ApplEnviron Microbiol 2005; 71:6150-8; PMID:16204533; http://dx.doi.org/10.1128/ AEM.71.10.6150-6158.2005.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
J Microbiol Methods 2000; 43:127-32; PMID:11121611; http://dx.doi.org/10.1016/S0167- 7012(00)00205-0.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Microbiol Res 2002; 157:13-7; PMID:11911609; http://dx.doi.org/10.1078/0944-5013-00126.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Lett Appl Microbiol 2002; 34:82-5;PMID:11849499; http://dx.doi.org/10.1046/j.1472- 765x.2002.01050.x.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Lett Appl Microbiol 1995; 21:376-9; PMID:8554764; http://dx.doi.org/10.1111/j.1472-765X.1995.tb01085.x.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Appl Microbiol Biotechnol 1999; 51:91-9; PMID:10077825; http://dx.doi.org/10.1007/s002530051368.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
FEMS Microbiol Lett 2000; 191:17-24;PMID:11004394; http://dx.doi.org/10.1111/j.1574- 6968.2000.tb09313.x.,OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
Microbiol Immunol 2003; 47:557-70; PMID:14524616; http://dx.doi.org/10.1111/j.1348- 0421.2003.tb03418.x.,Non-OADS,/arxiv_data1/oa_pdf/4d/13/kgmi-06-06-1105425.PMC4826140.pdf
"15Biochemically, phosphorylated TRBP2 stabilizes DicerKeywords: ERK Signaling, Dicer phos- phorylation, oocyte-to-embryo transition © Swathi Arur *Correspondence to: Swathi Arur; Email:sarur@mdanderson.org Submitted: 06/22/2015 Revised: 08/05/2015Accepted: 08/17/2015http://dx.doi.org/10.1080/21624054.2015.1086062 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop-erly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"A requirement for ERK-dependent Dicer phosphorylation in coordi- nating oocyte-to-embryo transition in C. elegans.Dev Cell 2014; 8;31(5):614-28; PMID: 25490268; http://dx.doi.org/10.1016/j.devcel.2014.11.004 www.tandfonline.com e1086062-1 WormWorm 4:4, e1086062; October/November/December 2015; Published with license by Taylor & Francis Group, LLCCOMMENTARY",Non-OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Curr Biol 2006; 16:1041-9; http://dx.doi.org/ 10.1016/j.cub.2006.04.005 2 Svoboda P, Flemr M. The role of miRNAs and endoge- nous siRNAs in maternal-to-zygotic reprogramming and the establishment of pluripotency.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"EMBO Rep 2010; 11:590-7; PMID:20651740; http://dx.doi.org/10.1038/embor.2010.102 3 Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G, Mello CC.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Cell 2001; 106:23-34; PMID:11461699; http://dx.doi.org/10.1016/S0092- 8674(01)00431-7 4 Slack FJ, Basson M, Liu Z, Ambros V, Horvitz HR, Ruvkun G. The lin-41 RBCC gene acts in the C. elegans heterochronic pathway between the let-7 regulatoryRNA and the LIN-29 transcription factor.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Mol Cell 2000; 5:659-69; PMID:10882102; http://dx.doi.org/ 10.1016/S1097-2765(00)80245-2 5 Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bet- tinger JC, Rougvie AE, Horvitz HR, Ruvkun G. The21-nucleotide let-7 RNA regulates developmental tim- ing in Caenorhabditis elegans.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Nature 2000; 403:901-6; PMID:10706289; http://dx.doi.org/10.1038/35002607 6 Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Nature 2004; 432:231-5; PMID:15531879; http://dx.doi.org/10.1038/nature 03049 7 Ketting RF, Fischer SE, Bernstein E, Sijen T, Hannon GJ, Plasterk RH.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
Genes Dev 2001; 15:2654-9; PMID:11641272; http://dx.doi.org/10.1101/ gad.927801 www.tandfonline.com e1086062-5 Worm,Non-OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Cancer Res2007; 67:7713-22; PMID:17699775; http://dx.doi.org/ 10.1158/0008-5472.CAN-07-1083 9 Ding XC, Slack FJ, Grosshans H. The let-7 microRNA interfaces extensively with the translation machinery to regulate cell differentiation.",Non-OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Cell Cycle 2008; 7:3083-90; PMID:18818519; http://dx.doi.org/10.4161/ cc.7.19.6778 10 Yigit E, Batista PJ, Bei Y, Pang KM, Chen CC, Tolia NH, Joshua-Tor L, Mitani S, Simard MJ, Mello CC.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Cell 2006; 127:747-57; PMID:17110334; http://dx.doi.org/ 10.1016/j.cell.2006.09.033 11 Gu W, Shirayama M, Conte D Jr, Vasale J, Batista PJ, Claycomb JM, Moresco JJ, Youngman EM, Keys J, Stoltz MJ, et al.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Mol Cell 2009; 36:231-44; PMID:19800275; http://dx.doi.org/10.1016/j.molcel.2009.09.020 12 Wedeles CJ, Wu MZ, Claycomb JM.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Chromosome Res 2013; 21:573-86; PMID:24178449; http://dx.doi.org/10.1007/s10577-013-9383-7 13 Schmitter D, Filkowski J, Sewer A, Pillai RS, Oakeley EJ, Zavolan M, Svoboda P, Filipowicz W. Effects ofDicer and Argonaute down-regulation on mRNA levels in human HEK293 cells.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Nucleic Acids Res 2006; 34:4801-15; PMID:16971455; http://dx.doi.org/ 10.1093/nar/gkl646 14 Tops BB, Plasterk RH, Ketting RF.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Cold Spring Harb Symp Quant Biol 2006; 71:189-94; PMID:17381296; http://dx.doi.org/10.1101/sqb.2006.71.035 15 Paroo Z, Ye X, Chen S, Liu Q. Phosphorylation of the human microRNA-generating complex mediates MAPK/Erk signaling.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Cell 2009; 139:112-22; PMID:19804757; http://dx.doi.org/10.1016/j.cell.2009.06.044 16 Hubbard EJ, Greenstein D. The Caenorhabditis elegans gonad: a test tube for cell and developmental biology.Dev Dyn 2000; 218, 2-22; PMID:10822256; http://dx.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Genetics 2007; 177:2039-62; PMID:18073423; http://dx.doi.org/10.1534/ genetics.107.081356 19 Church DL, Guan KL, Lambie EJ.",Non-OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Science 2001; 291:2144-7; PMID:11251118; http://dx.doi.org/10.1126/science.1057586 21 Drake M, Furuta T, Suen KM, Gonzalez G, Liu B, Kalia A, Ladbury JE, Fire AZ, Skeath JB, Arur S. A requirement for ERK-dependent Dicer phosphorylationin coordinating oocyte-to-embryo transition in C. ele- gans.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Dev Cell 2014; 31:614-28; PMID:25490268; http://dx.doi.org/10.1016/j.devcel.2014.11.004 22 Beshore EL, McEwen TJ, Jud MC, Marshall JK, Schisa JA, Bennett KL.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Dev Biol 2011; 350:370-81; PMID:21146518; http://dx.doi.org/10.1016/j.ydbio.2010.12.005 23 Knight SW, Bass BL.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
Science 2001; 293:2269-71;PMID:11486053; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
Curr Biol 2004; 14:111-6; PMID:14738731; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Dev Cell 2014; 31:523-4; PMID:25490263; http://dx.doi.org/10.1016/ j.devcel.2014.11.032 26 Emmerth S, Schober H, Gaidatzis D, Roloff T, Jacobeit K, B€uhler M. Nuclear retention of ﬁssion yeast dicer is a prerequisite for RNAi-mediated heterochromatin assem- bly.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
Dev Cell 18:102-13; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"EMBO J 2011; 30:4223-35; PMID:21847092; http://dx.doi.org/10.1038/emboj.2011.300 28 Ando Y, Tomaru Y, Morinaga A, Burroughs AM, Kawaji H, Kubosaki A, Kimura R, Tagata M, Ino Y, Hirano H, et al.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"NatStruct Mol Biol 2007; 14:934-940; PMID:17873886;http://dx.doi.org/10.1038/nsmb129330 Han T, Manoharan AP, Harkins TT, Bouffard P, Fitz- patrick C, Chu DS, Thierry-Mieg D, Thierry-Mieg J, Kim JK.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"PLoS Genet 2012; 8, e1002702; PMID:22829772; http://dx.doi.org/ 10.1371/journal.pgen.1002702 34 Warf MB, Johnson WE, Bass BL.",Non-OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"RNA 2011; 17:563-77; PMID:21307183; http://dx.doi.org/10.1261/rna.2432311 35 Murchison EP, Stein P, Xuan Z, Pan H, Zhang MQ, Schultz RM, Hannon GJ.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
Genes Dev 2007; 21:682-93;PMID:17369401; http://dx.doi.org/10.1101/gad.,OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Dev Biol 1997; 181:121-43; PMID:9013925; http://dx.doi.org/ 10.1006/dbio.1996.8429 37 Ma J, Flemr M, Stein P, Berninger P, Malik R, Zavolan M, Svoboda P, Schultz RM.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"Curr Biol 2010; 20:265-70;http://dx.doi.org/10.1016/j.cub.2009.12.042 38 Suh N, Baehner L, Moltzahn F, Melton C, Shenoy A, Chen J, Blelloch R. MicroRNA function is globally sup-pressed in mouse oocytes and early embryos.",OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
Curr Biol 2010; 20:271-7; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
Cell 2013; 155:807-16; PMID:24209619; http://dx.doi.org/10.1016/j.cell.2013.10.001 e1086062-6 Volume 4 Issue 4 Worm,OADS,/arxiv_data1/oa_pdf/0b/02/kwrm-04-04-1086062.PMC4826148.pdf
"the© Dena HS Block and Michael Shapira *Correspondence to: Michael Shapira; Email: mshapira@berkeley.edu Submitted: 09/30/2015; Revised: 11/03/2015; Accepted: 11/05/2015http://dx.doi.org/10.1080/21624054.2015.1118607 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
"14 Supporting autoregulation, ChIP-identiﬁed ELT-3 targets(http://data.modencode.org) 37included the elt-3 promoter.",Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Front Microbiol 2014;5:656; PMID:25506342; http://dx.doi.org/10.3389/ fmicb.2014.00656 3.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Semin Cell Dev Biol 2005; 16:137- 47; PMID:15659348; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Trends Immunol 2014; 35:233-42; PMID: 24786134; http://dx.doi.org/10.1016/j.it.2014.04.002 9 .,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
J Immunol 2007; 178:2491-8; PMID:17277157; http://dx.doi.org/10.4049/jimmunol.178.4.2491 10.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Embo J 1999; 18:4013-22; PMID:10406806; http://dx.doi.org/10.1093/emboj/18.14.4013 11.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
BMC Evol Biol 2008; 8:112; PMID:18412965; http://dx.doi.org/10.1186/1471-2148- 8-112 14.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Wiley Interdiscip Rev Dev Bio 2012; 1:861-78; PMID:23539299; http://dx.doi.org/ 10.1002/wdev.79 17.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Dev Biol 2015; 404:66-79; PMID:25959238; http://dx.doi.org/10.1016/j.ydbio.2015.04.025 e1118607-4 Volume 4 Issue 4 Worm,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
PLoS ONE 2006; 1:e77;PMID:17183709; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Curr Biol 2008; 18:481-9; PMID:18394898; http://dx.doi.org/ 10.1016/j.cub.2008.02.079 25.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
PLoS One 2010; 5: e9010; PMID:20126308; http://dx.doi.org/10.1371/journal.pone.0009010 26.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Cell Rep 2014;9:9-15; PMID:25284791; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Nucleic Acids Res 2015; 43:803-16; PMID:25552416; http://dx.doi.org/10.1093/nar/gku1360 28.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
PLoS Genet 2015; 11:e1005265; PMID:26016853; http://dx.doi.org/10.1371/journal.pgen.1005265 30.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Dev Biol 2007; 302:627-45; PMID:17113066; http://dx.doi.org/ 10.1016/j.ydbio.2006.10.024 31.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Mol Microbiol 2008;69:586-602; PMID:18547391; http://dx.doi.org/ 10.1111/j.1365-2958.2008.06297.x33.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Two GATA transcription fac- tors are downstream effectors of ﬂoral homeotic gene action in Arabidopsi s. Plant Physiol 2008; 147:707-18; PMID:18417639; http://dx.doi.org/10.1104/pp.107.115634 34.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
J Clin Invest 2012; 122:3504-15; PMID:23006330; http://dx.doi.org/10.1172/JCI63240 35.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Dev Biol 2007; 311:623-35; PMID:17869240;http://dx.doi.org/10.1016/j.ydbio.2007.08.018 36.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Nature 2009; 459:927-30; PMID:19536255; http://dx.doi.org/10.1038/459927a 38.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
J Biol Chem 2001; 276:28586-97; PMID:11382772; http://dx.doi.org/10.1074/jbc.M103166200 40.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Curr Biol 2014; 24:1-10; PMID:24332542; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
"Inoue H, Hisamoto N, An JH, Oliveira RP, Nishida E, Blackwell TK, Matsumoto K. The C. elegans p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response.Genes Dev 2005; 19:2278-83; PMID:16166371; http://dx.doi.org/10.1101/gad.1324805 43.",OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
PLoS Pathog 2011; 7: e1002453; PMID:22216003; http://dx.doi.org/ 10.1371/journal.ppat.1002453 44.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
PLoS Pathog 2012; 8:e1002673; PMID:22577361; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Science 1997; 278:1319-22; PMID:9360933; http://dx.doi.org/10.1126/science.278.5341.1319 48.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Curr Biol 2001; 11:1975-80; PMID:11747825; http://dx.doi.org/10.1016/S0960-9822(01)00594-2 49.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Nature 2003; 424:277-83; PMID:12845331; http://dx.doi.org/10.1038/nature01789 50.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Cell Metab 2013; 17:85-100; PMID:23312285; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Cell 2013; 154:676- 90; PMID:23911329; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Dev Biol 1999; 208:265-80; PMID:10191044; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
PLoS Pathog 2008; 4: e1000105; PMID:18636113; http://dx.doi.org/10.1371/journal.ppat.1000105 54.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Dev Biol 2011;357:356-69; PMID:21798253; http://dx.doi.org/ 10.1016/j.ydbio.2011.07.008 56.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Cell Host Microbe 2011; 9:425-35; PMID:21575913; http://dx.doi.org/ 10.1016/j.chom.2011.04.011 57.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Nat Immunol 2014; 15:833-8; PMID: 25086774; http://dx.doi.org/10.1038/ni.2957 58.,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Immunity 2015; 42:309-20; PMID:25692704; http://dx.doi.org/10.1016/j.immuni.2015.01.014 59.,OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
Nat Immunol 2009; 10:249-56;PMID:19198592; http://dx.doi.org/10.1038/ ni.1700 www.tandfonline.com e1118607-5 Worm,Non-OADS,/arxiv_data1/oa_pdf/b7/9c/kwrm-04-04-1118607.PMC4826149.pdf
"Examples include theactivation of the GATA transcription fac-tor gene end-1 in the EMS lineage, 10,11 the Nkx transcription factor gene ceh-22 in the distal tip cell precursor,12the Meis transcription factor gene psa-3 in the T lineage,13the homeodomain transcription factor gene ceh-10 in the AIY lineage14or the GATA transcription factor gene egl-18 in seam cell lineages.15These targets con- tain TCF binding sites in their cis-regula- tory elements and are directly activated by the POP-1:SYS-1 complex in the posteriordaughter and directly repressed by POP-1Keywords: C. elegans , POP-1, REF-2, SYS-1, transcription, TCF, Wnt signaling,Zic,b-catenin © Sabrina Murgan and Vincent Bertrand *Correspondence to: Vincent Bertrand; Email: vincent.bertrand@univ-amu.fr Submitted: 08/05/2015Accepted: 08/20/2015http://dx.doi.org/10.1080/21624054.2015.1086869 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop-erly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Dev Cell 2009; 17:9-26; PMID:19619488; http://dx.doi.org/10.1016/j.devcel.2009.06.016 2.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Cell 2012; 149:1192-205; PMID:22682243;http://dx.doi.org/10.1016/j.cell.2012.05.012 3.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Sci Signaling 2008; 1:pe43; PMID:18827220; http://dx.doi.org/10.1126/scisignal.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Curr Top Dev Biol 2012; 98:1-34; PMID:22305157; http://dx.doi.org/10.1016/B978-0-12-386499-4.00001-X 5.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Cell 1998;92:229-39; PMID:9458047; http://dx.doi.org/ 10.1016/S0092-8674(00)80917-4 7.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Trends Cell Biol 2007; 17:465-73; PMID:17919911; http://dx.doi.org/10.1016/j.tcb.2007.08.004 8.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Dev Cell 2009; 17:27-34; PMID:19619489; http://dx.doi.org/10.1016/j.devcel.2009.07.002 9.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Curr Opin Genet Dev 2010; 20:362-8;PMID:20537527; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Dev Biol 2005; 285:510-23;PMID:16084508; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Dev Biol 2005; 285:584-92; PMID:16112103; http://dx.doi.org/10.1016/j.ydbio.2005.07.008 12.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Curr Biol 2006; 16:287-95; PMID:16461282; http://dx.doi.org/10.1016/j.cub.2005.12.01513.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Dev Cell 2006;11:105-15; PMID:16824957; http://dx.doi.org/ 10.1016/j.devcel.2006.04.020 14.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Dev Cell 2009; 16:563-75;PMID:19386265; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Development 2013; 140:2093-102; PMID:23633508; http://dx.doi.org/10.1242/dev.091124 16.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Development 2009; 136:2735-46; PMID:19605496; http://dx.doi.org/10.1242/dev.038307 17.,Non-OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Dev Biol 2010; 340:209-21; PMID:19818340;http://dx.doi.org/10.1016/j.ydbio.2009.09.042 18.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Dev Biol 1983; 100:64-119; PMID:6684600; http://dx.doi.org/10.1016/0012-1606 (83)90201-419.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Dev Cell 2015;33:737-45; PMID:26073017; http://dx.doi.org/ 10.1016/j.devcel.2015.04.018 20.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
PLoS genetics 2014; 10:e1004509; PMID:25144371;http://dx.doi.org/10.1371/journal.pgen.1004509 23.,Non-OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Genes Dev 2007; 21:2923-35; PMID:18006687; http://dx.doi.org/10.1101/gad.450107 24.,OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
Nature 2003; 422:317-22; PMID:12646922; http://dx.doi.org/ 10.1038/nature01458 e1086869-4 Volume 4 Issue 4 Worm,Non-OADS,/arxiv_data1/oa_pdf/99/fc/kwrm-04-04-1086869.PMC4826150.pdf
"© Jeremy Michael Van Raamsdonk *Correspondence to: Jeremy Michael Van Raams- donk; Email: Jeremy.VanRaamsdonk@vai.org Submitted: 09/02/2015Accepted: 09/09/2015http://dx.doi.org/10.1080/21624054.2015.1094607 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop-erly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
PLoS Genet 2015; 11:e1004972; PMID:25671321; http://dx.doi.org/10.1 371/journal.pgen.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
J Gerontol 1956; 11:298-300; PMID:13332224; http://dx.doi.org/10.1093/geronj/ 11.3.298 2.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Genes Dev 2008; 22:3236-41; PMID:19056880; http://dx.doi.org/10.1101/ gad.5048083.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Mech AgeingDev 2009; 130:173-8; PMID:19059428; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
PLoS Genet 2009; 5:e1000361; PMID:19197346; http://dx.doi.org/ 10.1371/journal.pgen.1000361 5.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
"Yang W, Hekimi S. A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans.PLoS Biol 2010; 8:e1000556; PMID:21151885; http://dx.doi.org/10.1371/journal.pbio.1000556 7.",OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Curr Biol 2010; 20:2131- 6; PMID:21093262; http://dx.doi.org/10.1016/j.cub.2010.10.057 8.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Biogerontology 2010; 11:183- 95; PMID:19597959; http://dx.doi.org/10.1007/ s10522-009-9239-x 11.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Mol Metab 2013; 2:92-102; PMID:24199155; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Cell Metab 2007; 6:280-93; PMID:17908557; http://dx.doi.org/10.1016/j.cmet.2007.08.011 13.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Horm Metab Res 2011; 43:687-92; PMID:21932172; http://dx.doi.org/ 10.1055/s-0031-1286308 14.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Nat Commun2014; 5:3563; PMID:24714520; http://dx.doi.org/ 10.1038/ncomms4563 Figure 2.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Cell Metab 2012; 15:451-65; PMID:22482728; http://dx.doi.org/ 10.1016/j.cmet.2012.02.013 16.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
PLoS Genet 2015; 11:e1004972; PMID: 25671321; http://dx.doi.org/10.1371/journal.pgen.1004972 17.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Cell Metab 2011; 13:668-78; PMID:21641548; http://dx.doi.org/10.1016/j.cmet.2011.03.018 18.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Cell Metab 2013; 17:954-64; PMID:23747251; http://dx.doi.org/10.1016/j.cmet.2013.04.00319.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
radicals.Biochim Biophys Acta 1984; 778:579-85; PMID:6095912; http://dx.doi.org/10.1016/0005- 2736(84)90409-7 21.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Science 1996; 272:1010-3; PMID:8638122; http://dx.doi.org/ 10.1126/science.272.5264.1010 23.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Methods Mol Biol 2009;554:165-81; PMID:19513674; http://dx.doi.org/ 10.1007/978-1-59745-521-3_11 24.,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Free Radic Biol Med 2012; 52:850-9; PMID:22226831; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Cell 2008; 134:279-90; PMID:18662543; http://dx.doi.org/10.1016/j.cell.2008.06.017 26.,OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
Nature 2014; 514:E12-4; PMID:25341790; http://dx.doi.org/ 10.1038/nature13858 e1094607-4 Volume 4 Issue 4 Worm,Non-OADS,/arxiv_data1/oa_pdf/dd/f4/kwrm-04-04-1094607.PMC4826151.pdf
"sommer@tuebingen.mpg.de Submitted: 07/24/2015Accepted: 08/06/2015http://dx.doi.org/10.1080/21624054.2015.1082029 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Cell 2008; 134:25-36; PMID:18614008; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Evol Dev 2001; 3:109-19; PMID:11341673; http://dx.doi.org/ 10.1046/j.1525-142x.2001.003002109.x 5.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
PLOS Biol 2011; 9:e1001110; PMID:21814488;http://dx.doi.org/10.1371/journal.pbio.1001110 6.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Mol Ecol 2013; 22:2380-93; PMID:23530614; http://dx.doi.org/10.1111/mec.12286 8.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Genes Dev 2008;22:2149-65; PMID:18708575; http://dx.doi.org/ 10.1101/gad.1701508 11.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Curr Biol 2011; 21:R758-66; PMID:21959166; http://dx.doi.org/10.1016/j.cub.2011.06.034 12.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Dev Biol 1975; 46:326-42; PMID:1183723; http://dx.doi.org/10.1016/0012-1606 (75)90109-8 13.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Trends Genet 2009; 25:203-9; PMID:19361881; http://dx.doi.org/10.1016/j.tig.2009.03.006 17.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Zoology 2006; 109:96-108; PMID:16616467; http://dx.doi.org/10.1016/j.zool.2006.03.001 19.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
BMC Ecol 2015; 15:19; PMID:26170141; http://dx.doi.org/10.1186/s12898- 015-0050-z e1082029-4 Volume 4 Issue 4 Worm,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Mol Ecol 2012; 21:250-66; PMID:22126624; http://dx.doi.org/10.1111/j.1365- 294X.2011.05382.x 22.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Proc R Soc B 2011; 278:2784-90;PMID:21307052; http://dx.doi.org/10.1098/ rspb.2010.2760 23.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Curr Biol 2014; 24:1536-41; PMID:24980503; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
; http://dx.doi.org/10.1371/journal.pgen.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Proc R Soc B 1979; 205:489-511; http://dx.doi.org/10.1098/rspb.1979.0081 26.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Mol Microbiol 2006; 61:564-72; PMID:16879639;http://dx.doi.org/10.1111/j.1365-2958.2006.05249.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Curr Biol 2009; 19:67-71; PMID:19110431; http://dx.doi.org/ 10.1016/j.cub.2008.11.063 28.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Ann Rev Genet 2009; 43:167-95; PMID:19686082; http://dx.doi.org/10.1146/annurev-genet-102108-134805 30.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Trends Ecol Evol 2003; 18:292-98; http://dx.doi.org/ 10.1016/S0169-5347(03)00033-8 31.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Evolution 2007; 61:995-1016; PMID:17492956; http://dx.doi.org/ 10.1111/j.1558-5646.2007.00105.x 32.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Nat Rev Genet 2011; 12:692-702; PMID:21878963; http://dx.doi.org/10.1038/nrg3053 34.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Chichester: John Wiley & Sons Ltd 2013. http://dx.doi.org/10.1002/9780470015902.a0024603 35.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Trends Genet 2009; 25:404-13; PMID:19716618; http://dx.doi.org/ 10.1016/j.tig.2009.07.006 36.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Nat Genet 2008; 40:1193-98; PMID:18806794; http://dx.doi.org/10.1038/ng.227 37.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Genome Res 2010; 20:837-46; PMID:20237107; http://dx.doi.org/ 10.1101/gr.103119.109 38.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
BMC Genomics 2012; 13:254-70; PMID:22712530; http://dx.doi.org/10.1186/1471-2164-13-254 39.,OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
Science 1998; 282:2012-18; PMID:9851916; http://dx.doi.org/10.1126/ science.282.5396.2012 40.,Non-OADS,/arxiv_data1/oa_pdf/be/88/kwrm-04-04-1082029.PMC4826153.pdf
"7,8,12Conversely, activation of the UPRmtprotects mitochondria against stress and promotes survival.7,9Identifying factors or molecules that can activate the UPRmtmay therefore lead to novel therapeutic © Manish Rauthan and Marc Pilon *Correspondence to: Marc Pilon; Email: marc.pilon@cmb.gu.seSubmitted: 08/21/2015; Revised: 09/09/2015; Accepted: 09/15/2015 http://dx.doi.org/10.1080/21624054.2015.1096490 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Am J Cardiovasc Drugs 2008; 8:373-418; PMID:19159124; http://dx.doi.org/10.2165/0129784-200808060-00004 2.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Eur Heart J 2007; 28:664-72; PMID:17242008; http://dx.doi.org/ 10.1093/eurheartj/ehl445 3.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Nature 1990; 343:425-30; PMID:1967820; http://dx.doi.org/10.1038/343425a0 4.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Arch Biochem Biophys 2011;505:131-43; PMID:20932952; http://dx.doi.org/ 10.1016/j.abb.2010.09.028 5.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Lipids Health Dis 2011; 10:243; PMID:22204706; http://dx.doi.org/10.1186/1476- 511X-10-243 6.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Proc Nat Acad Sci USA 2013; 110:5981-6; PMID:23530189; http://dx.doi.org/ 10.1073/pnas.1218778110 8.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
PLoS One2014; 9:e100033; PMID:24918786; http://dx.doi.org/ 10.1371/journal.pone.0100033 9.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
G3 (Bethesda) 2015; 5:1639-48; PMID:26038366; http://dx.doi.org/full_text 10.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
J Exp Biol 2014; 217:137-43; PMID:24353213; http://dx.doi.org/10.1242/jeb.090738 11.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Sci- ence 2012; 337:587-90; PMID:22700657; http://dx.doi.org/10.1126/science.1223560 13.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Methods 2012; 56:103-13; PMID:22041718; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
J Cell Sci 2004; 117:4055-66; PMID:15280428; http://dx.doi.org/10.1242/jcs.01275 16.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
J Cell Sci 2010; 123:3849-55; PMID:21048161; http://dx.doi.org/10.1242/jcs.075119 18.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Mol Cell 2010; 37:529-40; PMID:20188671; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
PLoS Genet 2012; 8:e1002760; PMID:22719267; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Parasitology 1982; 85(Pt 1):127-48; PMID:7122121; http://dx.doi.org/10.1017/S0031182000054214 21.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
"Nature 2013; 497:451-7; PMID:23698443; http://dx.doi.org/10.1038/nature12188 2 2 .L i uY ,S a m u e lB S ,B r e e nP C ,R u v k u nG .",OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Nature 2014; 508:406-10;PMID:24695221; http://dx.doi.org/10.1038/nature 13204 23.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Proc Nat Acad Sci USA 2015; 112:4453-8; PMID:25831516; http://dx.doi.org/10.1073/ pnas.1504022112 24.,OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
J Med Chem 1993; 36:2219-27; PMID:8101879; http://dx.doi.org/10.1021/ jm00067a019 25.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
PLoS ONE 2011; 6:e23852; PMID:21909365; http://dx.doi.org/10.1371/journal.pone.0023852 27.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Nat Rev Drug Discov 2007; 6:541-55; PMID:17585331; http://dx.doi.org/10.1038/nrd2221 30.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Science 1989; 246:500-3; PMID:2814477; http://dx.doi.org/10.1126/science.2814477 31.,Non-OADS,/arxiv_data1/oa_pdf/85/35/kwrm-04-04-1096490.PMC4826155.pdf
Available at: http://www.whocc.,Non-OADS,/arxiv_data1/oa_pdf/fb/e3/NEUROLOGY2015684647.PMC4826334.pdf
Available at: http://www.fda.gov/downloads/ advisorycommittees/committeesmeetingmaterials/drugs/ peripheralandcentralnervoussystemdrugsadvisorycommittee/ ucm247490.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fb/e3/NEUROLOGY2015684647.PMC4826334.pdf
Available at: http://www.popdata.bc.ca/data.,OADS,/arxiv_data1/oa_pdf/d1/aa/NEUROLOGY2015669457.PMC4826338.pdf
Available at: http://www.popdata.bc.ca/data.,OADS,/arxiv_data1/oa_pdf/d1/aa/NEUROLOGY2015669457.PMC4826338.pdf
Available at: http://www.popdata.bc.ca/data.,OADS,/arxiv_data1/oa_pdf/d1/aa/NEUROLOGY2015669457.PMC4826338.pdf
Available at: http://publications.gc.ca/collections/Collection/H39-4- 21-2003E.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d1/aa/NEUROLOGY2015669457.PMC4826338.pdf
[Keywords : DNA methylation; DNA demethylation; TET; hydroxymethyl cytosine; hematopoiesis; leukemia]Corresponding author: kristian.helin@bric.ku.dkArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.276568.115.© 2016 Rasmussen and Helin This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after thefull-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/fc/86/733.PMC4826392.pdf
"After six months, it is available under a Creative CommonsLicense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/fc/86/733.PMC4826392.pdf
"In some stud- ies, up to 20% of patients (e.g., melanoma and colorectal cancer) were found to carry mutations in one or more of theTET genes (http://www.cBioPortal.org).",Non-OADS,/arxiv_data1/oa_pdf/fc/86/733.PMC4826392.pdf
"2012), while IgII and IgIII cooperate in ligand binding.In Fgfr1 –3, ligand binding specificity is largely determined by alternative splicing of the C terminus of the IgIIIdomain, which is encoded by either exon 8 or 9 to generate [Keywords : fibroblast growth factor; Fgfr; receptor tyrosine kinase; Erk1/2; signaling]Corresponding author: philippe.soriano@mssm.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.277137.115.© 2016 Brewer et al.",Non-OADS,/arxiv_data1/oa_pdf/fa/7d/751.PMC4826393.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/fa/7d/751.PMC4826393.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/fa/7d/751.PMC4826393.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.274167.115.© 2016 Aylon et al.,Non-OADS,/arxiv_data1/oa_pdf/cc/15/786.PMC4826395.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/cc/15/786.PMC4826395.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/cc/15/786.PMC4826395.pdf
Ele-vated SREBP2 expression is associated with human fattyliver disease (http://diseases.jensenlab.org) and is a driverof NAFLD (Horton et al.,Non-OADS,/arxiv_data1/oa_pdf/cc/15/786.PMC4826395.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.274951.115.© 2016 Li et al.,OADS,/arxiv_data1/oa_pdf/d0/99/798.PMC4826396.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License(Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/d0/99/798.PMC4826396.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.276873.115.© 2016 Takai et al.,OADS,/arxiv_data1/oa_pdf/26/44/812.PMC4826397.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/26/44/812.PMC4826397.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creati-vecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/26/44/812.PMC4826397.pdf
"The p.S322L variant was notseen in the 61,486 unrelated individuals present on theExome Aggregation Consortium (ExAC) browser (http://exac.broadinstitute.org, December 18, 2014, version)and was not annotated as a polymorphism in dbSNP.S322 is a highly conserved residue across mammalianPOT1 proteins (Fig.",Non-OADS,/arxiv_data1/oa_pdf/26/44/812.PMC4826397.pdf
Sequences from the indicated mammalian POT1 pro- teins were aligned using ClustalW using the MultAlin interface (http://multalin.toulouse.inra.fr/multalin).Takai et al.,OADS,/arxiv_data1/oa_pdf/26/44/812.PMC4826397.pdf
Regions of autozygos- ity were identified using AutoSNPa software with buildGRCh37/hg19 (http://dna.leeds.ac.uk/autosnpa; Carr et al.,OADS,/arxiv_data1/oa_pdf/26/44/812.PMC4826397.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.266718.115.© 2016 Wang et al.,OADS,/arxiv_data1/oa_pdf/1f/00/827.PMC4826398.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1f/00/827.PMC4826398.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/1f/00/827.PMC4826398.pdf
"Corresponding authors: aaa@caltech.edu, ydchung@uos.ac.krArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.276030.115.© 2016 Hur et al.",OADS,/arxiv_data1/oa_pdf/ba/52/840.PMC4826399.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/ba/52/840.PMC4826399.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ba/52/840.PMC4826399.pdf
"Adapter sequences were removed using the cutadapt tool (https://code.google.com/p/cutadapt), and reads>15 nt were retained.",OADS,/arxiv_data1/oa_pdf/ba/52/840.PMC4826399.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.276428.115.© 2016 Chen et al.,OADS,/arxiv_data1/oa_pdf/b6/df/856.PMC4826400.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b6/df/856.PMC4826400.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/b6/df/856.PMC4826400.pdf
"This is an Open Access article distributed under the terms of the Creative CommonsAttribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/4a/ciw085.PMC4826458.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"Table 1.The frequency of detection and hospital admission, length of hospital admission and mean age of individuals infected with C. jejuni MLST sequence types (ST) in Sweden, between November 2011 and October 2012 Identified in this study Admitted to hospital C. jejuni type Number Percentage Mean age (range) Number Percentage Mean age (range) Length of hospitalisation (days) ST-21 139 12.9 37.3 (0 /C187) 28 9.7 45.2 (0 /C187) 3.04 ST-50 116 10.8 39.1 (1 /C188) 37 12.8 42.7 (2 /C185) 2.51 ST-45 105 9.8 48.1 (1 /C187) 34 11.8 57.3 (1 /C187) 3.41 ST-19 104 9.7 41.6 (2 /C173) 20 6.9 48.7 (16 /C173) 3.15 ST-677 90 8.4 50.5 (1 /C186) 25 8.7 57.9 (1 /C186) 3.28 ST-48 88 8.2 40.6 (0 /C189) 24 8.3 44.9 (1 /C189) 4.21 ST-257 41 3.8 39.8 (0 /C177) 17 5.9 45.2 (10 /C177) 2.65 Othera392 36.5 43.0 (0 /C195) 104 36.0 51.9 (2 /C195) 3.28 All 1,075 42.5 (0 /C195) 289 50.0 (0 /C195) 3.20 aSequence types which were identified in les s than 33 isolates have been combined into this ‘other’ group.Epidemiology of C. jejuni infections Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"bND/C30not determined for variables with prevalence B3%.Epidemiology of C. jejuni infections Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"Variables investigated for their association with length of hospitalisation evaluated in univariable analysis using Cox regression in laboratory-conﬁrmed domestic cases of C. jejuni in Sweden, November 2011 /C1October 2012 Variable Me an stay (median) HR 95% CI P C. jejuni sequence type Other 3.28 days (3 days) /C1/C1/C1 ST-21 3.04 days (2 days) 1.12 0.74 /C11.71 0.56 ST-50 2.51 days (2 days) 1.34 0.92 /C11.95 0.13 ST-19 3.15 days (2 days) 1.01 0.63 /C11.63 0.97 ST-45 3.41 days (3 days) 0.85 0.58 /C11.26 0.42 ST-667 3.28 days (3 days) 0.98 0.63 /C11.51 0.91 ST-48 4.21 days (4 days) 0.96 0.62 /C11.49 0.86 ST-257 2.65 days (2 days) 1.49 0.89 /C12.50 0.13 County Other 3.25 days (2.5 days) /C1/C1/C1 Eskilstuna 2.30 days (2 days) 1.31 0.67 /C12.56 0.42 Falun 2.92 days (3 days) 0.97 0.53 /C11.81 0.94 Ga¨ vle 2.77 days (2 days) 1.07 0.59 /C11.95 0.82 Go¨ teborg 3.28 days (3 days) 0.89 0.61 /C11.30 0.56 Halmstad 3.83 days (4 days) 0.89 0.39 /C12.06 0.79 Karlstad 2.67 days (2.5 days) 0.84 0.36 /C11.93 0.68 Linko¨ ping 4.18 days (3 days) 0.77 0.40 /C11.45 0.42 Malmo ¨ 3.54 days (2.5 days) 0.85 0.52 /C11.34 0.46 Stockholm 2.81 days (2 days) 1.30 0.92 /C11.84 0.13 Umea ˚ 2.69 days (2 days) 1.22 0.68 /C12.23 0.50 O¨rebro 4.71 days (3 days) 1.05 0.62 /C11.81 0.84 Male gender No 3.11 days (2 days) /C1/C1/C1 Yes 3.34 days (3 days) 1.01 0.80 /C11.27 0.95 Age (years) B20 2.53 days (2 days) /C1/C1/C1 20/C139 2.14 days (2 days) 1.02 0.67 /C11.54 0.92 40/C160 3.12 days (2 days) 0.83 0.56 /C11.25 0.38 /C2160 4.07 days (3 days) 0.73 0.50 /C11.07 0.11 Co-morbidity No 2.84 days (2 days) /C1/C1/C1 Yes 4.16 days (3 days) 0.92 0.73 /C11.17 0.51Epidemiology of C. jejuni infections Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
EFSA J 2015; 13: 4329. doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
doi: http://dx.doi.org/10.1086/591530Heli Harvala et al.,OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"8 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"J Gen Micro 2011; 60: 661 /C19.Epidemiology of C. jejuni infections Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"10 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 31079 - http://dx.doi.org/10.3402/iee.v6.31079",Non-OADS,/arxiv_data1/oa_pdf/dd/2e/IEE-6-31079.PMC4826459.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 30346 - http://dx.doi.org/10.3402/jom.v8.30346 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30346 - http://dx.doi.org/10.3402/jom.v8.30346",Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
"The asterisk (*) depicts the moment ofsampling.Biofilm fluorescence Citation: Journal of Oral Microbiology 2016, 8: 30346 - http://dx.doi.org/10.3402/jom.v8.30346 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30346 - http://dx.doi.org/10.3402/jom.v8.30346",Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
"Remarkable is the increase in red ﬂuorescence intensity at day 24 (red circles) in both groups.The thickness of all bioﬁlms was 600 mm.Biofilm fluorescence Citation: Journal of Oral Microbiology 2016, 8: 30346 - http://dx.doi.org/10.3402/jom.v8.30346 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30346 - http://dx.doi.org/10.3402/jom.v8.30346",Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
"Studies on biofilms from different donors show very similar pheno- typic characteristics after prolonged exposure to the same environmental conditions (48), and the phenotype of the biofilm determines whether a microcosm biofilm fluor- esces red rather than the presence of specific species (10).Biofilm fluorescence Citation: Journal of Oral Microbiology 2016, 8: 30346 - http://dx.doi.org/10.3402/jom.v8.30346 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
Avail- able from: http://www.who.int/mediacentre/factsheets/fs318/en/[cited 8 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30346 - http://dx.doi.org/10.3402/jom.v8.30346",Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
"Palaeontol Electron 2001; 4, Available from: http://palaeo-electronica.org/ 2001_1/past/past.pdf [cited 8 November 2015].",Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
"Caries Res 2004; 38: 54 /C161.Biofilm fluorescence Citation: Journal of Oral Microbiology 2016, 8: 30346 - http://dx.doi.org/10.3402/jom.v8.30346 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/6a/b1/JOM-8-30346.PMC4826460.pdf
Supplementary Material Supplementary Material  can be found online at http://www.ntr.,Non-OADS,/arxiv_data1/oa_pdf/7f/e2/ntv148.PMC4826486.pdf
"Lifestyle Statistics, Health and Social Care Information  Centre; 2013. http://whyquit.com/NRT/UK/2012_NHS_SSS_Statistics.",Non-OADS,/arxiv_data1/oa_pdf/7f/e2/ntv148.PMC4826486.pdf
"London, United Kingdom: Department of Health;  2009. http://webarchive.nationalarchives.gov.uk/20130107105354/http:// dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicy - andguidance/dh_109696 .",Non-OADS,/arxiv_data1/oa_pdf/7f/e2/ntv148.PMC4826486.pdf
"London, United Kingdom:  Department of Health; 2008. http://healthtrainersengland.com/wp-con- tent/uploads/2014/05/NHSHealthTrainerHandbook.pdf .",Non-OADS,/arxiv_data1/oa_pdf/7f/e2/ntv148.PMC4826486.pdf
http://journals.rcni.com/doi/pdfplus/10.7748/ phc2007.07.17.6.35.c4427 .,Non-OADS,/arxiv_data1/oa_pdf/b3/07/ntv206.PMC4826488.pdf
"557 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/09/ntv220.PMC4826489.pdf
http://analytics.ncsu.edu/ sesug/2008/ST-154.pdf .,OADS,/arxiv_data1/oa_pdf/d4/09/ntv220.PMC4826489.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Alopecia areataToll-like receptorsIL-2 TNF-α IL-5 IL-4IL-17ATGF-β Gene expression 1.,Non-OADS,/arxiv_data1/oa_pdf/3a/16/main.PMC4826589.pdf
http://dx.doi.org/10.1016/j.bbacli.2016.03.006 2214-6474/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/16/main.PMC4826589.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3a/16/main.PMC4826589.pdf
"Developmental  Cognitive  Neuroscience  17  (2016)  131–137 Contents  lists  available  at  ScienceDirect Developmental  Cognitive  Neuroscience j  o  ur  nal  ho  me  pa  ge:  http://www.elsevier.com/locate/dcn Commentary The  audacity  of  speciﬁcity:  Moving  adolescent  developmental neuroscience  towards  more  powerful  scientiﬁc  paradigms  and translatable  models Jennifer  H.  Pfeifera,b,∗,  Nicholas  B.  Allena,b,∗ aDepartment of Psychology, University of Oregon,  United  States bCenter  for  Translational  Neuroscience,  Prevention  Science  Institute,  University  of  Oregon,  United  States a r t  i  c  l  e  i  n  f  o Article  history: Available  online  23  December  2015 Keywords:PrecisionTranslational neuroscience ModelsDual-systemsSocial reorientation In  this  issue  of  Developmental  Cognitive  Neuroscience ,  two articles revisit a  pair  of  seminal  models  that  have  permeated  devel- opmental  neuroscience  research  focused  on  adolescence.",Non-OADS,/arxiv_data1/oa_pdf/52/3d/main.PMC4826651.pdf
http://dx.doi.org/10.1016/j.dcn.2015.12.012 1878-9293/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/main.PMC4826651.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/52/3d/main.PMC4826651.pdf
Data were analyzed with SPM2 (Statistical Parameter  Mapping software version 2; http://www.fil.ion.ucl.,OADS,/arxiv_data1/oa_pdf/31/d4/DialoguesClinNeurosci-18-109.PMC4826766.pdf
doi:http://dx.doi.org/10.1016/S1471-1931(00)00028-8.,OADS,/arxiv_data1/oa_pdf/a5/11/DialoguesClinNeurosci-18-99.PMC4826776.pdf
"Carnforth, Lancs,  UK ; Park Ridge, NJ, USA: Parthenon Pub Group; 1990. http://catalog.ha - thitrust.org/Record/002235224.",Non-OADS,/arxiv_data1/oa_pdf/a5/11/DialoguesClinNeurosci-18-99.PMC4826776.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/bjophthalmol-2015-306939).,Non-OADS,/arxiv_data1/oa_pdf/dc/74/bjophthalmol-2015-306939.PMC4826887.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Ebrey T, Koutalos Y. Vertebrate Photoreceptors.",Non-OADS,/arxiv_data1/oa_pdf/dc/74/bjophthalmol-2015-306939.PMC4826887.pdf
"http://broadinstittute.github.io/picard 11 McKenna A, Hanna M, Banks E, et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/74/bjophthalmol-2015-306939.PMC4826887.pdf
"12 https://www.broadinstitute.org/gatk/guide/best-practices 13 Cingolani P, Platts A, Wang Ie L, et al.",Non-OADS,/arxiv_data1/oa_pdf/dc/74/bjophthalmol-2015-306939.PMC4826887.pdf
http://exac.broadinstitute.,Non-OADS,/arxiv_data1/oa_pdf/dc/74/bjophthalmol-2015-306939.PMC4826887.pdf
"http://www.ema.europa.eu/docs/  en_GB/document_library/EPAR_-_Product_Information/hum- an/002148/WC500107728.pdf (accessed Apr 15, 2015).",Non-OADS,/arxiv_data1/oa_pdf/0c/22/jgc-13-03-226.PMC4826892.pdf
http://www.upto- date.com/.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.uptodate.com/.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.uptodate.com/.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.uptodate.com/.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.uptodate.com/.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.uptodate.com/.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.uptodate.com/.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.ncbi .nlm.nih.gov/pmc/articles/ PMC2125377/pdf/800.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://radiationeffects.org/wp- content/uploads/2014/08/Billen-1990_SpontaneousDNAdamage- RadProt.pdf.,OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://pubs.rsna.org/doi/full/10.1148/radiol.2291030291.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://dos.sagepub.com/content/13/1/dose-response.15-003.Cuttler.full.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.ncbi .nlm.nih.gov/pmc/articles/ PMC3526333/.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
http://www.ncbi.nlm.nih.go v/pmc/articles/PMC4036399/.,Non-OADS,/arxiv_data1/oa_pdf/ce/00/10.1177_1559325816640073.PMC4826954.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/51/3b/10.1177_2325967116639895.PMC4826955.pdf
E-mail: inneswise@gmail.comCase Report DOI: http://dx.doi.org/10.4314/ovj.v6i1.9 Submitted: 19/12/2015 Accepted: 02/04/2016 Published: 07/04/201 6 Anaesthetic management of a unilateral adrenalectomy of an adre nocortical  tumour in a dog I.K.,Non-OADS,/arxiv_data1/oa_pdf/c5/99/OpenVetJ-6-62.PMC4826957.pdf
http://www.openveterinaryjournal.com I.K.,Non-OADS,/arxiv_data1/oa_pdf/c5/99/OpenVetJ-6-62.PMC4826957.pdf
http://www.openveterinaryjournal.com I.K.,Non-OADS,/arxiv_data1/oa_pdf/c5/99/OpenVetJ-6-62.PMC4826957.pdf
http://www.openveterinaryjournal.com I.K.,Non-OADS,/arxiv_data1/oa_pdf/c5/99/OpenVetJ-6-62.PMC4826957.pdf
http://www.openveterinaryjournal.com I.K.,Non-OADS,/arxiv_data1/oa_pdf/c5/99/OpenVetJ-6-62.PMC4826957.pdf
http://www.openveterinaryjournal.com I.K.,Non-OADS,/arxiv_data1/oa_pdf/c5/99/OpenVetJ-6-62.PMC4826957.pdf
" Annals of Surgical Treatment and Research 183pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.4.183 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Characterization of sphere-forming HCT116 clones by  whole RNA sequencing Eunkyung Chung*, Inkyung Oh1,*, Kil Yeon Lee1 R&D Center, L&K Biomed Co. Ltd., Seoul, 1Department of Surgery, College of Medicine, Kyung Hee University, Seoul, Korea INTRODUCTION Cancer stem cells (CSCs) are tumor cells that have the  principal properties of self-renewal, clonal tumor initiation  capacity, and clonal long-term repopulation potential.",OADS,/arxiv_data1/oa_pdf/25/2e/astr-90-183.PMC4826980.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/2e/astr-90-183.PMC4826980.pdf
SUPPLEMENTARY MATERIAL Supplementary Table 1 can be found via http://www.astr.,Non-OADS,/arxiv_data1/oa_pdf/25/2e/astr-90-183.PMC4826980.pdf
"194pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.4.194 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Validity of breast-specific gamma imaging for Breast  Imaging Reporting and Data System 4 lesions on mammography and/or ultrasound Min Jeng Cho, Jung-Hyun Yang, Yeong Beom Yu, Kyoung Sik Park, Hyun Woo Chung1, Young So1,   Nami Choi2, Mi Young Kim2 Departments of Surgery, 1Nuclear Medicine, and 2Radiology, Konkuk University Medical Center, Konkuk University School of  Medicine, Seoul, Korea INTRODUCTION Breast cancer is one of the most common cancers among  women with 16,000 new breast cancer cases reported in Korea  every year.",Non-OADS,/arxiv_data1/oa_pdf/6d/f9/astr-90-194.PMC4826981.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/f9/astr-90-194.PMC4826981.pdf
" Annals of Surgical Treatment and Research 201pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.4.201 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Clinicopathological factors increased the risk of  malignancy in thyroid nodules with atypical or follicular lesions of undetermined significance (AUS/FLUS) risk factor of malignancy in thyroid nodule with AUS/FLUS In Ki Hong, Jun Ho Kim1, Young Up Cho, Shin-Young Park, Sei Joong Kim Departments of Surgery and 1Radiology, Inha University School of Medicine, Incheon, Korea INTRODUCTION Thyroid nodules are common and are mostly benign, the risk  of malignancy is approximately 6.2% [1-3].",Non-OADS,/arxiv_data1/oa_pdf/0c/c8/astr-90-201.PMC4826982.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/c8/astr-90-201.PMC4826982.pdf
" Annals of Surgical Treatment and Research 207pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.4.207 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Relationship between low body mass index and  morbidity after gastrectomy for gastric cancer Jong-Man Kim1,2, Ji-Ho Park1,2, Sang-Ho Jeong1,2,3, Young-Joon Lee1,2,3, Young-tae Ju1,2,3, Chi-Young Jeong1,2,3,  Eun-Jung Jung1,2,3, Soon-Chan Hong1,2,3, Sang-Kyung Choi1,2,3, Woo-Song Ha1,2,3 1Department of Surgery, Gyeongsang National University School of Medicine and Gyeongsang National University Hospital, Jinju, 2Gyeongnam Regional Cancer Center, Gyeongsang National University Hospital, Jinju, 3Institute of Health Science, Gyeongsang  National University, Jinju, Korea INTRODUCTION Gastric cancer is the fourth most common form of cancer  worldwide, and almost a million new cases are diagnosed  annually [1].",Non-OADS,/arxiv_data1/oa_pdf/3c/2a/astr-90-207.PMC4826983.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/2a/astr-90-207.PMC4826983.pdf
Available from: https://www.nhlbi.nih.,Non-OADS,/arxiv_data1/oa_pdf/3c/2a/astr-90-207.PMC4826983.pdf
Available from: http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/3c/2a/astr-90-207.PMC4826983.pdf
" Annals of Surgical Treatment and Research 213pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.4.213 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Effect of ankaferd blood stopper in experimental  peritoneal adhesion model Gokhan Karaca, Oktay Aydin, Faruk Pehlivanli, Ahmet Kocael1, Recep Pekcici2, Esat Duymus2,   Sukran Akgedik3, Osman Guler2 Department of General Surgery, Faculty of Medicine, Kırıkkale University, Kırıkkale, 1Department of General Surgery, Ağrı State  Hospital, Ağrı, Departments of 2General Surgery and 3Pathology, Ankara Education and Research Hospital, Ankara, Turkey INTRODUCTION The most common cause of peritoneal adhesion (PA) is abdo - m inal surgery.",Non-OADS,/arxiv_data1/oa_pdf/0d/40/astr-90-213.PMC4826984.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/40/astr-90-213.PMC4826984.pdf
"218pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.4.218 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Current trends of major arterial diseases in Korea: based  on data from the Health Insurance Review and Assessment Service Mi-Hyeong Kim*, Sanghyun Ahn*, Jang-Yong Kim, Kang-Woong Jun, Sang-Seop Yun, Yong Sung Won Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea INTRODUCTION Korea is rapidly becoming an aging society; it is estimated  that the number of people aged over 65, which was 7% of total  Korean population on 2002, will reach 20% by 2026 [1].",Non-OADS,/arxiv_data1/oa_pdf/bb/8c/astr-90-218.PMC4826985.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/8c/astr-90-218.PMC4826985.pdf
Available from: http://www.nytimes.com/2015/01/30/business/medicare- payments-surge-for-stents-to-unblock- blood-vessels-in-limbs.html?_r=2#.,Non-OADS,/arxiv_data1/oa_pdf/bb/8c/astr-90-218.PMC4826985.pdf
"224pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.4.224 Annals of Surgical Treatment and ResearchORIGINAL ARTICLE Impact of a preoperative evaluation on the outcomes of  an arteriovenous fistula Sung Min Kim, Youngjin Han, Hyunwook Kwon, Hee Sun Hong, Ji Yoon Choi, Hojong Park1, Tae-Won Kwon,  Yong-Pil Cho Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 1Department of Surgery, Ulsan  University Hospital, Ulsan, Korea INTRODUCTION Autogenous arteriovenous fistulas (AVFs) are the preferred  vascular access for chronic hemodialysis because of better  outcomes, a lower complication rate once matured, and reduced costs compared with prosthetic arteriovenous grafts (AVGs) or central venous catheters [1-6].",Non-OADS,/arxiv_data1/oa_pdf/22/c5/astr-90-224.PMC4826986.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/c5/astr-90-224.PMC4826986.pdf
" Annals of Surgical Treatment and Research 231pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.4.231 Annals of Surgical Treatment and ResearchCASE REPORT Unusual intestinal obstruction due to idiopathic  sclerosing encapsulating peritonitis: a report of two cases and a review Chun-Seok Yang, Daedong Kim Department of Surgery, Daegu Catholic University Medical Center, Catholic University of Daegu School of Medicine, Daegu, Korea INTRODUCTION Sclerosing encapsulating peritonitis (SEP) is a rare cause  of intestinal obstruction, which is characterized by a fibro - c ollagenous membrane enveloping the small intestine like a  cocoon [1-3].",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/astr-90-231.PMC4826987.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/6c/astr-90-231.PMC4826987.pdf
" Annals of Surgical Treatment and Research 235pISSN 2288-6575  • eISSN 2288-6796 http://dx.doi.org/10.4174/astr.2016.90.4.235 Annals of Surgical Treatment and ResearchCASE REPORT Tailgut cyst accompanied with bony defect  Jae-Sang Oh, Jai-Joon Shim, Kyeong-Seok Lee, Jae-Won Doh Department of Neurosurgery, Soonchunhyang University Cheonan Hospital, Cheonan, Korea INTRODUCTION Retro-rectal cystic hamartoma, also known as tailgut cyst,  is an uncommon congenital developmental lesion, generally  located in the retro-rectal space [1].",Non-OADS,/arxiv_data1/oa_pdf/02/a7/astr-90-235.PMC4826988.pdf
"All  articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/a7/astr-90-235.PMC4826988.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/53/kjfm-37-105.PMC4826989.pdf
"Keywords: Dyslipidemias; Drug Users; Physical Activity; Energy Intake Received: February 27, 2015, Revised: September 9, 2015, Accepted: September 27, 2015 *Corresponding Author: Duk-Chul Lee Tel: +82-2-2228-2330, Fax: +82-2-362-2473, E-mail: faith@yuhs.ac †These authors contributed equally to this work.http://dx.doi.org/10.4082/kjfm.2016.37.2.105 • Korean J Fam Med 2016;37:105-110 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/34/53/kjfm-37-105.PMC4826989.pdf
"• Trends of Physical Activity and Caloric Intake in Lipid-Lowering Drug Users 106  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.105 INTRODUCTION Dyslipidemia is a major risk factor for cardiovascular disease; total cho- lesterol, low density lipoprotein cholesterol (LDLC), and triglyceride levels are directly proportional to the risk of cardiovascular mortality.",Non-OADS,/arxiv_data1/oa_pdf/34/53/kjfm-37-105.PMC4826989.pdf
• Trends of Physical Activity and Caloric Intake in Lipid-Lowering Drug Users http://dx.doi.org/10.4082/kjfm.2016.37.2.105www.kjfm.or.kr   107 month or once or more than once a month.,Non-OADS,/arxiv_data1/oa_pdf/34/53/kjfm-37-105.PMC4826989.pdf
• Trends of Physical Activity and Caloric Intake in Lipid-Lowering Drug Users 108  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.105 ated with statin use.,Non-OADS,/arxiv_data1/oa_pdf/34/53/kjfm-37-105.PMC4826989.pdf
"• Trends of Physical Activity and Caloric Intake in Lipid-Lowering Drug Users http://dx.doi.org/10.4082/kjfm.2016.37.2.105www.kjfm.or.kr   109 activity of Korean patients who reported taking lipid-lowering drugs,  which was not observed among the non-users during the 2010–2013 study period.",Non-OADS,/arxiv_data1/oa_pdf/34/53/kjfm-37-105.PMC4826989.pdf
• Trends of Physical Activity and Caloric Intake in Lipid-Lowering Drug Users 110  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.105 12.,Non-OADS,/arxiv_data1/oa_pdf/34/53/kjfm-37-105.PMC4826989.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
"Keywords: Adolescent; Caffeine Intake; Depression; Insomnia Received: February 28, 2015, Revised: September 21, 2015, Accepted: September 24, 2015 *Corresponding Author: Chang-Ho Yoon Tel: +82-53-200-5791, Fax: +82-53-200-5480, E-mail: ychfm@knu.ac.krhttp://dx.doi.org/10.4082/kjfm.2016.37.2.111 • Korean J Fam Med 2016;37:111-116 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
"• Caffeine Consumption and Psychological Health of Adolescents 112  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.111 INTRODUCTION Moderate caffeine intake has an awakening effect improving alertness  and reducing fatigue by stimulating the nervous system.1,2) It is report - ed that caffeine consumption through easily accessible coffee, sodas and chocolates has been increasing.",Non-OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
• Caffeine Consumption and Psychological Health of Adolescents http://dx.doi.org/10.4082/kjfm.2016.37.2.111www.kjfm.or.kr   113 ver.,Non-OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
• Caffeine Consumption and Psychological Health of Adolescents 114  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.111 for trend=0.015).,Non-OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
• Caffeine Consumption and Psychological Health of Adolescents http://dx.doi.org/10.4082/kjfm.2016.37.2.111www.kjfm.or.kr   115 intake of adolescents reported by Korea’s Ministry of Food and Drug  safety in 2013 (30 mg).14) The reason for the difference is thought that  high school students with a relatively high purchasing power were in-cluded in the later report.,Non-OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
• Caffeine Consumption and Psychological Health of Adolescents 116  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.111 pharmacology.,Non-OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
Available from: http://report.ndsl.kr/repDetail.do?cn=TRKO201000014956&topN=1.,OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
Available from: http://www.mfds.go.kr/index.do?mid=675&seq=20953.,OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
Available from: http://www.samhsa.gov/data/2k13/DAWN126/sr126-energy-drinks-use.pdf.,OADS,/arxiv_data1/oa_pdf/37/07/kjfm-37-111.PMC4826990.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
"Keywords: Periodontal Diseases; Smoking; Smoking Cessation Received: February 13, 2015, Revised: June 29, 2015, Accepted: September 24, 2015 *Corresponding Author: Jin-Young Shin Tel: +82-2-3410-2451, Fax: +82-2-3410-0388, E-mail: jinyoung.shin@samsung.comhttp://dx.doi.org/10.4082/kjfm.2016.37.2.117 • Korean J Fam Med 2016;37:117-122 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
"• Smoking and Periodontal Disease 118  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.117 INTRODUCTION Periodontal disease leads to a breakdown of the connective tissue and  bone that anchor the teeth1) and can eventually lead to the loss of  teeth.2) It is estimated that 1 in 2 men and 1 in 3 women over the age of  50 years in Korea have periodontal disease.3)  Periodontal disease has been associated with systemic disease and  increases the risk of diabetes, preterm low birth weight delivery, car - diovascular disease, osteoporosis, and pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
• Smoking and Periodontal Disease http://dx.doi.org/10.4082/kjfm.2016.37.2.117www.kjfm.or.kr   119 3.,Non-OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
"• Smoking and Periodontal Disease 120  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.117 daily cigarette consumption, smoking duration, and cumulative smok - ing exposure) and periodontal disease was analyzed in current smok - ers compared with never smokers.",OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
• Smoking and Periodontal Disease http://dx.doi.org/10.4082/kjfm.2016.37.2.117www.kjfm.or.kr   121 for current smokers compared with never smokers.,Non-OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
• Smoking and Periodontal Disease 122  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.117 for Disease Control and Prevention; 2014 [cited 2015 Feb 12].,Non-OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
Available  from: https://knhanes.cdc.go.kr/knhanes/index.do.,OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
Available from: https://knhanes.cdc.go.kr/knhanes/index.do.,OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
Available from: http://knhanes.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
Available from: http://dhds.cdc.gov/guides/healthtopics.,Non-OADS,/arxiv_data1/oa_pdf/d6/c5/kjfm-37-117.PMC4826991.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/kjfm-37-123.PMC4826992.pdf
"Keywords: Elderly; Dietary Supplement; Vitamins; Nutrition; Koreans Received: February 25, 2015, Revised: August 26, 2015, Accepted: September 24, 2015 *Corresponding Author: Yun Jin Kim Tel: +82-51-240-7834, Fax: +82-51-240-7843, E-mail: yujkim@pusan.ac.krhttp://dx.doi.org/10.4082/kjfm.2016.37.2.123 • Korean J Fam Med 2016;37:123-129 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/kjfm-37-123.PMC4826992.pdf
• Vitamin-Mineral Supplement Use Patterns in Elderly Koreans 124  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.123 INTRODUCTION Vitamin-mineral supplements are the most popular dietary supple- ment in Korea.,Non-OADS,/arxiv_data1/oa_pdf/b2/e1/kjfm-37-123.PMC4826992.pdf
"• Vitamin-Mineral Supplement Use Patterns in Elderly Koreans http://dx.doi.org/10.4082/kjfm.2016.37.2.123www.kjfm.or.kr   125 units, according to KNHANES guidelines.",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/kjfm-37-123.PMC4826992.pdf
• Vitamin-Mineral Supplement Use Patterns in Elderly Koreans 126  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.123 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b2/e1/kjfm-37-123.PMC4826992.pdf
"• Vitamin-Mineral Supplement Use Patterns in Elderly Koreans http://dx.doi.org/10.4082/kjfm.2016.37.2.123www.kjfm.or.kr   127  A previous study using KNHANES data from Korean adults (20 years  of age and older) reported that vitamin-mineral supplement use was  associated with older age and higher household income,10) but the  current study did not observe a similar association.",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/kjfm-37-123.PMC4826992.pdf
"• Vitamin-Mineral Supplement Use Patterns in Elderly Koreans 128  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.123 derly in Korea, which may partially explain the lack of association be- tween vitamin-mineral use and medical conditions.",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/kjfm-37-123.PMC4826992.pdf
• Vitamin-Mineral Supplement Use Patterns in Elderly Koreans http://dx.doi.org/10.4082/kjfm.2016.37.2.123www.kjfm.or.kr   129 elderly in Korea.,Non-OADS,/arxiv_data1/oa_pdf/b2/e1/kjfm-37-123.PMC4826992.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/82/kjfm-37-130.PMC4826993.pdf
"Keywords: Sleep; Hypertension; Obesity Received: August 21, 2015, Revised: October 28, 2015, Accepted: January 26, 2016 *Corresponding Author: Seung-Pil Jung Tel: +82-53-620-3180, Fax: +82-53-654-2413, E-mail: spjung@yu.ac.krhttp://dx.doi.org/10.4082/kjfm.2016.37.2.130 • Korean J Fam Med 2016;37:130-134 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/8a/82/kjfm-37-130.PMC4826993.pdf
"• The Association between Sleep Duration and Hypertension in Non-obese Premenopausal Women in Korea http://dx.doi.org/10.4082/kjfm.2016.37.2.130www.kjfm.or.kr   131 INTRODUCTION High blood pressure is a risk factor for ischemic heart disease syn- dromes and cerebrovascular disease, the main causes of more than 7 million deaths in the world each year.",Non-OADS,/arxiv_data1/oa_pdf/8a/82/kjfm-37-130.PMC4826993.pdf
"• The Association between Sleep Duration and Hypertension in Non-obese Premenopausal Women in Korea 132  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.130 2) Hypertension Hypertension was defined as a case of more than 140 mm Hg systolic blood pressure, more than 90 mm Hg diastolic blood pressure, or tak - ing antihypertensives.",Non-OADS,/arxiv_data1/oa_pdf/8a/82/kjfm-37-130.PMC4826993.pdf
"• The Association between Sleep Duration and Hypertension in Non-obese Premenopausal Women in Korea http://dx.doi.org/10.4082/kjfm.2016.37.2.130www.kjfm.or.kr   133 counted for (model 3), this statistically meaningful correlation be - tween sleeping hours and hypertension is no longer maintained (OR,  1.53, 95% CI, 0.84 to 2.81).",Non-OADS,/arxiv_data1/oa_pdf/8a/82/kjfm-37-130.PMC4826993.pdf
• The Association between Sleep Duration and Hypertension in Non-obese Premenopausal Women in Korea 134  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.130 vascular disease: the Strong Heart Study.,Non-OADS,/arxiv_data1/oa_pdf/8a/82/kjfm-37-130.PMC4826993.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/59/kjfm-37-77.PMC4826994.pdf
"Secondhand Smoke Exposure,  Depression Symptoms, and  Suicidal Ideation in Adults Soo Young Kim Department of Family Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Koreahttp://dx.doi.org/10.4082/kjfm.2016.37.2.77 • Korean J Fam Med 2016;37:77 Editorial eISSN: 2092-6715 Secondhand smoke, also called ‘environmental tobacco  smoke, ’ is a combination of smoke emitted from the burning end of a cigarette and smoke exhaled by a smoker.",Non-OADS,/arxiv_data1/oa_pdf/c8/59/kjfm-37-77.PMC4826994.pdf
http://dx.doi.org/ 10.1007/s00127-015-1164-5.,Non-OADS,/arxiv_data1/oa_pdf/c8/59/kjfm-37-77.PMC4826994.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/9f/kjfm-37-78.PMC4826995.pdf
"Keywords: Fatigue; Physical Activity; Life Style; Metabolic Equivalent Received: July 17, 2015, Revised: July 17, 2015, Accepted: September 24, 2015 *Corresponding Author: Woo Kyung Bae Tel: +82-31-787-7805, Fax: +82-31-787-4014, E-mail: naslig@hanmail.nethttp://dx.doi.org/10.4082/kjfm.2016.37.2.78 • Korean J Fam Med 2016;37:78-84 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/75/9f/kjfm-37-78.PMC4826995.pdf
• Fatigue Not Improved with Exercise http://dx.doi.org/10.4082/kjfm.2016.37.2.78www.kjfm.or.kr   79 INTRODUCTION Fatigue is a symptom that is commonly seen in primary care.,Non-OADS,/arxiv_data1/oa_pdf/75/9f/kjfm-37-78.PMC4826995.pdf
"• Fatigue Not Improved with Exercise 80  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.78 fatigue in this study.20) We classified the severe fatigue group as those  who scored at least 7 points by reference to the literature, moderate as  4 to less than 7 points, and mild as less than 4 points.19) 3) Exercise amountThe type of exercise reported in medical records and questionnaires was converted into dynamic physical activity according to metabolic  equivalents (METs).",Non-OADS,/arxiv_data1/oa_pdf/75/9f/kjfm-37-78.PMC4826995.pdf
• Fatigue Not Improved with Exercise http://dx.doi.org/10.4082/kjfm.2016.37.2.78www.kjfm.or.kr   81 ent questionnaire scores at the initial and final visit of each follow-up  period.,Non-OADS,/arxiv_data1/oa_pdf/75/9f/kjfm-37-78.PMC4826995.pdf
"• Fatigue Not Improved with Exercise 82  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.78 specific group of patients who visited the fatigue clinic, but had no un- derlying disease.",Non-OADS,/arxiv_data1/oa_pdf/75/9f/kjfm-37-78.PMC4826995.pdf
"• Fatigue Not Improved with Exercise http://dx.doi.org/10.4082/kjfm.2016.37.2.78www.kjfm.or.kr   83 alertness, but the fatigue eventually recurs within one hour after exer - cise.28) It is important to exercise regularly in sufficient quantities in a  fatigue-free state in order to obtain the benefits of exercise.",Non-OADS,/arxiv_data1/oa_pdf/75/9f/kjfm-37-78.PMC4826995.pdf
• Fatigue Not Improved with Exercise 84  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.78 randomized controlled trial.,Non-OADS,/arxiv_data1/oa_pdf/75/9f/kjfm-37-78.PMC4826995.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/10/kjfm-37-85.PMC4826996.pdf
"Keywords: Stroke; Inpatients; Smoking; Counseling; Smoking Cessation Received: March 1, 2015, Revised: September 8, 2015, Accepted: September 27, 2015 *Corresponding Author: Ah-Leum Ahn Tel: +82-2-2030-8140, Fax: +82-2-2030-5009, E-mail: arumi81@naver.com, 20130332@kuh.ac.krhttp://dx.doi.org/10.4082/kjfm.2016.37.2.85 • Korean J Fam Med 2016;37:85-90 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/16/10/kjfm-37-85.PMC4826996.pdf
"• Predictors of Smoking Cessation in Stroke Patients 86  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.85 INTRODUCTION Ever since the question was raised by Doll and Hill1) in the 1940s of the  association between lung cancer and smoking, numerous studies have  been conducted into the association of smoking with lung cancer and  chronic diseases.2) Diseases associated with smoking include cancer,  cardiovascular diseases, respiratory diseases, and reproduction-relat - ed diseases.",Non-OADS,/arxiv_data1/oa_pdf/16/10/kjfm-37-85.PMC4826996.pdf
• Predictors of Smoking Cessation in Stroke Patients http://dx.doi.org/10.4082/kjfm.2016.37.2.85www.kjfm.or.kr   87 divided into two groups based on whether drinking was above or be- low 14 servings per week.,Non-OADS,/arxiv_data1/oa_pdf/16/10/kjfm-37-85.PMC4826996.pdf
• Predictors of Smoking Cessation in Stroke Patients 88  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.85 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/16/10/kjfm-37-85.PMC4826996.pdf
• Predictors of Smoking Cessation in Stroke Patients http://dx.doi.org/10.4082/kjfm.2016.37.2.85www.kjfm.or.kr   89 therapies.,Non-OADS,/arxiv_data1/oa_pdf/16/10/kjfm-37-85.PMC4826996.pdf
"• Predictors of Smoking Cessation in Stroke Patients 90  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.85 on.13,19) However, in this study, 66.6% of the patients who attempted to  quit smoking wanted only CBT rather than the use of smoking cessa- tion drugs.",Non-OADS,/arxiv_data1/oa_pdf/16/10/kjfm-37-85.PMC4826996.pdf
Available from: http://www.ninds.nih.gov/doctors/NIH_Stroke_Scale.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/10/kjfm-37-85.PMC4826996.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/ed/kjfm-37-91.PMC4826997.pdf
"Keywords: Physicians; Cancer; Prevalence; Korea Received: August 11, 2015, Revised: August 16, 2015, Accepted: September 27, 2015 *Corresponding Author: Hyejin Chun Tel: +82-2-2650-5297, Fax: +82-2-2650-5297, E-mail: fmewha@naver.comhttp://dx.doi.org/10.4082/kjfm.2016.37.2.91 • Korean J Fam Med 2016;37:91-96 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/e9/ed/kjfm-37-91.PMC4826997.pdf
"• Cancer in Korean Physicians 92  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.91 INTRODUCTION As might be expected, physicians are reported to have healthier life- styles and lower mortality rates than the general population as a result of their professional medical knowledge.",Non-OADS,/arxiv_data1/oa_pdf/e9/ed/kjfm-37-91.PMC4826997.pdf
"• Cancer in Korean Physicians http://dx.doi.org/10.4082/kjfm.2016.37.2.91www.kjfm.or.kr   93 type(s) of cancer have you been diagnosed with?” , and “When were  you diagnosed with cancer?” 4.",Non-OADS,/arxiv_data1/oa_pdf/e9/ed/kjfm-37-91.PMC4826997.pdf
"• Cancer in Korean Physicians 94  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.91 Therefore, a total of 31 cancers were validated in this study.",Non-OADS,/arxiv_data1/oa_pdf/e9/ed/kjfm-37-91.PMC4826997.pdf
• Cancer in Korean Physicians http://dx.doi.org/10.4082/kjfm.2016.37.2.91www.kjfm.or.kr   95 was reported to be higher compared to the general population.,Non-OADS,/arxiv_data1/oa_pdf/e9/ed/kjfm-37-91.PMC4826997.pdf
• Cancer in Korean Physicians 96  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.91 study.,Non-OADS,/arxiv_data1/oa_pdf/e9/ed/kjfm-37-91.PMC4826997.pdf
"Copyright © 2016 The Korean Academy of Family Medicine This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/2c/kjfm-37-97.PMC4826998.pdf
"Keywords: Tobacco Smoke Pollution; Depressive Symptoms; Suicidal Ideation Received: August 13, 2015, Revised: September 4, 2015, Accepted: September 27, 2015 *Corresponding Author: Jun-Hyun Yoo Tel: +82-2-3410-2440, Fax: +82-2-3410-0388, E-mail: drjohn.yoo@samsung.comhttp://dx.doi.org/10.4082/kjfm.2016.37.2.97 • Korean J Fam Med 2016;37:97-104 Original Article eISSN: 2092-6715",Non-OADS,/arxiv_data1/oa_pdf/a3/2c/kjfm-37-97.PMC4826998.pdf
• Relationship of Secondhand Smoking with Mental Health 98  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.97 INTRODUCTION Smoking is a well-established risk factor for mental illness.,Non-OADS,/arxiv_data1/oa_pdf/a3/2c/kjfm-37-97.PMC4826998.pdf
"• Relationship of Secondhand Smoking with Mental Health http://dx.doi.org/10.4082/kjfm.2016.37.2.97www.kjfm.or.kr   99 matitis, myocardial infarction, chronic kidney disease, diabetes melli- tus, hypertension, dyslipidemia, and stroke, and subsequently classi-fied number of chronic disease into 3 groups: 0, 1, 2, or more.",Non-OADS,/arxiv_data1/oa_pdf/a3/2c/kjfm-37-97.PMC4826998.pdf
• Relationship of Secondhand Smoking with Mental Health 100  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.97 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/a3/2c/kjfm-37-97.PMC4826998.pdf
• Relationship of Secondhand Smoking with Mental Health http://dx.doi.org/10.4082/kjfm.2016.37.2.97www.kjfm.or.kr   101 5.,Non-OADS,/arxiv_data1/oa_pdf/a3/2c/kjfm-37-97.PMC4826998.pdf
"• Relationship of Secondhand Smoking with Mental Health 102  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.97 DISCUSSION A study conducted in the United States between 2011 and 2012 report - ed that 21.3% of adults aged 20 and older were exposed to secondhand  smoking,20) whereas this study found 50.3% of adults in South Korea  are exposed, which is more than twice as high as the US population.",Non-OADS,/arxiv_data1/oa_pdf/a3/2c/kjfm-37-97.PMC4826998.pdf
• Relationship of Secondhand Smoking with Mental Health http://dx.doi.org/10.4082/kjfm.2016.37.2.97www.kjfm.or.kr   103 chemical approach such as using the cotinine level.,Non-OADS,/arxiv_data1/oa_pdf/a3/2c/kjfm-37-97.PMC4826998.pdf
• Relationship of Secondhand Smoking with Mental Health 104  www.kjfm.or.kr http://dx.doi.org/10.4082/kjfm.2016.37.2.97 cents.,Non-OADS,/arxiv_data1/oa_pdf/a3/2c/kjfm-37-97.PMC4826998.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Bone Marrow Transplantation website (http://www.nature.com/bmt)Letter to the Editor 597 © 2016 Macmillan Publishers Limited Bone Marrow Transplantation (2016) 596 –597",Non-OADS,/arxiv_data1/oa_pdf/96/b9/bmt2015290a.PMC4827003.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)Mutant GCK in treating diabetes GL u et al 329 © 2016 Macmillan Publishers Limited Gene Therapy (2016) 323 –329",Non-OADS,/arxiv_data1/oa_pdf/0d/1e/gt20161a.PMC4827006.pdf
"Available at http://seer.cancer.gov/csr/1975_2004/.4 Chanan-Khan AA, Giralt S. Importance of achieving a complete response in multiple myeloma, and the impact of novel agents.",Non-OADS,/arxiv_data1/oa_pdf/7c/b9/bmt2015307a.PMC4827007.pdf
Available at http://www.clinicaltrials.gov/ct2/show/ NCT01734928?term = OPTIMISMM&rank = 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/b9/bmt2015307a.PMC4827007.pdf
A phase 3 study comparing oral IXAZOMIB plus lenalidomide and dexamethasone versus placebo plus lenalidomide and dexamethasone in adult patients with relapsed and/or refractory multiple myeloma.Available at http://www.clinicaltrials.gov/ct2/show/NCT01564537?term =NCT01564537&rank = 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/b9/bmt2015307a.PMC4827007.pdf
Available at http://www.clinicaltrials.gov/ct2/show/NCT01985126?term = NCT01985126&rank = 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/b9/bmt2015307a.PMC4827007.pdf
Available at http://www.clinicaltrials.gov/ct2/show/NCT02076009?term = NCT02076009&rank = 1.,Non-OADS,/arxiv_data1/oa_pdf/7c/b9/bmt2015307a.PMC4827007.pdf
Addition of daratumumab to combination of bortezomib and dexamethasone in participants with relapsed or refractory multiple myeloma.Available at http://www.clinicaltrials.gov/ct2/show/NCT02136134?term = dar atumumab&rank = 7.,Non-OADS,/arxiv_data1/oa_pdf/7c/b9/bmt2015307a.PMC4827007.pdf
Available at http://www.clinicaltrials.gov/ct2/show/NCT01239797 (Accessed 14 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/7c/b9/bmt2015307a.PMC4827007.pdf
Available at http://www.clinicaltrials.gov/ct2/show/NCT01568866.,Non-OADS,/arxiv_data1/oa_pdf/7c/b9/bmt2015307a.PMC4827007.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Removal of in ﬂamed eWAT attenuates NASH P Mulder et al 684 International Journal of Obesity (2016) 675 –684 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e3/53/ijo2015226a.PMC4827008.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Anemia and ID among mothers and breastfed infants RK Chandyo et al 462 European Journal of Clinical Nutrition (2016) 456 –462 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/eb/98/ejcn2015199a.PMC4827010.pdf
Available at http://issuu.com/msfuk/docs/squeac (accessed 20 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/5c/f3/ejcn2015140a.PMC4827011.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)Long-term outcomes following CMAM in India S Burza et al 444 European Journal of Clinical Nutrition (2016) 437 –444 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/5c/f3/ejcn2015140a.PMC4827011.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on International Journal of Obesity website (http://www.nature.com/ijo)Adipose tissue and gestational insulin resistance H Svensson et al 653 © 2016 Macmillan Publishers Limited International Journal of Obesity (2016) 646 –653",Non-OADS,/arxiv_data1/oa_pdf/8a/81/ijo2015232a.PMC4827013.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Maternal pre-pregnancy BMI, GWG and breastfeeding H Castillo et al 436 European Journal of Clinical Nutrition (2016) 431 –436 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/09/4d/ejcn2015232a.PMC4827014.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.For commercial re-use, please contact journals.permissions@oup.com.Neuro-Oncology Neuro-Oncology 18(5), 679–690, 2016 doi:10.1093/neuonc/nov248 Advance Access date 15 October 2015 679",Non-OADS,/arxiv_data1/oa_pdf/71/f5/nov248.PMC4827040.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ad/c5/10.1177_2325967116639044.PMC4827116.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a1/6c/10.1177_2325967116640263.PMC4827117.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/97/4c/10.1177_2325967116639578.PMC4827118.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 30379 - http://dx.doi.org/10.3402/jom.v8.30379 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30379 - http://dx.doi.org/10.3402/jom.v8.30379",Non-OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
"(genera): Number of corresponding genera.HOMIM and HOMI NGS technologies in microbiome analysis Citation: Journal of Oral Microbiology 2016, 8: 30379 - http://dx.doi.org/10.3402/jom.v8.30379 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30379 - http://dx.doi.org/10.3402/jom.v8.30379",Non-OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
"By using an iterative process toHOMIM and HOMI NGS technologies in microbiome analysis Citation: Journal of Oral Microbiology 2016, 8: 30379 - http://dx.doi.org/10.3402/jom.v8.30379 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30379 - http://dx.doi.org/10.3402/jom.v8.30379",Non-OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
"Genera accounting for 96% of total hits by HOMI NGS are represented.HOMIM and HOMI NGS technologies in microbiome analysis Citation: Journal of Oral Microbiology 2016, 8: 30379 - http://dx.doi.org/10.3402/jom.v8.30379 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 30379 - http://dx.doi.org/10.3402/jom.v8.30379",Non-OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
Available from: http://www.homd.org/ modules.php?op /C30modload&name /C30HOMD&ﬁle /C30index [cited 26 June 2015].,OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
J Oral Microbiol 2015; 7: 27429. doi: http://dx.doi.org/10.3402/jom.v7.27429 6.,Non-OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
doi: http://dx.doi.org/10.1016/j.joen.2015.08.022 16.,OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
"Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample.PNAS 2011; 108(Suppl 1): 4516 /C122.HOMIM and HOMI NGS technologies in microbiome analysis Citation: Journal of Oral Microbiology 2016, 8: 30379 - http://dx.doi.org/10.3402/jom.v8.30379 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/0f/c6/JOM-8-30379.PMC4827145.pdf
"MRI-based brain atrophy rates in ADNI phase 2: acceleration and  enrichment considerations for clinical trials Xue Huaa,i, Christopher R.K. Chinga,b, Adam Mezhera, Boris A. Gutmana, Derrek P. Hibara,i,  Priya Bhatta, Alex D. Leowc,d, Clifford R. Jack Jre, Matt A. Bernsteine, Michael W.  Weinerf,g,h, and Paul M. Thompsona,i,j,k,l,m,n,* the Alzheimer’s Disease Neuroimaging  Initiative1 aImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute,  University of Southern California, Marina del Rey, CA, USA bInterdepartmental Neuroscience Graduate Program, University of California, Los Angeles,  School of Medicine, Los Angeles, CA, USA cDepartment of Psychiatry, University of Illinois at Chicago, College of Medicine, Chicago, IL, USA dDepartment of Bioengineering, University of Illinois at Chicago, Chicago, IL, USA eMayo Clinic and Foundation, Rochester, MN, USA fDepartment of Radiology, University of California, San Francisco, San Francisco, CA, USA gDepartment of Medicine and Psychiatry, University of California, San Francisco, San Francisco,  CA, USA hDepartment Veterans Affairs Medical Center, San Francisco, CA, USA iDepartment of Neurology, Keck School of Medicine, University of Southern California, Los  Angeles, CA, USA jDepartment of Psychiatry, Keck School of Medicine, University of Southern California, Los  Angeles, CA, USA kDepartment of Radiology, Keck School of Medicine, University of Southern California, Los  Angeles, CA, USA lDepartment of Engineering, Keck School of Medicine, University of Southern California, Los  Angeles, CA, USA This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/db/c2/nihms741118.PMC4827255.pdf
A complete listing of ADNI investigators can be found at:  http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf .,OADS,/arxiv_data1/oa_pdf/db/c2/nihms741118.PMC4827255.pdf
"The ADNI-2 dataset Data from all ADNI-2 newly enrolled participants were downloaded from the ADNI Image  Data Archive (IDA, https://ida.loni.usc.edu/ ) on August 7, 2014.",OADS,/arxiv_data1/oa_pdf/db/c2/nihms741118.PMC4827255.pdf
Detailed MRI scanner  protocols for accelerated and nonaccelerated T1-weighted sequences by vendor are available  online ( http://adni.loni.usc.edu/methods/documents/mriprotocols/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/c2/nihms741118.PMC4827255.pdf
©2016TheAuthors.PublishedbyElsevierInc.ThisisanopenaccessarticleundertheCCBY-NC-ND license( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2a/1e/main.PMC4827258.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/ 4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2a/1e/main.PMC4827258.pdf
http://dx.doi.org/10.1016/j.jcte.2016.02.003Journal of Clinical & Translational Endocrinology 4 (2016) 28–31 Contents lists available at ScienceDirect Journal of Clinical & Translational Endocrinology journal homepage: www.elsevier.com/locate/jcte,Non-OADS,/arxiv_data1/oa_pdf/2a/1e/main.PMC4827258.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/82/nihms766426.PMC4827270.pdf
Supplementary data: Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.jpra.,OADS,/arxiv_data1/oa_pdf/d5/82/nihms766426.PMC4827270.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the orginal author(s)and the source are credited.JOURNAL OF COMPUTATIONAL BIOLOGY Volume 23, Number 4, 2016 Mary Ann Liebert, Inc. Pp.",Non-OADS,/arxiv_data1/oa_pdf/27/5a/cmb.2015.0205.PMC4827276.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 18, Number 4, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/dia.2015.0290 252",Non-OADS,/arxiv_data1/oa_pdf/32/94/dia.2015.0290.PMC4827283.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and re- production in any medium, provided the original author(s) and the source are credited.JOURNAL OF NEUROTRAUMA 33:681–687 (April 1, 2016) Mary Ann Liebert, Inc.DOI: 10.1089/neu.2015.4057 681",Non-OADS,/arxiv_data1/oa_pdf/da/4f/neu.2015.4057.PMC4827289.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.TISSUE ENGINEERING: Part C Volume 22, Number 4, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ten.tec.2015.0381 322",Non-OADS,/arxiv_data1/oa_pdf/6d/c3/ten.tec.2015.0381.PMC4827297.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permitsany noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF PALLIATIVE MEDICINE Volume 19, Number 4, 2016Mary Ann Liebert, Inc.DOI: 10.1089/jpm.2015.0478 349",Non-OADS,/arxiv_data1/oa_pdf/09/74/jpm.2015.0478.PMC4827299.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits anynoncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.DIABETES TECHNOLOGY & THERAPEUTICS Volume 18, Number 4, 2016 ªMary Ann Liebert, Inc. DOI: 10.1089/dia.2015.0283 240",Non-OADS,/arxiv_data1/oa_pdf/5d/85/dia.2015.0283.PMC4827300.pdf
"Subdireccio ´nd e Comunicacio ´n Cientı ´ﬁca y Publicaciones, Instituto Nacio- nal de Salud Pu ´blica, 2012. http://ensanut.insp.mx/doctos/ENSANUT2012_Sint_Ejec-24oct.pdf (accessed February 8, 2016).",Non-OADS,/arxiv_data1/oa_pdf/5d/85/dia.2015.0283.PMC4827300.pdf
"2014. https://courses.worldcampus.psu.edu/sp14/psych484/ 001/content/lesson09/lesson09_01.html (accessed February 23, 2014).",Non-OADS,/arxiv_data1/oa_pdf/5d/85/dia.2015.0283.PMC4827300.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncom-mercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ANTIOXIDANTS & REDOX SIGNALING Volume 24, Number 10, 2016 Mary Ann Liebert, Inc.DOI: 10.1089/ars.2015.6508 548",Non-OADS,/arxiv_data1/oa_pdf/81/07/ars.2015.6508.PMC4827317.pdf
"Supplemental Digital Content 2(seeFigure 2S , http://links.lww.com/JCVP/A212) displaysthe stress-strain curve of anterior (A) and posterior (B) tibial artery rings before and after treatment with vonapanitase.",Non-OADS,/arxiv_data1/oa_pdf/ed/27/jcvp-67-305.PMC4827324.pdf
"Treatment with vehicle didnot alter the stress-strain curves (see Figure 2S , panels C and D,Supplemental Digital Content 2 , http://links.lww.com/ JCVP/A212).",Non-OADS,/arxiv_data1/oa_pdf/ed/27/jcvp-67-305.PMC4827324.pdf
"Vehicle treatment did not alter the relationship between stretch and calculated diameter and calculated pressure (see Figure 3SA ,Supplemen- tal Digital Content 3 , http://links.lww.com/JCVP/A213), or the compliance (see Figure 3SC ,Supplemental Digital Content 3 , http://links.lww.com/JCVP/ A213), stress-strain (see Figure 3SE,Supplemental Digital Content 3 , http://links.lww.com/ JCVP/A213), or Einc curves (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/ed/27/jcvp-67-305.PMC4827324.pdf
"calculated pressures tested (see Figure 3SB ,Supplemental Digital Content 3 , http://links.lww.com/JCVP/A213).",Non-OADS,/arxiv_data1/oa_pdf/ed/27/jcvp-67-305.PMC4827324.pdf
"Vonapa- nitase treatment again increased compliance (see Figure 3SD , Supplemental Digital Content 3 , http://links.lww.com/JCVP/ A213) at low pressures, shifted the stress-strain (see Figure 3SF,Supplemental Digital Content 3 , http://links.lww.com/ JCVP/A213) curve to the right, and had no impact on Einc (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/ed/27/jcvp-67-305.PMC4827324.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9e/47/ott-9-2017.PMC4827414.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2017–2018OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2017LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10400 4Prognostic value of IGF-1r expression in  bone and soft tissue sarcomas: comments on a  meta-analysis by Liang et al Chao T u1 Jieyu He2 Zhihong Li3 1Department of Geriatric Surgery,   2Department of Geriatrics,   3Department of Orthopedics and  Institute of Senile and Aging Diseases,   The Second Xiangya Hospital of  Central South University, Changsha,   People’s republic of ChinaDear editor Recently, we read with deep interest a meta-analysis by Liang et al entitled “Prognostic  value of IGF-1R expression in bone and soft tissue sarcomas: a meta-analysis”1 pub- lished in OncoTargets and Therapy .",Non-OADS,/arxiv_data1/oa_pdf/9e/47/ott-9-2017.PMC4827414.pdf
"We take the attitude that  any effort to increase the credibility of meta-analysis should be attached importance Correspondence: Zhihong Li Department of Orthopedics and  Institute of Senile and Aging Diseases,  The Second Xiangya Hospital of Central  South University, People’s Middle road,  Changsha, 410011, Hunan Province,  People’s republic of China Tel/fax +86 731 8529 5167 email xyeyy_geri@126.co m Journal name: OncoTargets and Therapy Article Designation: Letter Y ear: 2016 Volume: 9 Running head verso: Tu et al Running head recto: Prognostic value of IGF-1R expression in bone and soft tissue sarcoma DOI: http://dx.doi.org/10.2147/OTT.S104004",Non-OADS,/arxiv_data1/oa_pdf/9e/47/ott-9-2017.PMC4827414.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9e/47/ott-9-2017.PMC4827414.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/47/ott-9-2017.PMC4827414.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5b/1b/ott-9-2019.PMC4827415.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 2019–2025OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2019Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10370 3The value of extensive transurethral resection in  the diagnosis and treatment of nonmuscle invasive  bladder cancer with respect to recurrence at the  first follow-up cystoscopy Yunkai Qie* hailong hu* Dawei Tian Yu Zhang linguo Xie Y ong Xu changli Wu Department of Urology, The second  hospital of Tianjin Medical University,   Tianjin institute of Urology, Tianjin,   People’s republic of china *These authors contributed equally  to this workObjective:  To evaluate the value of extensive transurethral resection (TUR) in the diagnosis  and treatment of nonmuscle invasive bladder cancer (NMIBC) and its further impact on the  recurrence rate at the first follow-up cystoscopy (RR-FFC).",Non-OADS,/arxiv_data1/oa_pdf/5b/1b/ott-9-2019.PMC4827415.pdf
"The quality of TUR directly affects the  diagnosis, post-TUR treatment, and even the prognosis of NMIBC.correspondence: Yong Xu; changli Wu Department of Urology, The second  hospital of Tianjin Medical University,  Pingjiang road 23, hexi District, Tianjin  300211, People’s republic of china Tel +86 22 8832 8603 Fax +86 22 2827 3211 email yxurologist@163.co m;  wujygc2003@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Qie et al Running head recto: Extensive transurethral resection for nonmuscle invasive BC DOI: http://dx.doi.org/10.2147/OTT.S103703",Non-OADS,/arxiv_data1/oa_pdf/5b/1b/ott-9-2019.PMC4827415.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5b/1b/ott-9-2019.PMC4827415.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/1b/ott-9-2019.PMC4827415.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a8/dd/ott-9-1997.PMC4827416.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1997–2005OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1997Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9692 5expression of PER, CRY, and TIM genes for the  pathological features of colorectal cancer patients Y ong Wang1 Yunsheng cheng1 gang Yu1 Benli Jia1 Zhihang hu1 lijiu Zhang2 1Department of general surgery,   2Department of gastroenterology,   The second affiliated hospital of  anhui Medical University, hefei,   People’s republic of chinaAbstract:  As typical clock gene machinery, period ( PER1 , PER2 , and PER3 ), cryptochrome  (CRY1  and CRY2 ), and timeless ( TIM), could control proliferation, cellular metabolism, and many  key functions, such as recognition and repair of DNA damage, dysfunction of the circadian clock  could result in tumorigenesis of colorectal cancer (CRC).",Non-OADS,/arxiv_data1/oa_pdf/a8/dd/ott-9-1997.PMC4827416.pdf
"In contrast, CRY and PER proteins  form the repression complex, translocating back into the nucleus and interacting with correspondence: lijiu Zhang Department of gastroenterology,  The Second Affiliated Hospital of Anhui  Medical University, 678 Furong  rd,  economic and Technological Development  Zone, hefei 230601, People’s republic  of china email zhanglj_anyi@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Pathological features of colorectal cancer patients DOI: http://dx.doi.org/10.2147/OTT.S96925",Non-OADS,/arxiv_data1/oa_pdf/a8/dd/ott-9-1997.PMC4827416.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a8/dd/ott-9-1997.PMC4827416.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/dd/ott-9-1997.PMC4827416.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/df/dc/tcrm-12-527.PMC4827417.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 527–533Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  527ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9922 4Clinical effects and safety of treating diabetic  macular edema with intravitreal injection  of ranibizumab combined with retinal  photocoagulation Panshi Yan Cheng Qian Wenzhan Wang Yi Dong guangming Wan Yue Chen Department of Ophthalmology, The  First affiliated hospital of Zhengzhou  University, Zhengzhou, People’s  Republic of ChinaBackground:  This study was designed to examine the clinical effects of treating diabetic  macular edema with an intravitreal injection of ranibizumab in combination with retinal  photocoagulation.",Non-OADS,/arxiv_data1/oa_pdf/df/dc/tcrm-12-527.PMC4827417.pdf
"Retinal photocoagulation is  found to be weak at improving vision, although it can effectively relieve DME with a  lasting curative effect.2 One study3 found that patients with DME whose blood sugar Correspondence: Panshi Yan Department of Ophthalmology, The  First Affiliated Hospital of Zhengzhou  University, no 1, Jianshe east Road,  Zhengzhou 450052, People’s Republic  of China email yanpsyps@163.co mJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Y an et al Running head recto: Clinical effects and safety of treating diabetic macular edema DOI: http://dx.doi.org/10.2147/TCRM.S99224",Non-OADS,/arxiv_data1/oa_pdf/df/dc/tcrm-12-527.PMC4827417.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/df/dc/tcrm-12-527.PMC4827417.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/dc/tcrm-12-527.PMC4827417.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/30/32/tcrm-12-515.PMC4827418.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 515–526Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  515ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9847 4Management of children’s acute diarrhea by  community pharmacies in five towns of Ethiopia:  simulated client case study Tadesse Melaku abegaz1 sewunet admasu Belachew1 Tamrat Befekadu abebe1 Begashaw Melaku  gebresilassie1 Fitsum sebsibe T eni2 habtamu gebremeskel Woldie3 1Department of Clinical Pharmacy, school  of Pharmacy, gondar University, gondar,   2Department of Pharmaceutics and social  Pharmacy, school of Pharmacy, College of  health sciences, addis ababa University,   addis ababa, 3Department of hospital  Pharmacy, Debremarkos Teaching and  Referral hospital, Debremarkos, ethiopiaBackground:  Acute diarrhea is the major cause of child morbidity and mortality in low-income  nations.",Non-OADS,/arxiv_data1/oa_pdf/30/32/tcrm-12-515.PMC4827418.pdf
"Acute diarrhea is emerging Correspondence: Tadesse Melaku abegaz Department of Clinical Pharmacy, school of  Pharmacy, gondar University, 15 Bekafa street,  PO Box 196, gondar, ethiopia Tel +251 985 7975 email melakutadesse98@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Abegaz et al Running head recto: Management of children’s acute diarrhea in Ethiopia DOI: http://dx.doi.org/10.2147/TCRM.S98474 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/30/32/tcrm-12-515.PMC4827418.pdf
Or use: http://youtu.be/Sx3ECGLybX EVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/30/32/tcrm-12-515.PMC4827418.pdf
"Available from: http://www.moh.gov.e t. Accessed September 21,  2015.",Non-OADS,/arxiv_data1/oa_pdf/30/32/tcrm-12-515.PMC4827418.pdf
"Available from: http://www.who.int/medicines/areas/ coordination/ethiopia_pharmaceutical.pdfi s. Accessed September 21,  2015.",Non-OADS,/arxiv_data1/oa_pdf/30/32/tcrm-12-515.PMC4827418.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics­and­clinical­risk­management­journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/30/32/tcrm-12-515.PMC4827418.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/32/tcrm-12-515.PMC4827418.pdf
Available from: http://www.moh.gov.et/ documents/26765/0/Health +and+Health+Related+Indicators +2005+E.,OADS,/arxiv_data1/oa_pdf/30/32/tcrm-12-515.PMC4827418.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/20/7a/ott-9-1839.PMC4827419.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 1839–1855OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1839PersPecTivesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S10383 2Pragmatic medicine in solid cancer: a translational  alternative to precision medicine Jan Brábek1 Daniel rosel1 Michael Fernandes2 1Department of cell Biology, Faculty  of science, charles University in  Prague, Prague 2, czech republic;   2Medbase, chapel Hill, N c, UsAAbstract:  The precision medicine (PM) initiative is a response to the dismal outlook in solid  cancer.",Non-OADS,/arxiv_data1/oa_pdf/20/7a/ott-9-1839.PMC4827419.pdf
"Here, we make the case for a shift in research and development (R&D) focus to  relevant clinical outcomes, antimetastasis, and away from tumor shrinkage.2 Tumor correspondence: Jan Brábek Department of cell Biology,  Faculty of science, charles University  in Prague, vinicna 7, 12843 Prague 2,  czech republic email brabek@natur.cuni.c z Journal name: OncoTargets and Therapy Article Designation: Perspectives Y ear: 2016 Volume: 9 Running head verso: Brábek et al Running head recto: Pragmatic medicine in solid cancer DOI: http://dx.doi.org/10.2147/OTT.S103832",Non-OADS,/arxiv_data1/oa_pdf/20/7a/ott-9-1839.PMC4827419.pdf
Available from: http://www.the-scientist.,Non-OADS,/arxiv_data1/oa_pdf/20/7a/ott-9-1839.PMC4827419.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/20/7a/ott-9-1839.PMC4827419.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/7a/ott-9-1839.PMC4827419.pdf
"http://dx.doi.org/10.1016/j.gendis.2015.12.004 2352-3042/Copyright ª2016, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2016) 3,1 1e40",Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ nrm3470 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
November 2015. http://dx.doi.org/10.1038/labinvest.2015.144 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ labinvest.3700509 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/0092- 8674(87)90038-9 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/ abbs/gmr079 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/jcs.00089 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1006/excr.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/nature01611 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2012; 337:59 e64.http://dx.doi.org/10.1126/science.1222879 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1042/BJ20061476 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2012; 364:32 e41.http://dx.doi.org/10.1016/j.ydbio.2012.01.009 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.devcel.2006.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1101/gad.10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2014; 10:61e68.http://dx.doi.org/10.1038/nchembio.1392 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/ S0968-0004(99)01539-X .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1046/ j.1432-1033.2000.01478.x .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/dev.02881 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.M403407200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.devcel.2005 .11.017 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.M802059200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.cell.2006.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1002/ dvdy.22541 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.ydbio.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S0092-8674(00) 81677-3 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/carcin/bgi379 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1002/ dvdy.22067 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ nrd2518 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1124/ pr.57.2.5 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.M609618200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.274.23.16180 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.M508324200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/dev.01045 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/jcs.00451 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2001;412:86 e90.http://dx.doi.org/10.1038/35083601 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
1999;83: 27e37.http://dx.doi.org/10.1016/S0925-4773(99)00046-5 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2009;17: 9e26.http://dx.doi.org/10.1016/j.devcel.2009.06.016 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/sj.onc.1210055 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.C00 0639200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.M20136 4200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1126/ science.275.5307.1787 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/ emboj/16.13.3797 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/emboj/19.10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/ j.jmb.2010.11.013 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.M105148200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1128/MCB.25.11.4371- 4376.2005 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1101/gad.1142603 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1002/jcb.20350 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S0304-419X(97) 00008-5 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/emboj/20.22.6203 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1006/jmbi.2000.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.devcel.2004.10.017 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.bbamcr.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/ j.jmb.2006.04.064 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/ jbc.M111.323337 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.molcel.2004.08.001 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.molcel.2004.08.010 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/sj.onc.1203359 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/hmg/ddn338 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/ hmg/ddn095 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/jcs.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/emboj/20.21.5929 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2006;7:3. http://dx.doi.org/10.1186/1471-2121-7-3 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.ceb.2008.02.001 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1006/bbrc.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/35077108 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.M109.092130 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/dev.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/35035117 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S1097-2765(03) 00427-1 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/jcs.002956 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/dev.013540 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/382638a0 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/emboj/ 19.8.1839 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/emboj/20.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1126/science.281.5382.1509 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/18884 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1073/ pnas.261574498 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1128/MCB.26.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/ jbc.M407810200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.semcancer.2006.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2015;(4):107. http://dx.doi.org/10.1093/ jnci/dju505 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.gde.2015.07.001 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1101/gad.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ncb1508 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ncb1905 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1172/JCI39675 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.275.6.4374 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1242/jcs.026096 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ 18899 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.mcn.2004.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/382595a0 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S1097-2765(00) 80067-2 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/S0925-4773(97) 00125-1 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ 17820 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/34848 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/35083081 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/nature756 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ sj.onc.1208303 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/emboj/cdg599 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
2007;22: 19e28.http://dx.doi.org/10.1359/jbmr.061002 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1074/jbc.M413274200 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1086/318811 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.devcel.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.4161/cc.5.1.2305 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.modgep.2006.08.006 .,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1093/hmg/ 1.2.83 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1038/ng1093-180 .,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.1016/j.cub.,OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/dc/64/main.PMC4827448.pdf
